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Amyloid fibrils spontaneously formed by the aggregation of a diverse class of polypeptides and proteins
are the hallmarks of numerous neurodegenerative diseases (e.g. Alzheimer’s disease and Parkinson’s
disease) and nonneuropathic localized diseases (e.g. Type II diabetes). Among those proteins, amyloidbeta (Aβ) peptides are the most well-known species because of their fibrillar aggregations constituted the
insoluble amyloid deposits in the brain of Alzheimer's patients. After years of studies, the mechanism by
which they nucleate and extend to form amyloid fibrils remains unclear, as so does their fibrillar
structures. In this thesis, I mainly perform atomic force microscopy (AFM) to (1) investigate the kinetics
of surface effects on Aβ12-28 fibril growth and (2) quantitatively characterize the polymorphism
(polymorphic structures) of Aβ40 fibrils in mesoscale using imaging analysis techniques. The first
section demonstrates that the surface-mediated fibrillization can rapidly happen while incubating the lowconcentrated Aβ12-28 peptide solution on the mica substrate within one hour. The formation of surfacemediated fibrils with one-peptide thickness feature, ~0.5 nm, can be imaged by AFM after drying the
samples with an appropriate spin-coating procedure. Furthermore, the incubation time controls reveal the
evolution of the length of surface-mediated fibrils during kinetic growth on the surface. A proposed twodimensional diffusion-limited aggregation model can predict the experimental length evolution that
suggests a diffusion limited aggregation mechanism behind the surface-mediated fibrillization. In the
second section, two distinct methods are developed to quantitatively study the polymorphism of Aβ40
fibrils at various length scales. One utilizes the height histograms of AFM images to correct for the tipdilation effect and provide the relative volume content of various species at mesoscale. The other is
performed the high-resolution AFM equipped with ultrasharp tip to identify the molecular basis of various
polymorphs at molecular-level. Overall, our AFM works provide a guideline for accurate studies on
aggregation mechanism, amyloid polymorphism, and fibrillar structures, that are critical in advancing the
field.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Chemistry

First Advisor
Zahra Fakhraai

Second Advisor
Tobias Baumgart

Keywords
Amyloid-beta peptides, Amyloid Fibrils, Atomic Force Microscopy, Polymorphism, Surface-Mediated
Fibrillization

Subject Categories
Biophysics | Physical Chemistry

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2427

INVESTIGATING THE FORMATION AND STRUCTURE OF AMYLOID FIBRILS
IN SOLUTION AND ON SURFACE
Yi-Chih Lin
A DISSERTATION
in
Chemistry
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2017

Supervisor of Dissertation

________________________
Dr. Zahra Fakhraai, Assistant Professor of Chemistry

Graduate Group Chairperson

________________________
Dr. Gary A. Molander, Hirschmann-Makineni Professor of Chemistry

Dissertation Committee
Dr. Tobias Baumgart, Associate Professor of Chemistry
Dr. Feng Gai, Professor of Chemistry
Dr. Amish J. Patel, Assistant Professor of Chemical and Biomolecular Engineering
Dr. E. James Petersson, Associate Professor of Chemistry

ACKNOWLEDGMENT
First, I am extremely grateful to my research supervisor, Zahra Fakhraai, for her close
mentorship and guidance throughout my studies. Thank you Zahra. Your diligence,
ingenuity, patience, and kindness help me grow as a research scientist. Your advice on
both research as well as on my career have been priceless. I also want to give my gratitude
to my dissertation committee members, Dr. Tobias Baumgart, Dr. Feng Gai, Dr. Amish
Patel and Dr. E. James Petersson. Your feedbacks and advices during past committee
meetings have pushed my research forward, and I am very fortunate to learn from all of
you. I also really appreciate the opportunity to work with distinguished collaborators: Dr.
E. James Petersson, Dr. Paul H. Axelsen, Dr. Hiroaki Komatsu, Dr. Jianqiang Ma, Dr.
Yanxin (Jerri) Wang, Dr. Tomohiro Tanaka, John J. Ferrie, Dr. Conor Haney, Dr. Milton
H. Repollet-Pedrosa, Dr. Tobias Baumgart, Chun Liu, and Vinicius Ferreira. I also want to
thank my former research supervisor Dr. Pi-Tai Chou at National Taiwan University for
his moral support.

I thank all of my lab mates, Tianyi Liu, Chen Li, Yue Zhang, Etha Glor, Zhaoxia Qian,
Simon Hastings, Guoyu Yang, William Zhang, Mu Li, Yuetong Kang, Jennifer Saouaf,
Mahima Shah, Lindsey Klinge, Paul Straus, Patricia Campos, Michael Thees, Kareem
Wahid, Rachel Margulies, Richard Potter, Eric Chen, Sarah Wolf, Melissa Vettleson, Gabe
Angrand, Sharareh Tavaddod, Haonan Wang, Connor Woods, Aixi Zhang, Subarna
Samanta, and Richard Stephens for their friendship and help in Zahra's lab. You are all
very nice and I will miss the time that we worked together.

ii

Friends at Penn, Chun-Wei Lin, Chun Liu, Chih-Jung Hsu, ZhengZheng Liao, Wan-Ting
Hsieh, Yu-Hsiu Wang, Chi-Mon Chen, Yi-Ju Chen, Zheng Shi, Shi Liu, TingTing Wu,
Zhiming Chen, Xinle Liu, Yi Fang, Fang Liu, Hongwei Li, Qingjie Lo, Jing Yang, Bo Li,
Xing Chen, Mengnan Zhang, Wenhao Liu, Tian Qiu, without you I would not make it
through to this point.

Finally, I want to thank my family. My parents and brother have always supported me in
everything. I greatly miss my Dad and I wish he is proud of me. Mom and Yi-Hsien, thank
you for your encouragement, thank you for your perspective, and thank you for your love.

iii

ABSTRACT
INVESTIGATING THE FORMATION AND STRUCTURE OF AMYLOID
FIBRILS IN SOLUTION AND ON SURFACE
Yi-Chih Lin
Zahra Fakhraai

Amyloid fibrils spontaneously formed by the aggregation of a diverse class of polypeptides
and proteins are the hallmarks of numerous neurodegenerative diseases (e.g. Alzheimer’s
disease and Parkinson’s disease) and nonneuropathic localized diseases (e.g. Type II
diabetes). Among those proteins, amyloid-beta (Aβ) peptides are the most well-known
species because of their fibrillar aggregations constituted the insoluble amyloid deposits
in the brain of Alzheimer's patients. After years of studies, the mechanism by which they
nucleate and extend to form amyloid fibrils remains unclear, as so does their fibrillar
structures. In this thesis, I mainly perform atomic force microscopy (AFM) to (1)
investigate the kinetics of surface effects on Aβ12-28 fibril growth and (2) quantitatively
characterize the polymorphism (polymorphic structures) of Aβ40 fibrils in mesoscale using

imaging analysis techniques. The first section demonstrates that the surface-mediated
fibrillization can rapidly happen while incubating the low-concentrated Aβ12-28 peptide
solution on the mica substrate within one hour. The formation of surface-mediated fibrils
with one-peptide thickness feature, ~0.5 nm, can be imaged by AFM after drying the
samples with an appropriate spin-coating procedure. Furthermore, the incubation time
controls reveal the evolution of the length of surface-mediated fibrils during kinetic
growth on the surface. A proposed two-dimensional diffusion-limited aggregation model
iv

can predict the experimental length evolution that suggests a diffusion limited aggregation
mechanism behind the surface-mediated fibrillization. In the second section, two distinct
methods are developed to quantitatively study the polymorphism of Aβ40 fibrils at various
length scales. One utilizes the height histograms of AFM images to correct for the tipdilation effect and provide the relative volume content of various species at mesoscale. The
other is performed the high-resolution AFM equipped with ultrasharp tip to identify the
molecular basis of various polymorphs at molecular-level. Overall, our AFM works provide
a guideline for accurate studies on aggregation mechanism, amyloid polymorphism, and
fibrillar structures, that are critical in advancing the field.
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CHAPTER 1. Introduction
The accumulation of amyloid deposits mostly composed of a specific protein or peptide is
the pathological hallmark of several neurogenerative diseases and non-neuropathic
amyloidosis, as listed in Figure 1-1.1–4 These disease-related proteins are different in
sequences, native structures and physiological functions, but their misfolded aggregation
can generally form filamentous structures with a common feature of cross-β-sheets
orientated along the fibril axis.5–8 Such highly ordered, self-associated structures are wellknown as amyloid fibrils, the main components that organized into amyloid deposits.8–12
Therefore, the mechanism of amyloid formation and its association with disease’s progress
are of great current interest in biomedical research.2–4,9,11,13–20 For neurodegenerative
diseases, Alzheimer’s disease (AD) accounts for up to 60-80% of dementias and exhibits
the pathological symptoms of extracellular β-amyloid plaques (amyloid-β peptides) and
intracellular neurofibrillary tangles (tau proteins).21,22 In 2010, about 4.7 million
Americans suffer the AD, and the number is expected to increase to 13.8 million in 2050.23
Worldwide, the number of patients with dementia is predicted to rise from 35 million in
2010 to 115 million in 2050.24 Up to date, the therapeutic treatment only can improve the
symptoms, but there is no cure available.21,25–27 Due to the urgent demands in medical
therapies, a great number of research is focused on the detailed mechanism of fibril
formation and fibrillar structures to prevent and cure AD. In this chapter, the fundamental
background of AD and recent progress in the aggregation mechanism and fibrillar
structures of amyloid β peptides will be introduced as the motivation of this work.
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Figure 1-1. Some human diseases associated with protein misfolding and amyloid
aggregation. Reprinted with permission from Tuomas P. J. Knowles, Michele
Vendruscolo, Christopher M. Dobson, Nat. Rev. Mol. Cell Biol. 15, 384–96 (2014).
Copyright 2014 Nature Publishing Group.

1.1 Alzheimer’s Disease and Amyloid-β peptides
1.1.1 Alzheimer’s Disease
AD is an age-related neurogenerative disorder with the progress of cognitive
impairment, including memory and thinking skills.28 One of the pathological hallmarks of
AD is the senile plaques formed at the extracellular space in brain tissues, which were first
identified by Dr. Alois Alzheimer in 1907.29 The correlation between AD symptoms and
amyloid-β (Aβ) peptides was then discovered by Masters et al.30 and Tanzi et al.31 until
1980s. It has been shown that Aβ peptides are the main components composed of these
insoluble amyloid plaques.25,26,32–34 However, even after years of study, the aggregated
2

states of Aβ peptides and their association with neuron toxicity remain unclear due to
many factors involved in the AD pathogenesis.22,26,35–38 Several hypotheses have been
proposed as the cause of AD.8,38–43 The most well-known one is the amyloid cascade
hypothesis that describes the Aβ aggregates, including fibrils and plaques, are the
pathogenic agents triggered the toxicity in AD.44–49 The other famous theory is the
oligomer cascade hypothesis, which suggests the Aβ oligomers are the main toxic species
involved in the early stage of AD.41,50–52 Most recently, an integrative model combined with
Aβ fibrils and toxic oligomers has been proposed to explain the role of toxic microglia in
the inflammation hypothesis of AD.53–62 To date, it is still controversial in identifying the
toxic Aβ species for AD.

1.1.2 Amyloid β Peptides
In normal brain, the concentration of amyloid-β (Aβ) peptides are constantly at a
low level (~picomolar), and potentially serve several physiological functions in synaptic
activity and neuronal survival.63 They are produced from amyloid precursor protein (APP),
a type 1 transmembrane glycoprotein expressed in various tissue64, after the sequential
cleavage by β- and γ-secretase (Figure 1-2, amyloidogenic cleavage). Since γ-secretase can
cut at neighboring positions on C-terminus, Aβ peptides are a group of peptides with a
sequence length ranging from 36-43. Based on the fibrillar structures, the hydrophobic Cterminus and central hydrophobic residues (-LVFFA-) are considered as the main core for
Aβ aggregation.26,65 The fibrillization of Aβ fragments further showed that the central
hydrophobic residues (-LVFFA-) is the self-recognition region for β-sheet formation.66–72
In physiological conditions, the major components of Aβ peptides are Aβ40 (~80-90%) and
Aβ42 (~5-10%).25,73 Both peptides have the tendency to form oligomers and fibrils, and play
3

a key role in the formation of amyloid plaques in the brain of Alzheimer’s patients. 12,19,74–
76

Therefore, their aggregation mechanism and fibrillar structures have been investigated

extensively in the past two decades.5,8,12,19,25,35,66,73–79 It is interesting to address that the
Aβ42 is easier to aggregate into oligomeric forms than Aβ40 due to the two additional amino
acids at the C-terminus.78–80

Figure 1-2. Schematic representation of amyloid precursor protein (APP) and its
cleavage by α-, β-, and γ-secretases. (Top) The non-amyloidogenic and amyloidogenic
cleavage of APP produce the Aβ(17-40/42) and Aβ(1-40/42), respectively. Both cleavages
are sequentially cleaved by α- or β-secretase, and then by γ-secretase. The AICD means
APP intracellular domain. (Bottom) Amyloid acid sequence of Aβ(1-42). Black: flanking
APP residues; Red: Cu2+-binding residues; Blue: hydrophilic residues; Green:
hydrophobic residues; Underlined: self-recognition region. Aβ peptides have a hydrophilic
N-terminus and a hydrophobic C-terminus. Reprinted with permission from Masha G.
Savelieff; Sanghyun Lee; Yuzhong Liu; Mi Hee Lim; ACS Chem. Biol. 2013, 8, 856-865.
Copyright 2013 American Chemical Society.
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1.2 The Aggregation Mechanism of Amyloid β Peptides
1.2.1 Aggregation in Solution Phase (3D)
The formation of amyloid fibrils generally involves the morphological transitions
from native monomers to filamentous structures with multiple cross-β-sheets oriented
along the fibril axis (Figure 1-3).81 Therefore, numerous tools can be used to monitor the
aggregation processes via the change in size, intermolecular distance, secondary structure,
or morphology.73,82–86 The evolution in secondary structures can be monitored by
spectroscopic techniques, e.g. thioflavin T (ThT) fluorescence assay, CD spectroscopy, IR
spectroscopy.84,87 Single molecule imaging techniques82,86,88,89, such as transmittance
electron microscopy (TEM) and atomic force microscopy (AFM) are commonly used to
visualize the morphological changes.
For most amyloid proteins (including Aβ peptides), the aggregation mechanism in
solution phase can be described by a nucleation dependent polymerization (NDP). 90 The
general driving forces include intermolecular hydrogen bonding, hydrophobic and
electrostatic interactions between the backbones and sidechains, and chain entropy.91,92 In
this mechanism, the formation of structured oligomers (Figure 1-3) is the ratedetermining step (RDS) for amyloid fibrillization, which requires the bulk concentration
to be higher than a critical concentration for nucleation (~ in tens of μM).73 Under
quiescent conditions, the primary nucleation process is usually slow and takes an amount
time ranged from hours to weeks before fibrillization (depending on the bulk
concentration). Both critical concentration and lag time are sensitive to the protein
properties, solution conditions (pH, ions, buffer solution) and environments (temperature
and chemical molecules). Once the structured oligomers exist, the later elongation
controls the formation protofilaments and mature fibrils. Adding seeds (oligomers or
5

fibrils) to the solution or shaking the solution (caused fragmentation) can facilitate the
fibril’s formation. This suggests the amyloid fibrillization is governed by not only the
primary nucleation, but also the other catalyzed processes.

Figure 1-3. Scheme representing the mechanism of the conversion of globular proteins
into amyloid fibrils commencing from partially unfolded conformation and proceeding
through the protofibrillar structures (oligomers and protofilaments) into mature fibrils.
Oligomers are assembled from either unfolded protein refolded into a cross-β-sheet or by
short fragments (also folded into cross-β-sheets), which are obtained by hydrolysis of the
monomeric form of the proteins. Reprinted with permission from Jozef Adamcik;
Raffaele Mezzenga; Macromolecules 2012, 45, 1137-1150. Copyright 2011 American
Chemical Society.
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Among different tools, ThT fluorescence assay is the most widely used in vitro
technique to monitor the formation of structures with a cross-β conformation, like
amyloid fibrils.93 In Figure 1-4, the red curve shows a typical ThT fluorescence response
as a function of time in an aggregation trial without agitation. Starting from a solution only
has monomeric forms of amyloid protein, the steep increase of ThT fluorescence intensity
separates the periods of nucleation (lag phase) and fibrillization (growth phase). Once no
new fibrils form, the ThT fluorescence intensity reaches a stationary phase (plateau). The
growth phase can be more or less sharp depending on the dominant underlying
mechanism.80 It is worth noting that the existing fibrils can assemble into more complex
structures during the stationary phase. Adding seeds can effectively shorten the lag time,
as indicated by green curve in Figure 1-4. In kinetic viewpoint, this can be explained by
lowering the kinetic energy barrier of fibrillization, but the details need further studies.

Figure 1-4. The responses of thioflavin T (ThT) fluorescence intensity as a function of
time during fibrillization. The red curve is under a quiescent condition. Green curve is
adding seeds in the beginning of an aggregation trial.
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Besides the primary nucleation, Ferrone et al.94 first introduced that the surface of
preexisting filaments composed of sickle haemoglobins can be served as template for
generating the additional nuclei, which is denoted as the secondary nucleation 94–97. The
same process can be identified in the fibrillization of other amyloid proteins, including
short amylin (islet amyloid polypeptide) fragment97, tau protein98, Aβ peptide99,100 and αsynuclein protein101. Knowles et al.79,80,99,101–106 proposed several kinetic models combined
with ThT fluorescence response curve to explore the detailed mechanism of fibrillization
under various experimental conditions. In principle, the number of nucleus influences the
length of lag phase that elucidates the seeding effects on amyloid fibrillization.83,106–108 The
secondary nucleation and fragmentation can facilitate the growth kinetics and change the
slop and shape of ThT fluorescence response curve at growth phase.83,108
For Aβ peptides, both Aβ40 and Aβ42 can process primary and secondary nucleation
to form amyloid fibrils under quiescent conditions.79,99 The primary nucleation is
dominated in the low monomer concentration at early time due to no aggregates supplied
for secondary nucleation. There are near two order of magnitudes difference on the
primary nucleation rates between Aβ40 ( 2×10−6 M −2 s−1 ) and Aβ42 ( 3×10−4 M −2 s−1 ),
which results that Aβ42 can aggregate into fibrils in a relatively low monomer
concentration. In the high monomer concentration, the secondary nucleation becomes
RDS for fibrillization because the primary nucleation occurs quickly. The rates of
secondary nucleation are determined as 3×103 M−2 s −1 for Aβ40 and 104 M −2 s −1 for Aβ42.
The secondary nucleation is important for Aβ40 to overcome the slow primary nucleation.
These kinetic studies indicate the two additional amino acids at the C-terminus of Aβ42
(residues 41 and 42) plays a certain role in facilitating the amyloid fibrillization via both
primary and secondary nucleation.
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1.2.2 Aggregation on Surface (2D)
Even though the other catalyzed processes can facilitate the fibril formation in
solution, the monomer concentration still needs to be higher than a critical concentration
for nucleation, which is near 20 μM for Aβ ppetides.26,78 But, the concentration of Aβ
peptides in physiological fluids (10-12 〜10-9 M)109,110 is several orders of magnitude lower
than this critical concentration. The disparity in peptide concentration implies that other
mechanisms may control the formation of amyloid fibrils in vivo. Because Aβ peptides are
inherited from the membrane domain of APP, they exhibit the amphipathic characters of
interacting with lipids or proteins on membrane surface.111–116 Thus, membrane-assisted
fibrillization has been suggested as an alternative pathway to govern the formation of
amyloid fibrils in vivo. Several studies indicate that membrane-amyloid interactions can
modulate fibrillization by increasing the local concentration on two-dimensional (2D)
space, lowering the interfacial energy for aggregation, and inducing a preferred
orientation in the bound proteins.16,26,117,118 These membrane effects are also highly
associated with the oligomer cascade hypothesis that assumes the toxic oligomers
interfere with membranes. However, the membranes in vivo are too complex to directly
obtain their influence on protein aggregation, which causes the membrane-assisted
fibrillization is only distinguished for Aβ peptides and α-synuclein proteins (another
amyloid protein related to Parkinson’s Disease).
In recent years, to mimic the surface properties given by membranes, many
artificial surfaces or interfaces have been used to investigate the interfacial effects of
hydrophobicity, charge, molecular chirality, and crowded molecules on the aggregation of
amyloid fibrils.119–130 The air-water interface (AWI) is initially introduced in the bulk
solution under agitation and shacking conditions, and can be considered as a special case
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of hydrophobic interface.131–134 Several experiments demonstrate that AWI can accumulate
amyloid proteins126,135–137, induce secondary structures changes135,136, and then accelerate
the fibril formation125,138,139. Similar processes can also be observed at the solid-liquid
interfaces, ranging from hydrophilic surfaces119,140,141, hydrophobic surfaces141–144,
nanoparticles with various chemistry122,124,145,146, charged lipid menbrane16,120,147–178, chiral
surfaces179–181, and surface coated with biomolecules182–187. Among above studies, only a
few works investigate on the surface-mediated fibrillization in low monomer
concentration, at least below the critical concentration.140,143,144,181,188 Their results show
that the enhanced fibril formation and aggregation rates under these conditions requires
mobile surface precursors143, high surface concentration140, and preferred orientation of
adsorbed proteins181. The change in dimensionalities from solution to surface increases
the local concentration and the probability of encounter for aggregation. These features
are similar to the membrane-assisted fibrillization and reveal the importance of
interactions of amyloid peptides with surfaces and interfaces in mediating fibril growth at
physiologically relevant concentrations.16,26,117,118 However, the detailed mechanism of
surface-mediated fibrillization remains unclear.
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1.3 Polymorphism of Aβ Fibrils
Amyloid fibrils are structurally composed of one or several filamentous
substructures (protofilaments) self-assembled by the amyloid proteins with a cross-β
motif189, determined by X-ray diffraction experiments (Figure 1-5)5,190,191 and supported by
electron diffraction192, electron microscopy193 and solid-state nuclear magnetic resonance
(ssNMR)194. The cross-β structure represents the backbone hydrogen bonds attach βstrands of amyloid proteins with an interstrand spacing ~4.7 Å to form a β-sheet plane
structures orientated in the direction paralleled to the main fibril axis (Figure 1-5B). The
sharp and bright meridional reflection in Figure 1-5A indicate the low variability and high
repetition of the underlying molecules along the fibril axis. Typically, amyloid fibrils
contain more than two cross-β layers stacked via the side-chain interactions that show the
weak reflection at ~10 Å in equatorial direction. This intersheet spacing ranges from 8.8
to 14.6 Å and highly depends on the peptide sequence constructing the fibril structure. 195
Thus, the structure of amyloid fibrils is variable in the fibril cross-section. Recently, the
cross-β motifs (steric zippers, Figure 1-5B) have been revealed in the crystallographic
studies of microcrystals contains short peptide segments196,197, but not for full-length Aβ
peptides due to the lack of suitable crystals. In the past two decades, the building blocks
of A fibrils also have been extensively studied using the other spectroscopic techniques,
such as ssNMR12,19,74–76,198–205 and two-dimensional infrared spectroscopy (2D-IR)206–210.
However, the detailed structures remain unclear because the diverse polymorphic
structures (polymorphism) spontaneously form in most of in-vivo and in-vitro
samples.7,19,74,100,199,201,211–233 These spectroscopic techniques can only provide an average
picture for the polymorphic structures, but the variance among different polymorphs is
undetectable.
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Figure 1-5. Cross‐β structure of amyloid fibrils. (A) Cartoon representation of a cross-β
X‐ray diffraction pattern. The defining features are a meridional reflection at ~4.7 Å and
an equatorial reflection on the order of ~10 Å . The ~4.7 Å reflection is generally much
brighter and sharper than the reflection at ~10 Å . (B) The cross‐β core structure of amyloid
fibrils. Parallel β‐sheets are depicted, but the structure could equivalently be composed of
antiparallel β‐sheets or a mix of parallel and antiparallel. The ~4.7 Å spacing of β‐strands
within each β‐sheet is parallel to the long fibril axis. The depicted ~10 Å sheet‐to‐sheet
spacing actually ranges from about 5 to 14 Å 195, depending on the size and packing of amino
acid side chains. Amyloid fibrils have diameters on the order of 100 Å . Reprinted form
publication In Advances in Protein Chemistry, Vol. 73, Nelson, R. and Eisenberg, D.,
Structural Models of Amyloid‐Like Fibrils., pp. 235–28, Copyright (2006), with
permission from Elsevier.
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As introduced in Section 1.2, amyloid fibrils are the end products of a complex
fibrillation pathway that proceeds from abundant intermediates.16 Therefore, a
complicated interplay between protein structure, environmental conditions, and
aggregation pathways appears to influence the rate of formation and morphology
of these fibrils.79,80,101 In Figure 1-6B, the polymorphism of amyloid fibrils can be either
defined as the difference between the number and relative orientation of underlying
protofilaments (morphological polymorphism), or the variations in the protofilament’s
substructure (molecular-level polymorphism). Single particle imaging tools, such as
transmission electron microscopy (TEM) and atomic force microscopy (AFM), are widely
used to identify morphological polymorphs based on their characteristic widths, heights,
or crossover distances.214,234 An example of morphological polymorphism caused by the
protofilament number and orientation is demonstrated in Figure 1-6A (fibrils labeled with
1, 2 and 3). The isomorphous fibrils 1, 1′ and 1′′ indicates the different bending geometries
along the fibril axis. Because of the lack of structural information, both imaging tools are
insufficient to distinguish the molecular-level details of fibril structures. The molecularlevel polymorphism can only be monitored by spectroscopic techniques (e.g. ssNMR19 and
2D-IR210) or a variety of diffraction techniques (e.g. X-ray scattering190) that offers atomiclevel resolution for the studied amyloid fibrils. However, connecting such information to
the structures observed on mesoscale is quite challenging, especially for quantifying the
number of cross-β motifs within individual protofilament (the fundamental unit of Aβ
fibrils).
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Figure 1-6. Polymorphism and structural deformations of Aβ fibrils. Typical Aβ fibril
samples are affected by heterogeneity, which arises both from the intra-sample
polymorphism of different fibril structures and from their deformations from ideal helical
symmetry (bending and twist variability). (a) Negative stain TEM image of Aβ40 fibrils
illustrating the fibril variability. Fibrils 1, 2 and 3 show fibril polymorphism. Isomorphous
fibrils 1, 1′ and 1′′ differ in bending. The twist variability (crossover distance) of fibril 1 is
highlighted in yellow. (b) Schematic representations of fibril cross-sections to illustrate
three types of fibril polymorphism. Differences depend on the number, orientation or
substructure of the underlying protofilaments. Reprinted form publication Trends in
Biochemical Sciences, Vol. 36, Fändrich, M., Schmidt, M. and Grigorieff, N., Recent
progress in understanding Alzheimer's β-amyloid structures, pp. 338–345, Copyright
(2011), with permission from Elsevier.
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To date, only the mass-per-length (MPL) analysis can be used to impose molecular
constrains on the unstained fibrils imaged by the EM-based techniques, including
STEM199,201,235 and dark-field TEM236. The general concept of this method is that the
scattered electron intensity should be proportional to the mass of imaged objects with a
well-defined packing schemes, like the cross-β motifs within amyloid fibrils.237,238
Combined with morphological features and dimensions, the MPL analysis has been made
a major contribution to our understanding of the protofilaments within various amyloid
fibrils and their structural modeling.201,235,239 However, such analysis usually gives a broad
mass distribution or overestimates the MPL values due to the highly-localized electron
density in compact geometries or retained salts, which increases electron scattering
efficiency of an object.240 Furthermore, the weak scattering intensity could potentially
depress the spatial resolution in identifying morphological features and polymorphic
forms, especially for smaller features consisting of fewer protofilaments or oligomers.
Therefore, in the case of highly polymorphic A40 fibrils, it becomes more difficult to
investigate the association between various polymorphic types and their MPL values. To
improve such deficiency, one needs an imaging tool that can characterize structural
features of individual fibril and measure the quantity parameter (e.g. mass and volume)
on the same fibril.
To overcome the polymorphic problem during the characterization of amyloid
fibrils, a homogeneous pool of monomorphic fibrils or the capability of selecting analytes
is required for further structural characterization and modeling. Figure 1-7 shows the
current existing protofilament models for A40 fibrils. Tycko and his co-workers199–201
utilize the self-propagating property to prepare homogeneous A40 fibrils formed under
different experimental conditions. Figure 1-7A and Figure 1-7B shows the molecular
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structural models for “twisted” and “striated ribbon” fibrils developed from ssNMR and
electron microscopy measurements. Based on ssNMR data, both polymorphs contain Ushape A40 molecules adopted within the protofilament. The U-shape conformations
includes a disordered N-terminal segment, two β-strands in residues 10-22 and 30-40,
and a loop in residues 23-29. Two β-strands segments form similar cross-β motifs with inregister parallel β-sheets. The MPL analysis and TEM data show two-fold and three-fold
symmetric protofilaments within pure striated-ribbon like and twisted A40 fibrils,
respectively.
In contrast to spectroscopic measurements, high resolution cryo-electron
microscopy (cryoEM) can specifically select analyzed fibril and reconstruct 3D topography
of twisted forms of A40 fibrils with the aid of simulations.211,240,241 Grigorieff et al.211,240
demonstrate the 3D profile of an A40 fibril with two-fold symmetry (Figure 1-7 C-E) after
reconstructing the fibril’s electron density map from cryoEM data. Protofilament crosssectional dimensions of 4 × 11 nm have been found in these measurements. A central
region holds near two-fold symmetry, which is sandwiched between two peripheral
protofilaments. Interestingly, within the other 12 chosen A40 twisted polymorph in the
same sample, they are all consistent with the two-fold symmetry demonstrated here.211 For
A42 fibrils, the cryoEM examinations show a peptide dimer structures with a core formed
two peptide C termini, which explains the physiological role of two additional C-terminal
amino acids on the fibril’s formation.239
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Figure 1-7. Structural models of Aβ fibrils. Previous structural models deviate
significantly for the most highly resolved Aβ fibril structures, which were obtained by cryoEM. Hence, the latter encompass a different peptide assembly. (A, B) Structural models
assuming a U-shaped peptide fold; side views and top views shown; only residues 9–40
modeled. (A) Three Aβ40 molecules per cross-sectional layer.201 (B) Two Aβ40 molecules
per cross-sectional layer.200 (C, D) Cryo-EM structure of an Aβ40 fibril (0.8 nm).240 (C, D)
side views, (E) cross-section. Images in (C, E) are superimposed with a β-sheet model,
which is derived from these cryo-EM data, and highlights the peptides forming the crossβ regions in yellow or blue (the lines are not meant to imply continuous β-strands over
their entire length; these regions might instead contain several shorter strands). Images
in (A–C) and (E) are displayed with the same scale. Reprinted form publication Trends in
Biochemical Sciences, Vol. 36, Fändrich, M., Schmidt, M. and Grigorieff, N., Recent
progress in understanding Alzheimer's β-amyloid structures, pp. 338–345, Copyright
(2011), with permission from Elsevier.241
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1.4 Atomic Force Microscopy in Amyloid Studies
Compared to other single particle imaging tools, atomic force microscopy (AFM)
has its advantage to directly visualize 3D morphologies of a nanostructure without staining
or labeling requirements.66,88,234,242,243 Since Binning et al.244 invented AFM in 1986,
this technique had been demonstrated to have an ultimate capability of imaging
oligomeric and fibrilar aggregates on various surfaces, either under ambient or aqueous
environment.100,119,128,141,143,159,188,234,243,245–251 Currently, the resolution of AFM is defined
by the sharpness of scanning probes, typically in the range of 2-10 nm in the lateral
(xy) directions.242,252 This non-invasive and high resolution imaging technique has
been widely used in structural characterization.125,221,234,242,243,245,253–259 For example,
Quist et al.260 used high-resolution AFM to characterize the structures of Aβ 40 tetramers
and hexamers formed in reconstituted membranes, which resemble the ion channels in
cell membranes. Mastrangelo et al.245 monitored the soluble Aβ42 oligomers deposited
from solution phase to mica substrates and illustrated the early stage of fibril growth.
Adamcik et al.234 studied the polymorphism of β-lactoglobulin fibrils through statistical
analysis of AFM images.
Most AFMs offer a temporal resolution with a rate of few minutes per frame to
investigate dynamic processes. This capability of probing dynamic processes has been
widely

applied

to

studying

the

surface

effects

on

amyloid

fibril

formation.42,117,120,121,124,126,127,129,141,142,147,150,162,164,165,170,181,188,261–275 For example, Kowalewski
et al.141 and Blackley et al.119 tracked the time-evolution of Aβ fibrils forming on mica
substrate. Jeong et al.100 observed the secondary nucleation of Aβ40 peptides using in-situ
measurements. Recent progress in AFM instrumental development promotes the frame
rate to seconds (video-rate AFM), which enables studies of rapid process with a high
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spatial resolution. Watanabe-Nakayama et al.276 performed the high-speed AFM to show
two distinct growth modes on the elongation of Aβ42 aggregates.
Besides the imaging capability, AFM can also measure mechanical properties of a
sample (including live cells) via indentation, bending and pulling.81,151,153,158,242,252,259,277–289
For example, Kim et al.290 used dynamic force spectroscopy to measure the stability of
transiently formed Aβ40 dimers. Knowles and Buehler summarized the mechanical
properties of amyloid fibrils in their review article.291 Recently, a peak force quantitative
nanomechanical AFM (PF-QNM) technique was developed. It allows one to obtain
mechanical properties from a wide range of samples at relatively high speed (similar to
standard tapping mode) with high imaging resolution.155,181,213,259,277,278,286,287,292–299
Adamcik et al.292 showed that the Young’s modulus of amyloid fibrils assembled from
several amyloid proteins is fall in the range of 2–4 GPa.
AFM combined with the near-field effects can greatly enhance the spectroscopic
response in Ramen spectrum or IR spectrum, which provides the chemical information
for the imaged samples.300–307 This can overcome the problem with the lack of structural
information during the morphological characterization of amyloid aggregates. Paulite et
al.305 showed the near-field IR spectrum can obtain topography and secondary
information of β2-microglobulin fibrils. Recently developed infrared nanospectroscopy
has been used to characterize the conformational rearrangements of amyloid proteins
during their aggregation.295
After 30 years of development, AFM nowadays can provide both high spatial
resolution and high temporal resolution for characterization of the formation of amyloid
aggregates. The recent developed peak-force image mode can rapidly explore the
mechanical properties of nanostructures. AFM combined with the spectroscopic methods
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can obtain the structural and chemical information at the same time. Those features can
help us understand the amyloid fibrillization from the aspects of morphologies, secondary
structures, and kinetics.

1.5 Summary
In this thesis, I will discuss my PhD work on investigating the formation and
structure of amyloid fibrils in solution and on surfaces. In my studies, AFM is intensively
used as a major technique to study surface-mediated fibrillization of Aβ12-28 peptides on
mica substrate and to characterize the polymorphism of Aβ40 fibrils formed in solution
phase. Several complementary methods, such as ThT fluorescence, cryoEM, TEM, and
MPL analysis, are also used to examine the structures of amyloid aggregates.
In Chapter 2 and 3, a series of experimental controls has been performed to explore
the formation of surface-mediated fibrils in low peptide concentration and the potential
artifacts while preparing the dried samples. In Chapter 4, both experiments and numerical
simulation are performed to investigate the kinetics of surface-mediated fibrillization.
Chapter 5 studies the role of spin-coating process in the preparation of surface-mediated
fibrils samples. Chapter 6 and 7 propose two quantitative analyses to characterize the
polymorphism of amyloid fibrils in different length scale. Chapter 8 demonstrates the
potential future works on amyloid studies.
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CHAPTER 2. Exploring the Formation of Surface-Mediated Fibrils
Reprinted with Permission from Yi-Chih Lin, E. James Petersson and Zahra Fakhraai.
Surface Effects Mediate Self-Assembly of Amyloid-β Peptides. ACS Nano, 2014, 8, 10178–
10186. Copyright 2014 American Chemical Society.

2.1 Abstract
In this work, we present a label-free method for studying the mechanism of surface effects
on amyloid aggregation. In this method, spin coating is used to rapidly dry samples, in a
homogeneous manner, after various incubation times. This technique allows the control
of important parameters for self-assembly, such as the surface concentration. Atomic
Force Microscopy (AFM) is then used to obtain high-resolution images of the morphology.
While imaging under dry conditions, we show that the morphologies of self-assembled
aggregates of a model amyloid-beta peptide, Aβ12-28, are strongly influenced by the local
surface concentration. On mica surfaces, where the peptides can freely diffuse,
homogeneous, self-assembled protofibrils formed spontaneously and grew longer with
longer subsequent incubation. The surface fibrillization rate was much faster than the
rates of fibril formation observed in solution, with initiation occurring at much lower
concentrations. These data suggest an alternative pathway for amyloid formation on
surfaces where the nucleation stage is either bypassed entirely or is too fast to measure.
This simple preparation procedure for high resolution atomic force microscopy imaging
of amyloid oligomers and protofibrils should be applicable to any amyloidogenic protein
species.
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2.2 Introduction
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disease,3,14,17,30,37 as well as other serious conditions such as diabetes308 and amyloidosis.305
Alzheimer’s disease and Parkinson’s disease are among the ten leading causes of death in
the United States, with healthcare costs totaling more than $200 billion annually.309–311
Understanding the molecular mechanisms responsible for the aggregation of meta-stable
soluble proteins into highly ordered cross-β fibrils is central to the prediction and
treatment of these diseases.17,26,308 Indeed, stabilizing non-toxic, soluble forms of these
proteins has emerged as a viable and potentially general therapeutic strategy.312,313
Amyloid-beta (Aβ) peptide, the main component of insoluble plaques in the brains of
Alzheimer's disease patients,1 is one of the most studied amyloid peptides.52,199,314,315
Despite years of study, many questions about the in vivo mechanism of Aβ fibrillization
remain unanswered.
In vitro, Aβ peptide undergoes a nucleation-limited polymerization process to
form fibrils.90,316 Depending on the solution conditions and the peptide sequence, the
nucleation step requires a critical concentration for fibrillization. 26,90,106,317 However, the
critical concentration is usually much higher than the concentration of Aβ peptide under
physiological conditions (~nM range).109 In vivo, membrane-mediated fibril formation
can provide an alternative pathway, with potentially lower barriers for fibrillization.
Previous studies indicate that membrane-amyloid interactions can modulate fibrillization
by increasing the local concentration and inducing a preferred orientation in the bound
proteins.16,26,117,118 Pronchik et al.122 demonstrated that the presence of hydrophobic
interfaces can accelerate fibrillization. Shen et al.143 showed that the existence of a mobile
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fibril precursor near a surface determines fibril formation ability, particularly when the
solution concentration is below the critical concentration. These results reveal the
importance of interactions of amyloid peptides with surfaces and interfaces in mediating
fibril growth at physiologically relevant concentrations. However, the detailed mechanism
of surface-mediated fibril growth remains unexplored and merits further investigation.
It has been suggested that Aβ oligomers and protofibrils formed during the
nucleation stage are neurotoxic and may be the main cause of Alzheimer's disease.314,315,318
Due to limitations in existing experimental techniques, it is extremely difficult to
determine pre-fibrilar structures and understand the mechanisms by which surfaces affect
the early stages of fibril growth at the nanoscale. Fluorescence-based techniques,316,319–322
solid-state NMR spectroscopy199 and 2D infrared spectroscopy206,208 are common methods
used to study fibril growth, but labeling and staining can potentially alter the interactions
at surfaces. Other label-free methods, such as quartz crystal microbalance
measurements323 and electron microscopy324, are only feasible on specific substrates.
Atomic Force Microscopy (AFM) is a powerful imaging technique for studying pre-fibrilar
and fibrilar nanostructures on various surfaces, either in air or in an aqueous
environment.100,119,128,141,143,159,188,234,243,245–251 For example, Mastrangelo et al.245 measured
soluble Aβ42 oligomers adsorbed on mica using high-resolution AFM and Adamcik et al.234
studied fibril structures with statistical analysis. This technique can also be used to study
the growth rate of fibrilar structures if they are adsorbed on a surface. For example,
Kowalewski et al.141 and Blackley et al.119 imaged the time-evolution of fibril formation on
mica, and Jeong et al.100 monitored secondary nucleation in an in-situ measurement.
However, imaging these nanostructures under liquid is not easy due to the instability of
the microscope as well as the motion of the fibrils during imaging. Therefore, only
relatively large structures can be imaged. Furthermore, if the AFM scanning rate is
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comparable to or slower than the fibril growth rate, the results may be hard to interpret.
Additionally, the peptides may adhere to the AFM tip and reduce the resolution or produce
artifacts. On the other hand, drop-casting solutions for imaging under dry conditions can
present other types of artifacts, such as rapid deposition of peptides in some areas of the
surface and inhomogeneous drying. Therefore, it is imperative to develop sample
preparation methods that allow one to control important variables such as surface
concentration, deposition rate and substrate interactions.
Here, we present a simple method that allows one to control these variables
independently, which allows us to reliably study surface mediated fibril formation using
AFM. We show that on surfaces where the peptide can freely diffuse, amyloid protofibrils
rapidly self-assemble, even when the solution concentration is well below the critical
concentration for nucleation. Under these conditions, the nucleation stage is bypassed and
amyloid protofibrils form through a process that resembles diffusion-limited
aggregation.325 We construct the phase diagram of the final fibril length and show that the
morphology of the fibrils on the surface is strongly correlated with the local concentration
of peptides adsorbed on the surface.

2.3 Materials and Methods
2.3.1 Sample Preparation
The synthetic Aβ12-28 peptide was purchased from rPeptide with high purity, >95%, and
directly used without further purification. We dissolved Aβ12-28 in 1 % NH4OH(aq) at a
concentration of 1 mg/ml. Once dissolved, the solution was sonicated for 2 minutes, then
diluted with Milli-Q water to a concentration of either 1 μM or 10 μM. The samples were
filtered with a 0.22 μm PTFE membrane syringe filter to eliminate large aggregates, then
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incubated at room temperature without agitation for two days. As such, the real
concentration was expected to be lower than the reported values. Before preparing dried
samples, the 10 μM sample solution was diluted to 3.33 μM or 6.67 μM by placing 1 or 2
drops of water on the substrate. A 1 μM sample solution was prepared following the same
procedure and diluted to 0.33 μM and 0.67 μM.
2.3.2 Spin Coating Process
The 10 μM sample solution was used to prepare all spun-cast samples. Three droplets of
sample solution were deposited on the mica substrate and incubated for 0, 30, or 60
minutes, then dried using a spin coater (WS-650 MZ-23, Laurell Technologies Corp.) with
different spinning rates. The drying times for spun-cast samples at 1000 and 3000 RPM
were 3 minutes and 30 seconds, respectively. However, the fast fibrilar formation reported
here can be reproduced using fresh solutions with the same concentration.
2.3.3 Cryogenic Transmission Electron Microscopy (Cryo-TEM)
Vitreous cryo-TEM samples of Aβ12-28 were prepared for imaging as follows. A 5 μL droplet
of the amyloid peptide solution (10.0 μM, incubated for 3 days) was placed on a lacy
carbon-coated copper grid (Ted Pella, Inc.) in a humidity and temperature controlled
environment vitrification system (Vitrobot, FEI, Inc.). The humidity was controlled at
100% and the temperature of the chamber was 22.0 ˚C. Then, the sample was blotted to
remove excess solvent and create a thin film of the peptide on the grid surface using a -2
mm blotting force, a 1.0 s blot time, and a 10 s drain time to equilibrate any stresses in the
sample caused by blotting. The resulting sample grid was vitrified by plunge freezing into
liquid ethane (-183 ˚C). A Tecnai T-12 TEM operating at 120 kV was used to obtain the
Cryo-TEM images.
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2.3.4 Atomic Force Microscopy (AFM)
The dried samples were prepared by depositing three droplets of sample solution on the
freshly cleaved mica surface and dried via different methods. The morphologies of
nanostructures on mica were imaged using an Agilent 5500 AFM (Agilent Technologies)
with a multi-purpose XYZ closed-loop scanner. Rotated monolithic silicon probes with
aluminum reflex coating (BudgetSensors, Tap-300G, resonance frequency ~300 kHz, tip
radius of curvature <10 nm, force constant 40 N/m) were used to record topographic,
amplitude, and phase images with 512 x 512 pixel resolution. Imaging under dry
conditions allowed us to achieve high resolution in the Z dimension and observe one
peptide-thick protofibrils. Gwyddion and ImageJ packages were used to analyze the AFM
results. Quantitative analysis methods were provided in the Section 2.6.

2.4 Results and Discussion
2.4.1 Amyloid Structures in Sample Solution
In order to demonstrate surface-mediated self-assembly, we chose a simple
peptide system, Aβ12-28, a fragment of the wild-type Aβ peptide that contains the main
sequence for cross-β aggregation.324,326 Solutions of this Aβ fragment with concentrations
between 0.33 μM and 10 μM were prepared in Milli-Q water. Cryogenic transmission
electron microscopy (Cryo-TEM) images showed no evidence of fibrilar structure in the 10
μM sample solution (Figure 2-1). The solutions with varying peptide concentrations were
then used to prepare self-assembled fibrils on mica substrates by slowly drying the
samples as shown schematically in the top row of Figure 2-2. Only the 10 μM sample
solution was used in our spin coating experiments, depicted at the bottom of Figure 2-2.
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Figure 2-1. Cryo-TEM images of Aβ12-28 sample solution with 10 μM concentration after
incubating for three days. No fibrilar structures were observed.

Figure 2-2. Schematic diagram of different sample preparation methods. Top: Slowlydried sample under ambient conditions. Middle: Samples prepared by spin-coating with
a speed of 1000 RPM after 30 or 60 minutes of incubation. Bottom: Samples prepared by
spin-coating with a speed of 3000 RPM after 30 or 60 minutes of incubation.
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2.4.2 Slow-drying Samples Exhibit Inhomogeneous Morphologies
Three 50 µL droplets of the sample solution were deposited on freshly cleaved mica
and allowed to slowly dry over about ~2.5 hours. Figure 2-3 A-F show the various forms
of fibrils, monolayers and multilayers that were observed on the surface of these films
(more images are shown in Figure 2-4). This ensemble of morphologies can be classified
based on the fibril length, l, and thickness, h. The structures can then be categorized as
short fibrils with l < 1 μm, h < 0.5 nm, (Figure 2-3A), long fibrils with l > 1 μm and h < 0.5
nm (Figure 2-3 B-D), monolayers with random patterns and h < 1 nm, (Figure 2-3E), and
multi-layers with random patterns and h > 1 nm (Figure 2-3F). Fibrilar structures were
observed on the surface at all initial solution concentrations except for the highest
concentrations of 6.67 μM and 10 μM, where multi-layers predominated (see Figure 2-4).
While fibrils were observed on the mica surface using the slow-drying method, we
were unable to further study the specific conditions that lead to the rapid fibrillization, due
to lack of control over the process. For example, the shrinking of the bulk droplet on the
surface during the slow-drying process may gradually increase the peptide's concentration
at the edge of the droplet, resulting in a high local concentration and inhomogeneous
distribution of the peptides on the surface. As a result, it was impossible to distinguish
structures that formed before drying, when the surface coverage was homogeneous, and
structures that formed during drying as a result of the increased local concentration. Other
techniques usually used to quickly remove excess water suffer from similar problems. Brief
descriptions of these techniques and the resulting morphologies are given in the Chapter
3. Similar to slow-drying, the resulting morphologies are not homogeneous and depend
strongly on the method used to dry the sample.
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Figure 2-3. AFM images of Aβ12-28 peptide samples prepared using different drying
methods.

(A-F) Representative images of slowly-dried samples. The solution

concentration is 0.33 μM in (A), 0.67 μM in (B), 0.33 μM in (C), 3.3 μM in (D), 3.3 μM in
(E), and 6.6 μM in (F). (G-L) Representative images of spun-cast samples on mica with
different incubation times and spin speeds. (G) 0 minutes, 1000 RPM, (H) 30 minutes,
1000 RPM, (I) 60 minutes, 1000 RPM, (J) 0 minutes, 3000 RPM, (K) 30 minutes, 3000
RPM, and (L) 60 minutes, 3000 RPM. The drying times for spun-cast samples at 1000
and 3000 RPM of 3 minutes and 30 seconds, respectively, need to be added to the
incubation time. The scale bar is 500 nm for all images. The color frame around each
image highlights the observed morphology and corresponds to the color of phases in the
phase diagram (Figure 2-5).
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Figure 2-4. AFM images of slowly-dried samples. Each column represents different
areas of one sample prepared using the reported concentration of the initial solution
(black) and the concentration of the final solution (blue).

2.4.3 Spin-coating Process Reveals Surface-Mediated Fibrillization
In order to probe the mechanisms leading to self-assembly and fibril formation,
important variables such as the surface and bulk concentrations, the deposition rate, and
the duration of the deposition need to be controlled independently. We used spin coating
to control the drying process and maintain uniform surface coverage during self-assembly.
A combination of certain pre-spin incubation times and spin rates allowed for precise
control of the peptide concentration on the surface, and therefore the aggregate
morphology, as schematically shown in Figure 2-2. Figure 2-3 G-L show some of the
structures obtained after spin coating. When the spin rate was slow (1000 RPM),
homogeneously distributed fibril-like structures were observed on the surface. The
structures grew in length with longer incubation times (Figure 2-3 G-I). In contrast, at the
fast spin rate (3000 RPM), globular structures predominated on the surface of all samples.
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At zero incubation time (Figure 2-3J), the samples did not contain the other types of
nanostructures observed under slow-drying and slow-spinning conditions, while some
fibrilar structures were observed underneath the globular structures at longer incubation
times (Figure 2-3 K-L). We note that under the two spin rates used in this study, 1000
RPM and 3000 RPM, the drying time was 3 minutes and 30 seconds, respectively. This
defined the shortest incubation times available in these experiments and effectively
increased the incubation times reported in Figure 2-3.
Spin coating involves dispensing a solution onto a substrate, then spinning to
achieve a uniform film, or uniform surface coverage. During fast spinning, the centrifugal
force is strong enough to break the solution film into many small droplets on the surface
as shown schematically in the bottom of Figure 2-2. Because of the low bulk concentration,
each droplet may contain a dilute mixture of monomers, oligomers, and micelles. Rapid
drying under fast-spinning conditions prevents the peptides from further rearrangement
and self-assembly, and allows us to study the structure of the peptides as they existed in
solution (Figure 2-3J). The fact that fibrils are not observed in these samples, further
confirms that the original solution is fibril-free. When the samples are incubated for 3060 minutes (Figure 2-3K and L), some peptides are deposited on the surface and have a
chance to self-assemble before the droplet is broken and rapidly dried. In contrast to the
non-incubated case, the fact that here we observe fibrils underneath globular structures,
provides strong evidence that the fibrilar structures formed during incubation. This
suggests that during the incubation period some peptides were adsorbed on the surface
and had a chance to diffuse and self-assemble on the surface before rapid drying by fastspinning.
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2.4.4 Local Concentration Determines the Surface Morphology
Below, we discuss the details of the assembly process using the data obtained by
the slow-drying and the slow-spinning processes. The observation of various
morphologies for a single bulk concentration during slow drying indicates that the bulk
concentration does not play a major role in the surface-mediated self-assembly of these
peptides. The variations in the morphology are instead, probably correlated with the local
concentration of peptides, which can strongly vary on the surface due to inhomogeneous
drying and coffee-stain effects during slow drying,327 as shown schematically in the top of
Figure 2-2. The morphological heterogeneity observed within a sample, such as the 3.33
μM sample with long fibrils, monolayers, and multilayers (Figure 2-4), implies that the
local concentration may determine the observed morphologies. When the local
concentration was too high, monolayers or multilayers formed, while at lower local
concentrations, elongated fibrilar structures were observed. We note that all of these
fibrils rapidly formed at a 0.33 μM concentration, which is much lower than the critical
micelle concentration of Aβ42 in buffer solution, 17.5 μM.317
As shown in Figure 2-3G, we observed fibrilar structures on the mica surface even
for the shortest incubation time possible in our experiment, the 〜3 min drying time for
the slow spinning process. Therefore, the lag time usually observed for the nucleation
process in solution is either too short to be observed, or entirely absent. Furthermore,
fibrils of all lengths and sizes were formed by slow-drying at concentrations that are too
low for nucleation-limited fibril formation in solution. Therefore, our data suggest that the
nucleation step is bypassed during surface-mediated self-assembly and another process is
responsible for such unprecedented rapid fibril formation rates. The self-assembly on the
two-dimensional surface is governed by the translational motion and conformational re32

arrangement of peptides during the incubation and drying. Two factors that can affect
such self-assembly are the deposition and the surface diffusion rates.325 The local number
density depends on the flux of incoming molecules during the incubation period and the
adsorption-desorption rate. The strength of the interaction with the surface is important
in the adsorption rate of the peptides, which can enhance fibril formation rate. However,
the rapid growth of the fibrils, as shown in Figure 2-3, indicates that the peptides can
diffuse on the substrate and form hydrogen bonds after self-assembly, which indicates low
barriers for surface diffusion and rearrangement, despite high adsorption rates.

2.4.5 A Phase Diagram for the Surface-Mediated Fibrillization
In order to quantify the relationship between surface coverage and self-assembled
morphology, each AFM image taken after slow drying (included these shown in Figure 23 A-F and Figure 2-4) was analyzed as follows. Two important parameters, the surface
coverage and the two-dimensional number density, were calculated. The former is defined
as the percentage of the image area occupied with nanostructures, and the latter is the
average number of molecules per unit area of the same image, i.e. the two-dimensional
concentration. Comparing these two parameters can distinguish between mono-layers,
where the two parameters are fully correlated, and multi-layered structures, where the
surface coverage is at almost 100%. Figure 2-5 illustrates the correlation between the
surface coverage, the number density, and the observed morphologies. As the number
density or the surface coverage increases, the morphology changes from short fibrils to
long fibrils, to monolayers, and eventually multilayers. In this phase diagram, several
boundaries between different types of morphologies can be observed. Two interesting
features can be highlighted. First, two distinct types of fibrils are present in this diagram.
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At low number densities (<104 μm-2) the fibrils are short and scattered; while at
intermediate number densities (104-105 μm-2) the fibrils are many microns long, well
packed, and cover a large surface area. Second, the regions of well-packed long fibrils and
monolayer overlap around a number density of 105 μm-2. In this region, the deposition rate
is high and the initial alignment of the fibrils on the surface probably determines the final
morphology.

Figure 2-5. Phase diagram of Aβ12-28 samples, prepared in slow-dried and slow-spinning
conditions. Each data point is obtained from a single AFM image based on analysis
described in the Supporting Information. The shape of each symbol represents the
observed morphology, with circles, squares, downward triangles and upward triangles
representing short fibrils (l < 1 μm, h < 0.5 nm), long fibrils (l > 1 μm, h < 0.5 nm),
monolayers (h < 1 nm), and multi-layers (h > 1 nm) respectively. The data obtained by
spin-coating at 1000 RPM with various incubation times are categorized according to the
observed morphology. The solid lines highlight the approximate phase boundaries.
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Further characterization of the observed morphologies required controlled
deposition afforded by spin coating. In order to compare the results of experiments under
slow-drying and slow-spinning conditions, the slow-spinning data were analyzed in the
fashion described above and added to the data presented in the phase diagram of Figure
2-5. These data points strongly follow the same trend and provide additional confirmation
that the surface coverage and number density are good indicators of the observed
morphologies. In contrast to the slow-drying conditions, the morphology of the slowspinning aggregates can be precisely controlled using variations of the solution
concentration and the incubation time, thereby controlling the deposition rate and local
concentration. This provides a unique form of control over important variables for the
surface-mediated self-assembly of these peptides. The slow-spinning samples (fibrilar
structure in Figure 2-3 H-I) can also be compared with samples prepared using
conventional methods of drying (Chapter 3), as well as the slow-drying samples (multilayers in Figure 2-4 A-C) with the same initial bulk concentrations. These comparisons
show the clear advantage of this method over other sample preparation methods in
keeping the surface morphology uniform and intact. Under the slow-spinning conditions,
the surface is uniformly covered with only one structure and inhomogeneous coverage and
coffee-stain effects can be completely prevented.

2.4.6 The Properties of Surface-mediated Fibrils
To further understand the surface-mediated fibrillization process, we analyzed the
statistics of the height and the length of the fibrils as a function of time. The height of the
fibrils, determined from line profiles of the AFM images, is 3.0± 1.0 Å (Figure 2-6B). The
mean height of the fibrils can also be derived from fitting two Gaussian functions to the
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height histogram as shown in Figure 2-6C. These measurements are consistent with the
image processing and lead to a thickness of 2.2± 1.0 Å . Thus, these fibrils can be classified
as protofibrils, with a thickness consistent with that of a single peptide. The fibrils never
cross each other, which is a strong indication that the rearrangements and fibrillization
occurred on the two-dimensional surface and that bulk peptides did not participate in the
elongation process. We also analyzed the distribution of fibril lengths using five AFM
images on different areas of the substrate. Figure 2-6D shows the normalized length
distributions of the slow-spinning samples after 30 (blue) and 60 minutes (orange) of
incubation, respectively. The length distribution right shifts and broadens as the
incubation time is increased. This is consistent with the assumption that the self-assembly
mechanism is through a diffusion-limited aggregation (DLA) process on the surface,325
where the adsorbed peptides diffuse on the surface until they adhere to a cluster or to each
other. In contrast to a standard DLA process, the anisotropic hydrogen bonding
interactions of the peptide backbones lead to the formation of long chains instead of fractal
clusters. This will be further explored in Chapter4.
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Figure 2-6. Statistical analysis on surface-mediated fibrils. (A) Representative AFM
image of 60 min-1000 RPM Aβ12-28 sample. (B) Line profile of the three white lines
indicated in a. (C) Normalized height distribution of the image shown in (A). Two Gaussian
functions are fit to the data. The Gaussian peak on the left (gray) shows the position of the
mica substrate and highlights the roughness of mica substrate and the AFM noise. The
Gaussian peak on the right (green) shows the height distribution of the protofibrils, which
is wider than the background noise. (D) Normalized distribution of fibril lengths 30 min1000 RPM and 60 min-1000 RPM Aβ 12-28 samples. The right shift reflects the growth of
protofibrils on surface.
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On the surface of the 30 min-1000 RPM sample, we observed interesting dropletlike patterns on the edge of the mica, as shown in Figure 2-7A. At the edge of the sample,
the uniform film of water broke into small droplets, roughly 10 to 15 μm in diameter, which
dried much later than the rest of the sample. The inner and outer morphologies of the
droplet-like patterns were quite different as shown in Figure 2-7B. Long, randomlydistributed protofibrils can be found everywhere outside the droplets, but parallel-packed
bundles of protofibrils can only be seen within the droplets. The difference between the
morphologies indicates that, similar to the individual peptides, the protofibrils also diffuse
on the surface, even after peptide deposition has stopped. The protofibrils bundle into
longer and more packed protofibrils, potentially due to hydrophobic interactions.
However, the detailed mechanism of this process merits further studies and will be
addressed in future.

Figure 2-7. AFM images of 30 min-1000 RPM Aβ12-28 sample near the edge of the mica
substrate. (A) Large area image. (B) Zoomed-in image near the boundary of the dropletlike structure, highlighted by red square frame in (A). (C) Zoomed-in image inside the
droplet-like structure, green square frame in (B).
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2.5 Conclusions
In summary, we have observed that surface-mediated self-assembly of peptides,
due to adsorption and diffusion of peptides on the surface, can lead to the rapid formation
of protofibrils even with low bulk concentrations. The morphologies of the fibrils strongly
depend on the number density of the peptides on the surface, which in turn depends on
the deposition and diffusion rates of the peptides. Using a spin-coating process, we could
control the fibril formation rates and final morphologies of the fibrils on the surface. We
have shown that protofibrils can be made on the surface homogeneously, and the slowspinning data are consistent with the trend of morphology transitions in the phase
diagram. This simple, but reliable technique will allow us to systematically study specific
interactions that lead to rapid fibril formation on the surface by using various peptides,
buffer conditions, and substrate systems, including larger amyloidogenic proteins such as
α-synuclein and more physiologically-relevant surfaces such as lipid monolayers. It will
also allow us to explore the effect of common protein labels such as fluorophores on
aggregation rates and morphologies. Most importantly, our work highlights the need for
concern that aggregate morphologies observed using surface imaging techniques may not
accurately reflect the populations and structures in solution. Our continued work in this
area will further delineate the role of surface effects so that the Biochemistry community
may better understand how to interpret AFM data in protein misfolding studies.

2.6 Supplementary Materials
2.6.1 Quantitative Analysis
Surface Coverage and Number Density. All topographic images were flattened by
removing the third-order polynomial background in Gwyddion software.328 After
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flattening the AFM image, the surface coverage of nanostructures was measured by setting
an appropriate height threshold in the Gwyddion software (an example is shown in Figure
2-8). Then, the total volume of peptide in the selected area was calculated. In order to
obtain the total number of peptides, the total volume was divided by a single peptide's
volume, 2366 Å 3. Here, the volume of a single peptide was calculated using the web-based
Peptide

Property

Calculator

(Northwestern

university:

http://www.basic.northwestern.edu/biotools/proteincalc.html). The number density is
equal to the total number of peptides divided by the area of the AFM image.

Height Histogram and Height Profile. The height histogram and height profile were
analyzed and extracted by Gwyddion software after flattening, then plotted in SigmaPlot
(Systat Software, Inc).
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Figure 2-8. An example of quantitative analysis for the 60 min-1000 RPM sample. (A)
The topography image after flattening. (B) The masked AFM image with appropriate
height threshold. The green color highlights the selected nanostructure, which is higher
than the threshold. (C) The binary map of selected nanostructures. (D) The phase image.
(E) The amplitude image. The scale bar of each image is 500 nm.

Cumulative Length Distribution. Using the height threshold set up before, a binary
map in Gwyddion can be created, as shown in Figure 2-8C. ImageJ software329 was used
to manually measure the fibril's length (end-to-end distance) in the binary map (Figure 28C). In some cases, it was difficult to judge the fibril's length due to the small signal-tonoise ratio. As a result, the topography (Figure 2-8A), phase (Figure 2-8D) and amplitude
(Figure 2-8E) images were also used to help determine the fibril's length. Each normalized
length distribution in Figure 2-6D included five AFM images, as shown in Figure 2-9,
taken from different areas of the same sample.

Figure 2-9. AFM images of slow spinning samples. Five different areas of the (A) 30
min-1000 RPM sample and (B) 60 min-1000 RPM sample used to calculate the
normalized fibril length distributions. The scale bar of each image is 500 nm.
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CHAPTER 3. Identification of Potential Drying Artifacts in the
Preparation of Surface-Mediated Fibrils Samples
Reprinted with Permission from Yi-Chih Lin, Milton H. Repollet-Pedrosa, John J. Ferrie,
E. James Petersson and Zahra Fakhraai. Potential Artifacts in Sample Preparation
Methods Used for Imaging Amyloid Oligomers and Protofibrils due to Surface-Mediated
Fibril Formation. J. Phys. Chem. B, 2017, 121, 2534–2542. Copyright 2017 American
Chemical Society.

3.1 Abstract
Accurate imaging of nanometer-sized structures and morphologies is essential to
characterizing amyloid species formed at various stages of amyloid aggregation. In this
work, we examine the effect of different drying procedures on the final morphology of
surface-mediated fibrils formed during the incubation period, which may be then
mistaken as oligomers or protofibrils intentionally formed in solution for a particular
study. AFM results show that some artifacts, such as globules, flake-like structures, and
even micrometer-long fibrils, can be produced under various drying conditions. We also
demonstrate that one can prevent drying artifacts by using an appropriate spin-coating
procedure to dry amyloid samples. This procedure can bypass the wetting/dewetting
transition of the liquid layer during the drying process, and preserve the structure of
interest on the substrate without generating drying artifacts.
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3.2 Introduction
The formation of amyloid fibrils is one of the hallmarks of neurodegenerative
diseases (e.g. Alzheimer's disease and Parkinson's disease) and other conditions such as
type II diabetes.4 In most in-vitro experiments, the fibril formation in bulk is through
nucleation and growth mechanisms, and requires the sample concentration to be higher
than the critical concentration for nucleation.26,78 Structural evolution of these fibrils can
be monitored by spectroscopic techniques (e.g. thioflavin T, or ThT, fluorescence assay,
CD spectroscopy, IR spectroscopy, and NMR spectroscopy) 84,87, and then visualized by
single molecule techniques, such as transmittance electron microscopy (TEM) and atomic
force microscopy (AFM).82,86,88,89 For both popular tools, samples are typically dried at
various aggregation stages for further characterization of the amyloid species prepared in
solution. Among different types of aggregates, structured oligomers have been recognized
as potentially more toxic species than other structures.330–332 However, characterizing
these small structures is still challenging, particularly due to challenges associated with
proper sample preparation.
One of the primary challenges in sample preparation stems from surface effects
catalyzing amyloid fibril formation and generating oligomeric and/or fibrilar structures
during drying. Recent studies indicate that the liquid-substrate interface can provide an
alternative route to form amyloid fibrils that differs from bulk mechanisms, often allowing
aggregation at concentrations well below the critical concentration for amyloid
nucleation.140,143,144,181,188 Under such conditions, the mobility of surface-bound proteins or
peptides as well as high surface concentration are important factors in determining the
rate of aggregation.140,143 As demonstrated in our previous work, in the presence of a mica
substrate, surface-mediated fibrils (mostly in mono-layer form with maximum height of
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〜 0.5 nm) can form quickly (within 30 minutes).13 Since these surface-mediated fibrils
are themselves mobile on the surface, specific attention must be paid during sample
preparation to retain structures of interest and prevent potential artifacts due to
aggregation during drying. Advanced fast-scanning AFM276 can bypass the drying
procedure, but imaging such tiny features with high accuracy is very difficult at high
imaging speeds and mobile species can potentially move on the surface during imaging.
For studies of the morphologies of amyloid species formed in the bulk (e.g. mature
fibrils or toxic oligomers), during sample preparation one needs to incubate the sample
solution on the substrate prior to the drying and subsequent imaging processes. The
underlying assumption is that the amyloid structures formed in solution can physically
deposit on the substrate in ratios similar to those found in bulk. However, if the monomers
are not completely depleted, the surface-mediated fibrillization process can potentially
compete with fibril deposition during the incubation period and generate new species that
did not exist in the bulk solution. Consequently, some fine structures formed by the
surface-mediated process can be misinterpreted as the products of bulk aggregation.
Furthermore, inappropriate drying procedures can also introduce morphological changes
during drying due to self-concentration and surface rearrangement of the deposited
fibrils.333,334 Therefore, understanding the potential drying-artifacts in studies of surfacemediated fibril formation and for oligomer imaging becomes crucial in avoiding these
situations.
In this chapter, various drying procedures are employed to prepare surfacemediated fibrils for AFM imaging. We demonstrate that spin-coating at slow rates can
prevent drying artifacts for the surfaces that are already covered by some physically
adsorbed protofibrils during incubation. In contrast, fast-spinning without incubation can
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help to trap larger species of fibrils, but may also produce aggregates due to the formation
of small droplets that can be mistaken as oligomers. By establishing procedures for proper
drying, one can prevent the formation of such artifacts and enhance the ability to
accurately identify the existence of oligomers and protofibrils in bulk samples.

3.3 Materials and Methods
Sample Solutions. Synthetic Aβ12-28 peptide (purity > 95%, rPeptide) was directly used
to prepare sample solutions without further purification. The Aβ12-28 peptide was first
dissolved in 1 % NH4OH(aq) at a concentration of 1 mg/ml. The solution was sonicated for
2 minutes, and subsequently diluted with Milli-Q water to a concentration of 10 μM. To
remove large aggregates, the solution was filtered using a 0.22 μm PTFE membrane
syringe filter. Since Aβ12-28 does not have an absorbance band in the UV-VIS region, this
commonly used method could not be employed to determine the exact concentration of
the sample. The real sample concentration is expected to be lower than the reported value,
as it is likely that some peptides were absorbed on the vial’s walls. The peptide solutions
were incubated at room temperature without agitation for durations of three hours (3H),
two days (2D), or three days (3D) for further experiments. The aggregation of the mature
fibril sample was performed by shaking a 100 μM peptide solution (same preparation
procedure as used for the low-concentrated peptide solution) at 37 °C and 800 rpm on an
IKA MS3 digital orbital shaker in parafilm-sealed 1.7 mL Eppendorf tubes to ensure
minimal solvent evaporation.
Cryogenic Transmission Electron Microscopy (CryoTEM). An aliquot volume of
5 μL sample solution (10 μM, 3H or 3D peptide solution) was deposited on a lacy carboncoated copper grid (Ted Pella, Inc.) in a humidity and temperature controlled environment
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vitrification system (Vitrobot, FEI, Inc.). The humidity was controlled at 100% and the
temperature of the chamber was 22.0 ˚C. The sample was then blotted to remove excess
solvent and create a thin film of the peptide on the grid surface using a 2 mm blotting force,
a 1.0 s blot time, and a 10 s drain time to equilibrate any stresses in the sample caused by
blotting. The resulting sample grid was vitrified by plunge freezing into liquid ethane (183 ˚C). A Tecnai T-12 TEM operating at 120 kV was used to obtain the cryoTEM images.
Thioflavin T (ThT) Fluorescence Measurements. 30 μL peptide solutions (3H and
2D) were separately mixed with 100 μL ThT solution (20 μM in PBS buffer solution). The
fluorescence spectra were recorded on a Tecan M1000 multimode plate reader, with
excitation at 440 nm.
Spin Coated Samples. Three droplets of as-prepared incubated peptide solutions (3H
or 2D) were placed on fresh-cleaved mica and were either spin-coated immediately, or
incubated for 30 minutes before the spin-coating process. Spin-coating (WS-650 MZ23, Laurell Technologies Corp.) was used to dry the samples under various spinning rates
in the range of 1000 to 3000 RPM. The acceleration rate was 250 RPM/s for all spun-cast
samples, except for the fast-spinning samples displayed in Figure 3-2B and Figure 3-2F,
where 400 RPM/s was used.
Kimwipe-prepared and Nitrogen-dried Samples. Three droplets of peptide
solution (3H or 2D) were incubated on the mica substrate for 30 minutes. To remove the
excess solution, the samples were blotted by Kimwipe or gently dried using a weak
nitrogen stream after rinsing with 0.2 mL Milli-Q water. The Kimwipe-prepared samples
dried rapidly without the need for nitrogen blowing. During both procedures, the substrate
was tilted 30-45° to prevent the solution from flowing backwards. The total drying times
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for Kimwipe and nitrogen-dried procedures were estimated to be 5 and 8 minutes,
respectively.
Atomic Force Microscopy (AFM). The samples prepared using various drying
procedures were imaged in tapping mode using a Keysight 5500 AFM instrument
(Keysight Technologies) equipped with a closed-loop scanner. Rotated silicon probes with
aluminum reflex coating (BudgetSensors, Tap-300G, resonance frequency ~300 kHz, tip
radius <10 nm, force constant 40 N/m) were used to record topographic, amplitude, and
phase images with 512 x 512 pixel resolution. For the spinning samples, the images were
taken from the central region of the substrate to avoid the potential effects at the edges of
the sample, where the drying rate could be slower. An example of such an effect is reported
in our previous report14. The AFM images were analyzed by Gwyddion package. A thirdorder polynomial was used to flatten the background for topographic images. The analyses
of globular structures in spinning control section were performed by the grain analysis
tool with structural mask in the Gwyddion software.

3.4 Experimental Results
3.4.1 Structural Characterization of Peptide Solutions
To study potential artifacts of preparing dry samples, we first examined amyloid
structures formed in the as-prepared low-concentration peptide solutions using cryoTEM
and ThT fluorescence measurements. CryoTEM can directly visualize structures present
in the solution and ThT examines the β-sheet content, i.e. the existence of amyloid fibrils,
in solution. In cryoTEM images (Figure 3-1A), only spherical dispersions with average
diameter of 49.4 ± 7.9 nm and 27.2 ± 6.1 nm were observed in three hour (3H) and three
day (3D) sample solutions, respectively. No fibrillar structures or larger aggregates were
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detected in either sample. We note that since no fibrilar structures were observed in the
cryoTEM imaging of the 3D solution, they should also be absent in the two day (2D)
solution because the bulk aggregation mechanism is a time-dependent nucleation-growth
process and should proceed further after 3 days. As shown in Figure 3-1B, the ThT
fluorescence experiments display a weak increase of intensity peaked at 480 nm, roughly
2-3 times higher than the control solution (pure water mixed with ThT solution). When
amyloid fibrils existed in the solution, the ThT fluorescence increased more than one
hundred-fold for the ThT concentration used here. Therefore, the ThT fluorescence
measurements also suggest no significant amounts of fibrils were formed in the solution.
Both cryoTEM and ThT results are consistent with the fact that the peptide solutions were
prepared with a concentration below the critical concentration for nucleation (see
discussion in Section 3.8), and as such the peptides were not expected to aggregate into
amyloid fibrils prior to drying.

Figure 3-1. Structural characterization of the peptide solutions. (A) Representative
cryoTEM images of the 3H and 3D sample solutions. Red arrows indicate the globular
aggregates. Scale bar = 200 nm. (B) Fluorescence signal of ThT solution mixed with
different sample solutions, compared with ThT solution mixed with pure water. The
concentrations of 3H and 2D peptide solutions were 10 μM. The inset figure displays the
ThT fluorescence response of the fibril sample.
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3.4.2 Surface-Mediated Fibrils under Various Drying Processes
In the absence of surface-mediated fibrillization, samples prepared using these
peptide solutions should only yield globular aggregates as suggested by the cryoTEM
results. However, recent studies show that fibrils can quickly form in the presence of
surfaces.140,143,181,188 To investigate the potential artifacts induced by surface-mediated
fibrillization during the incubation and drying processes, all samples studied in this
section were first incubated on the substrate for 30 minutes, before drying under various
methods. We have previously demonstrated that this incubation period will result in the
formation of short protofibrils that are only a monolayer thick. 140 The samples were then
subjected to various drying processes, including slow-spinning (1000 RPM), fast-spinning
(3000 RPM), Kimwipe-drying, or nitrogen-blowing methods, and then imaged by AFM
under ambient conditions. More details of these procedures are described in the Section
3.3. Statistically representative morphologies observed for each drying method are
displayed in Figure 3-2, with some characteristic features analyzed in Figure 3-3. The
control experiments of the non-incubated samples prepared using various drying
processes are demonstrated in Figure 3-4, Figure 3-6A and Figure 3-6C.
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Figure 3-2. Representative AFM images of surface-mediated fibrils dried under various
procedures. (A, B) Slow-spinning, (C, D) fast-spinning, (E, F) Kimwipe, and (G, H)
nitrogen-blowing procedures. The left column shows samples produced from the 3H
solution and the right column shows samples prepared from the 2D peptide solution. All
samples were incubated on mica substrate for 30 minutes before drying. The scale bars in
each panel are 500 nm and 2 μm for the left and the right images, respectively. The
dimensions of morphologies highlighted using white rectangles are extracted and plotted
in Figure 3-3.
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Figure 3-3. Cross-sectional line profiles along characteristic morphologies observed in
Figure 3-2. The heights and widths of the (A) fibrillar structures, (B) large globular
structures, (C) small globular structures, and (D) flake-like geometries are extracted from
one of the features labeled in Figure 3-2 using white rectangles. The colors are consistent
with labels in Figure 3-2.
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Figure 3-4. Representative AFM images of (A) Nitrogen-dried samples and (B) Kimwipeprepared samples without incubation. The 3H peptide solution was used to prepare the
dried samples. The Nitrogen-dried sample only exhibits globular structures, which result
from drying artifacts due to the dewetting process. In contrast, the Kimwipe-dried sample
had nothing adsorbed on the mica substrate.

In the top row of Figure 3-2, images of slow-spinning samples are shown with
isotropically distributed protofibrils on the mica substrate with feature heights of ~0.5 nm
(a1 and b1 features in Figure 3-2A and Figure 3-2B). This is expected as we have previously
demonstrated that surface diffusion of adsorbed peptides can result in the formation of
surface-mediated fibrils under these conditions.140 The 2D solution formed slightly longer
fibrils compared to the 3H solution. When the spinning speed is increased to 3000 RPM,
the main features observed on the surface are globular structures (c2 and d2 in Figure 32C and Figure 3-2D). Some surface mediated fibrils (c1 and d1 structures) could also be
observed on these samples. The fibrils in the background are the surface-mediated fibrils
formed on the surface during the incubation period. At 3000 RPM, the solution droplet
ruptures during spinning and the globular structures are attached to the surface as the
small droplets on the surface dry to leave their content behind. The morphologies observed
on the slow-spinning and fast-spinning samples are consistent with our previous work,
53

and demonstrate that the 1000 RPM speed, which is below the rupture threshold of the
solutions used here, can preserve the surface-mediated fibrils on the substrate and avoid
the deposition of peptides and aggregates from the solution during spinning. 140 A more
detailed comparison of the effect of spin speed on morphology will be addressed in the
next section.
Kimwipe-drying or nitrogen-blowing processes are also widely used to prepare
samples for TEM and AFM imaging.143,159,188,305,308 Figure 3-2E and Figure 3-2F display
images of the surface after a Kimwipe was used to blot the excess solution after the
formation of surface-mediated fibrils such as those shown in Figure 3-2A and Figure 3-2B.
The Kimwipe-dried samples exhibited sparse, short protofibrils (Figure 3-2E for the 3H
peptide solution) and long, well-oriented fibrils (Figure 3-2F for the 2D peptide solution),
covering the entire substrate. Despite changes in the length of the fibrils observed in both
samples, the heights of the protofibrils were near 0.5 nm, a signature of surface-mediated
fibrils,140 as shown in Figure 3-3A (e1 and f1). It is important to note that the surface
morphologies of the Kimwipe-prepared samples prepared by 2D peptide solution were not
homogeneous. In some areas, the fibrils’ length and density were like the slow-spinning
samples (Figure 3-5F). This is an indication that the surface-mediated fibrils could
rearrange during Kimwipe drying to form longer fibrils. Since the heights of the structures
didn’t change, it is unlikely that the fibrils were detached from the surface during the
drying process. It is also unlikely that any of the content from the solution, such as
aggregates, were attached to the surface during this procedure.
Nitrogen-dried samples showed an even more dramatic change in their surface
morphologies, showing diverse morphologies such as fibrilar structures (h1), small (g2'
and h2') and large globular structures (g2 and h2), and flake-like geometries (g3 and h3)
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as shown in Figure 3-2G and Figure 3-2H. The heights of fibrilar and large globular
structures were 0.5 nm and 2.0 nm, respectively (Figure 3-3A and Figure 3-3B), and were
similar to the ones observed in the slow- and fast-spinning samples. Two other types of
structures, small globular structures and flake-like geometries, were scarcely observed in
the samples prepared by other drying procedures. The heights of these structures are
measured to be near 1.2 nm and 0.5 nm for the samples prepared by 3H and 2D peptide
solution, respectively. As such, it is likely that some form of deposition from the solution
occurred during nitrogen drying, likely due to the formation of small droplets on the
surface. More AFM images of these samples in different areas are provided in Figure 3-5.

Figure 3-5. AFM images of different areas of slow-spinning samples (A-B), fast-spinning
samples (C-D), Kimwipe-prepared samples (E-F) and Nitrogen-dried samples (G-H).
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3.4.3 The Influence of Spinning Speed on Sample Preparation
As demonstrated in the previous section, different spinning speeds can influence
the morphologies observed on the substrate. To further study the influence of spinning
speed, the morphologies of the samples dried at various spin speeds were studied under
two different conditions. One set of samples were spun-cast without any incubation on
mica (top row of Figure 3-6); another set were incubated for 30 minutes before spinning
(bottom row of Figure 3-6). The difference between these two sets of samples is the
formation of surface-mediated fibrils on the second set before the start of the spin casting
process.

Figure 3-6. Spinning speed control for the spin-coating process. The 3H peptide solution
was used to deposit on mica, and dried immediately (A-C) or dried after 30 minutes of
incubation (D-F) at different spinning speeds. The spin speed was 1000 RPM for (A and
D), 2000 RPM for (B and E), and 3000 RPM for (C and F), respectively. The inset figure
in (F) is the zoomed-in image of self-assembled fibrils (2 μm × 2 μm). The results for other
spinning speeds, 1500 and 2500 RPM, are provided in Figure 3-7. The scale bar in each
image is 2 μm.
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Figure 3-7. The effect of spinning speed on the spin-coating process. The 3H peptide
solution was deposited on mica and dried immediately by spin-coating (A-B) or after 30
minutes of incubation (C-D) at different spinning speeds. The scale bars in each image are
2 μm.

In the top row of Figure 3-6, in the absence of surface-mediated fibrils, only
globular structures are observed in the samples that were not incubated. In contrast, with
increased spinning speed, the incubated samples with surface-mediated fibrils show
morphological changes from fibrils to globular structures (bottom row of Figure 3-6).
Several features are notable in these samples. First, globular structures are observed in all
spun-dried samples, except for the one imaged in Figure 3-6D. There, surface-mediated
fibrils are present on the surface when the spinning speed is below the rupture threshold
of the solution, a speed between 1000 and 1500 RPM (based on the observed
morphological change from surface-mediated fibrils to globular structures, Figure 3-6 and
Figure 3-7). This observation indicates that the globular structures are the residual
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peptides and aggregates that are left behind once small droplets of water are dried on the
substrate. Second, the sizes of these structures vary slightly different among these samples.
After tracking thousands of globular structures in each sample, the average size and
volume of the globular structures were measured as plotted in Figure 3-8 and summarized
in Table 3-1. The data presented in Figure 3-8 clearly indicate that the dimensions of the
aggregates became smaller when the drying speed is increased. At higher spin speeds, the
size of the water droplets is smaller, leaving smaller amounts of residual peptides behind,
resulting in smaller-sized aggregates. Overall, these observations further confirm that
inside the water droplets left on the surface, there are no fibrils that had previously formed
in the solution. Furthermore, the size of the aggregates is defined by the droplet size and
as such, these globular structures are not the well-defined oligomers that had formed in
solution. Third, besides the globules, self-assembled structures are also observed in the
samples with 30 min incubation. For example, the zoomed-in image in the inset of Figure
3-6F shows a self-assembled structure that is composed of multiple surface-mediated
fibrils, aggregated together. This is consistent with observations in Kimwipe and nitrogen
drying procedures where the surface-mediated fibrils can rearrange during the drying of
larger water droplets. Again, it is worth emphasizing that none of these features belong to
the state of the peptide aggregation in the solution.
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Figure 3-8. The average size (A) and volume (B) of the globular structures formed under
different spinning speeds. Req is the average equivalent radius of the globular structures
that is proportional to the size of globules. The error bars are the root mean square of the
size variations and the lower bound of the error in volume is zero.

Table 3-1. Statistical results of the globular structures imaged in spinning control section.
Req (nm) a
Volume (× 10-24 m3)
Incubation
Terminal # of globular
# of
Time
standard
standard peptidesb
Speed (RPM) structures
average
average
(minute)
derivation
derivation

0

30

1000

6297

23.8

8.8

2.2

3.5

938

1500

24936

21.0

6.2

1.7

1.8

716

2000

20817

16.9

6.4

1.4

2.8

581

2500

17675

15.9

5.5

1.2

2.2

503

3000

16624

15.6

6.1

1.0

2.0

440

1500

7385

26.3

7.0

1.6

1.4

683

2000

7369

26.1

7.1

1.7

1.7

718

2500

16943

23.7

5.8

1.7

1.6

732

3000

4327

22.2

5.3

1.6

1.6
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Req is the equivalent radius of the analyzed globular structures. b The number of peptides inside each
globular structure was calculated by using the average volume of the structure divided by the estimated
volume of a single peptide. (5.23 nm3, web-based Peptide Property Calculator, Northwestern university:
http://www.basic.northwestern.edu/biotools/proteincalc.html)
a
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3.5 Discussion
The results presented in Figure 3-2 and Figure 3-3 show that the method of sample
preparation can have a strong effect on the morphology observed on the surface, despite
identical initial sample preparation conditions. Under the conditions chosen for this study,
in the solution phase, the amyloid structures are spherical dispersions with an average size
smaller than 50.0 nm, or individual peptides that cannot be observed in cryoTEM. This
result is consistent with the fact that a 0.22 μm size exclusion filter was used to remove
large, insoluble amyloid species during the preparation of the peptide solution.
Furthermore, in agreement with previous reports, the peptide concentration is too low for
nucleation and growth of fibrils in solution, and the preparation time is shorter than the
typical lag times for nucleation-limited aggregation mechanism (several hours to days)78.
We attribute the slight increase of ThT fluorescence to the formation of the spherical
objects observed in cryoTEM as previous reports indicate335, as the fluorescence is not
strong enough to originate from long mature fibrils. No evidence of the existence of
smaller stable oligomers with well-defined sizes is observed in these samples. As such, all
the protofibrils and aggregates observed under various drying conditions, after 30 min
incubation period, are formed through surface-mediated fibril formation on the mica
substrate and drying induced artifacts. When the samples were dried by spin-coating
without incubation on the surface, only globular structures were observed, as shown in the
top row of Figure 3-6 with an average size that depends on the spin speed as shown in
Figure 3-8. The average sizes at all speeds are slightly smaller than those measured in bulk
by cryoTEM, suggesting that most of these aggregates are formed by the peptide content
left over after drying of small droplets, and that most of the peptides are in aggregates
smaller than those observed by cryoTEM (most probably just single peptides). Thus, no
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stable well-defined oligomeric species is observed under the preparation conditions of this
study.
Once surface-mediated fibrils are formed on a substrate, there are some limitations
in the current techniques to directly image them in aqueous environments. First, their
dimensions are too small to be effectively imaged with the more limited resolution of wet
AFM, e.g. 〜0.5 nm in height and 10-20 nm in width (Figure 3-3A). Second, they may be
too mobile on the surface to be imaged in fluid for most imaging tools. This mobility can
be seen in the change in peptide morphology and length upon drying using different
methods as shown in Figure 3-2. Therefore, the sample needs to be dried for the operation
of high-resolution AFM measurements, and also for preventing the mobility or growth of
those fibrils during the imaging process. Here, four distinct procedures were used to dry
the samples. Based on the experimental results, only the slow-spinning condition can
gently remove peptide solution and excess material while keeping the surface-mediated
fibrils intact on the substrate with isotropic distribution. The other drying procedures also
had some surface-mediated fibrils dispersed on the substrate; for example, the
morphologies of a1-h1 species labeled in Figure 3-2. However, other types of structures,
such as globules, μm-long fibrils, and flake-like structures, were also observed in those
samples, all due to various drying artifacts resulting from the motion of the surfacemediated fibrils during drying, as well as deposition of material from the solution.
For the slow-spinning samples, the one prepared by 3H peptide solution (Figure
3-2A) has relatively shorter fibrils and less surface coverage compared with the one
prepared by 2D peptide solution (Figure 3-2E). This is most probably due to a difference
in concentration between the solutions used to prepare the samples that would change the
rate of peptide deposition and thus fibril growth on the surface. Unfortunately, we are
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unable to precisely define the final solution concentration due to the lack of chromophores
in this peptide sequence. Instead, an example of the concentration effect on the length of
surface-mediated fibrils is shown in Figure 3-9 to explain the dependence of the fibril
length and surface coverage on the concentration of the bulk solution. Based on these
results, the concentration of 3H peptide solution is expected to be slightly lower than that
of the 2D peptide solution, for which longer fibrils are observed, despite their absence in
either the 3H or 3D solution cryoTEM images.

Figure 3-9. Representative AFM images of surface-mediated fibrils prepared by
incubating the 2D peptide solution on mica for 30 minutes, and then drying under the
slow spinning procedure. The concentration of the peptide solution was 10 μM and 5 μM
in (A) and (B), respectively. The scale bars in each panel are 500 nm and 2 μm for images
in the left and right columns, respectively. The high peptide concentration led to the
formation of longer surface-mediated fibrils with higher density. This indicates that the
rate of fibril growth on substrate highly depends on the initial concentration of the peptide
solution.
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The surface morphologies observed for the other samples are not only influenced
by the peptide concentration, but also by the drying method. Assuming that the slowspinning procedure can preserve surface morphologies at the drying stage, the
morphological differences between slow-spinning samples (top row of Figure 3-2) and the
other samples reflect the impacts of the different drying procedures. Under the Kimwipedrying procedure, as shown in Figure 3-2E and Figure 3-2F, the fibril distribution becomes
less isotropic on the surface and areas with either low coverage (Figure 3-2E) or highly
crowded areas with well-oriented long fibrils (Figure 3-2F) can be observed on the surface.
In particular, the fibrilar patterns displayed in Figure 3-2F suggest that the induced liquid
flow during the blotting step allows the fibrils to move around on the surface, merge to
form longer fibrils, and orient along a particular direction, presumably along the direction
of blotting. These data also indicate that the surface-mediated fibrils are loosely bound to
the substrate and can move with the flow, consistent with our earlier observations 140.
There is, however, no evidence that the fibrils can detach from the surface during this
procedure, or that additional material from the solution is deposited on the surface during
blotting.
For nitrogen-dried samples, large morphological changes are observed. The major
morphologies observed on the surface are flake-like and globular structures that are
completely different than the slow-spinning samples. The flake-like structures had been
reported as intermediate species in an early aggregation stage based on in-situ AFM
measurements.336 However, in our case, they are evidently formed due to motion of
surface-mediated fibrils during drying, as our control experiments indicate that these
structures did not exist in solution. As such the flake-like structures observed here are
formed during the drying period and are artifacts of the method used to prepare them.
Unlike the self-assembled surface-mediated fibrils in the inset of Figure 3-6F, the flake63

like structures have no fibrilar sub-morphologies, instead, only several size-mismatched
globules can be found inside them (Figure 3-10). These structures as similar in size to
globular structures (g2' and h2') observed in Figure 3-3C. These globules are likely formed
due to droplets produced by the nitrogen-drying procedure that were then blown along
the surface and stretched before drying.

Figure 3-10. Comparison between self-assembled, surface-mediated fibrils and flakelike structures. (A) Inset figure of Figure 3-6F. The observed morphology involves
multiple surface-mediated fibrils aggregated together due to surface diffusion. The spininduced globules are observed around this self-assembled structure. (B) Left image in
Figure 3-2G, flake-like structure in nitrogen-dried sample. (C) Zoomed-in image of Figure
3-2H, flake-like structure in nitrogen-dried sample. For both flake-like structures, there
are some size-mismatched globules inside the observed morphology. No significant
fibrilar structures are found in (B) and (C).

Based on the differences observed between the morphologies of the slow-spinning
and fast-spinning samples, the spinning process is not always appropriate for retaining
the surface-mediated fibrils. The fast spin speed can deposit globular artifacts on the
surface and eliminate or displace the surface-mediated fibrils. The formation of surfacemediated fibrils potentially modifies the surface chemistry, resulting in different
morphologies and sizes of the globular objects. This is likely because changes in surface
chemistry result in formation of slightly larger droplets during fast-spinning, so that larger
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globular structures are formed. Therefore, we prepared two sets of samples with two
different incubation periods (0 or 30 minutes) before performing experiments at different
spinning speeds. Surface-mediated fibrils were only observed in samples with preincubation on mica (the bottom row of Figure 3-6). This is consistent with the fact that the
surface-mediated fibril formation mechanism is a kinetically-controlled process, which is
on the time scale of the 30-minute incubation. The usage of 1000 RPM, a speed below the
rupture threshold (1500 RPM), seems to be the best condition to keep these surfacemediated fibrils undisturbed on the surface. When the speed is above 1500 RPM, the
globules appear and become the major species observed on the surface. A dimensional
analysis (Figure 3-8) indicates the dimension of the globules decreases with increasing
spinning speed. Finally, the distribution of globular structures, especially the network-like,
polygonal geometries displayed in Figure 3-6E, are like the dewetting pattern. Such
topographies have been widely observed in thin polymer or glass films, caused by the
balance between interfacial tensions.337,338 The wetting or dewetting behavior during spincoating may explain why some spinning speeds are not appropriate to dry the samples.
The detail of this process merits further investigation and will be addressed in the future.
It is worth nothing that if one desires to measure a species already formed in
solution, as opposed to the surface-mediated fibrils, then the best strategy is to avoid any
incubation time on the surface, or ensure that no oligomers are present in the solution.
One can also try multiple incubation times, to distinguish surface-mediated structures
that grow with time from those that do not change and are formed in solution. It is also
important to note that if spin-coating is used to dry such samples, the spin speed can affect
the process, and some globular structures can be due to the aggregation of oligomers or
single peptides as small droplets are dried. Such structures would change size with spinspeed, while well-defined oligomers formed in solution are expected to be invariant and
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insensitive to spin-speed. Using such control experiments are imperative for proper
identification of important oligomeric species in experiments performed on dried samples.
Besides the hydrophilic mica substrate presented in this study, other types of substrates –
such as highly oriented pyrolytic graphite (HOPG), silicon, and cover glass – are also
widely used to prepare dried samples for various studies. Drying can be different on
various substrates due to the variations in substrate interactions, which may cause
different types of artifacts than those presented in this study. In any case, these potential
artifacts need to be carefully examined when preparing samples.

3.6 Conclusions
In summary, we have shown how the drying procedure can influence the morphologies of
surface-mediated fibrils of Aβ12-28 peptides. Under the conditions used in this study, these
self-assembled fibrils are loosely bound on the substrate, and can be either washed or
rearranged and aligned to form μm-long fibrils in the direction of flow. Other artifacts,
including globules and flakes, can also be observed on samples prepared by two widely
used procedures, Kimwipe and nitrogen drying. Spin-coating provides a path to preserve
these structures on the surface. If spun below the rupture threshold of the solution,
between 1000 RPM and 1500 RPM, surface-mediated fibrils stay intact during the drying
stage. These results suggest the importance of the choice of the drying procedure and
control experiments for preparing peptide samples that have weak interactions with the
substrate, or include large concentrations of individual peptides. If the aim is to image
amyloid species already formed in the solution, e.g. oligomers and mature fibrils, the best
strategy is to avoid long incubation times on the surface prior to the drying stages in order
to prevent self-assembled fibrils from forming. Furthermore, the structural variations
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under different drying methods can be compared to distinguish the species from the
solution from those formed on the surface due to drying of droplets and other similar
factors. Our measurements provide procedures and guideline to properly prepare samples
both for studies of the formation of surface-mediated fibrils, as well as imaging of
oligomers and fibrils formed in solution that need to be dried prior to imaging.
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3.8 Supplementary Materials
3.8.1 Critical Concentration of used Peptide Solutions
The growth of amyloid fibrils in solution phase had been monitored for a period of
two months using ThT fluorescence assay. Under the conditions used in this study with no
buffer, no agitation, and no shaking, both 10 μM and 100 μM peptide solutions exhibited
no ThT fluorescence response, which suggests that the lag time is longer than the
experimental time windows or the concentration is too low to form amyloid fibrils. Thus,
a control experiment was performed by shaking 10 μM and 100 μM samples at 800 RPM
for two months. In this set of experiments, only the 100 μM sample had a ThT fluorescence
response, as demonstrated in the inset of Figure 3-1B. We note that, after two weeks, no
ThT fluorescence response was observed in either sample. Therefore, we believe that 10
μM is well below the critical concentration for the conditions used here. Surface-mediated
fibrillization is the main mechanism that contributes to the rapid fibrillization
demonstrated in this report.
Although a critical concentration has not, to our knowledge, been reported for the
particular Aβ12-28 peptide, we estimate the critical concentration for aggregation to be 2550 µM based on the following literature reports for Aβ fragments:
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Table 3-2. Fibril critical concentration.
Aβ fragments

Concentration

Aβ11-28

<2 mM339

Aβ1-28

90 µM340

Aβ1-40

20-100 µM90,341,342

Aβ1-42

2-20 µM90

Table 3-3. Oligomer/aggregation critical concentration.
Aβ fragments

Concentration

Aβ9-25

~7 µM343

Aβ1-28

90 µM340

Aβ16-22

33 µM344

Aβ1-40

~100 nM345,346

Aβ1-42

<200 nM346,347

(studies did not specifically monitor fibrils)
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CHAPTER 4. Kinetics of Surface-Mediated Fibrillization

4.1 Abstract
Surfaces or interfaces have been considered as key factors in facilitating the formation of
amyloid fibrils in physiological conditions. In this report, we employ a spin-coating based
drying procedure to control the exposure time of a mica substrate to a low-concentrated
solution of amyloid- peptide fragment (Aβ12-28), and then study the growth of surfacemediated fibrils as a function of time via atomic force microscopy (AFM). The evolution of
surface-mediated fibrils can be quantitatively characterized in terms of length histogram
of the surface fibrils and the surface concentration as a function of time.

A two-

dimensional (2D) kinetic model is then used to numerically simulate the length evolution
of the surface-mediated fibrils by assuming a diffusion-limited aggregation (DLA) process
along with size-dependent rate constants. We find that both conditions are required to
accurately model the length histograms as a function of time. The best-fit simulated data
can accurately describe the key features of experimental length histograms, and suggests
that mobility of loosely-bound amyloid species is crucial in regulating the kinetics of
surface-mediated fibrillization. We determine the fractal exponent for the sizedependence on the DLA rate constants is =0.55, which suggests that the diffusion of
loosely-bound surface fibrils roughly depends on the inverse of the square-root of their
size. These studies elucidate the influence of surface specific effects on the formation of
surface-mediated amyloid fibrils.
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4.2 Introduction
Self-assembly

of

amyloid

proteins

has

been

widely

associated

with

neurodegenerative diseases (e.g. Alzheimer's disease, Parkinson's disease, and
Huntington's disease) and non-neuropathic localized diseases (e.g. Type II diabetes).4,6
Among those proteins, amyloid-beta (Aβ) peptide is the most well-known and has been
extensively studied for more than two decades.26,66,77 Recent studies suggest that
fibrillization of Aβ peptides can accumulate insoluble fibrils in the extracellular space of
various tissues to form the amyloid deposits in the brain of Alzheimer's
patients.12,30,78,348,349 In 2013, the Alzheimer's disease was reported as the sixth leading
cause of death in the U.S. and an estimated 5.1 million Americans suffered the symptom
of cognitional disabilities.350,351 Therefore, it is crucial to understand the formation
mechanisms of Aβ fibrils which may help the development of pathogenesis investigations
and therapeutic strategies.17,26,352
Several mechanisms have been proposed to explain the aggregation pathways from
soluble proteins to insoluble amyloid fibrils.16,26,79,80,90,117,316,353 When the peptide
concentration is high (>17.5 μM, the critical concentration for Aβ aggregation 317),
nucleation-limited polymerization governs the formation of amyloid fibrils in solution
phase.80,90,316 However, the concentration of Aβ peptide in physiological fluids is several
orders of magnitude lower than this critical concentration.109 This disparity suggests that
other mechanisms may control the formation of amyloid fibrils in vivo. In recent years,
the effects of surfaces or interfaces on the growth of amyloid fibrils have been studied as
possible fibrillization catalysts.119–129 For example, hydrophobic nanoparticles122 and the
air-water interface125 have been shown to facilitate the formation of amyloid fibrils. A few
studies focused on surface-mediated fibrillization (SMF) under low protein concentration
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conditions (at least below the critical concentration),140,143,144,181,188 indicating that the
enhanced fibril formation and aggregation rates under these conditions requires mobile
surface precursors143, high surface concentration140, and preferred orientation of adsorbed
proteins181. Those features are similar to the membrane-assisted fibril formation which
has been recognized as the potential mechanism in vivo.16,26,117,118 As such, it is worth to
further investigate the details of surface-mediated mechanism.
However, simultaneous tracking the formation of heterogeneous nano-structures
is still a challenge for most of current imaging techniques. There is a trade-off between the
temporal and spatial resolution due to instrumental or systematic limitations. Recently
developed fast-scanning AFMs can be used to study dynamic processes in nanoscale276
when the fibrils themselves are immobile on the surface. Most other studies rely on images
that reflect a steady-state growth or snapshots of a time-lapsing process. For example, we
have previously demonstrated that a slow-spinning drying procedure can be used to
capture snapshots of surface-mediated fibrillization after drying the samples at different
incubation periods.140,354 Our previous results suggested that the fragment of amyloid beta
peptide, Aβ12-28, can rapidly self-assemble into amyloid fibrils on mica surface within 30
minutes in low bulk concentration conditions, but the detailed mechanism remains
unclear.
In this chapter, we employ the same protocol to investigate the kinetics of surfacemediated fibrillization in detail. The AFM snapshots and fibrillar analysis indicate the
rapid fibrillization is originated from peptide’s adsorption and a series of surface-mediated
aggregations. Based on our proposed 2D diffusion-limited aggregation (DLA) model, we
are able to numerically simulate the evolution of the lengths of surface-mediated fibrils
and their distribution during the SMF process. Through bulk concentration control, we
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demonstrate the correlation between fibril’s size and the corresponding DLA rate
constants (kernels). Furthermore, the best-fit simulated results suggested both surface
concentration and surface mobility of amyloid species can modulate the kinetics of fibril’s
formation. In the case of A diffusion on mica, fibrils are mobile on the surface, with a
fractal exponent =0.55, which significantly enhances the SMF process.

4.3 Materials and Methods
Sample Preparation. The sample solutions were prepared using the same procedures

described in our previous works.140,354 To monitor the surface-mediated fibrillization, 150
L solution of A12-28 peptide solution at various concentrations was placed on freshcleaved mica, and then incubated for a specific period of time (between 5 to 60 minutes)
prior to the drying process. A spin coater (WS-650 MZ-23, Laurell Technologies Corp.)
was used to remove excess solution and dry the samples using 1000 RPM speed and an
acceleration of 250 RPM.s without further water-raising process. This speed is below the
rupture threshold of the droplet, allowing for stain-free, artifact-free drying of the surface
as demonstrated in our previous work.354
Atomic Force Microscopy (AFM). The samples prepared at various drying times were
imaged in tapping mode (93% of free amplitude) using AFM (Keysight Technologies,
5500 AFM) equipped with a XYZ closed-loop scanner (for most of samples) or a highresolution scanner (for 5-min samples). Rotated silicon probes with aluminum reflex
coating (Budget Sensors, Tap-300G, resonance frequency ~300 kHz, tip radius <10 nm,
force constant 40 N/m) were used to record topography, amplitude, and phase images
with 512 × 512-pixel resolution for all images.
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Image Processing and Data Analysis. All topographic images were flattened using a
third-order polynomial background in the Gwyddion software328 prior to the imaging
analysis.
Surface density: The total volume of each nanostructure was measured by setting an
appropriate height mask in the Gwyddion software, and then converting into the total
number of peptides assuming that the volume of a single peptide is 2366 Å 3. The surface
density was then calculated as the total number of peptides divided by the area of the AFM
image. Each data point represented in Figure 4-4 is the average surface density of more
than seven AFM images taken from various areas of each same sample.
Cumulative Length Distribution: Using the height mask set before, a binary map can be
created in Gwyddion. ImageJ software329 was used to manually measure the fibril's length
(end-to-end distance) in the binary map. In some cases, it was difficult to judge the fibril's
length due to the small signal-to-noise ratio. Thus, the topography, phase, and amplitude
images were also used to help determine the fibril's length. Each normalized length
distribution in Figure 4-1B includes the results analyzed from more than seven AFM
images taken at various areas of the same sample.
Fractal Dimension Analysis: The fractal dimension of the surface-mediated fibrils (𝑑𝑓,3𝐷 )
was analyzed in the Gwyddion software using the cube counting method. Due to the
constant small height of these fibrils, the fractal dimension can be calculated as 𝑑𝑓,3𝐷 =
𝑑𝑓,𝐴𝐹𝑀 + 1 , where 𝑑𝑓,𝐴𝐹𝑀 is the 2D projected dimension.
Numerical Simulations. The length evolution for the SFM fibrils was calculated in
MATLAB 2016b using the leapfrog algorithm. The details of numerical simulations are
provided in Section 4.7.1.
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4.4 Experimental Results
4.4.1 Evolution of Surface-Mediated Fibrillization
Figure 4-1A shows representative AFM images of samples prepared by incubating
10 μM Aβ12-28 peptide solution on mica substrate for various time periods before drying.
At the low peptide concentration and short incubation times used in this study, there is no
evidence of bulk fibril formation as demonstrated in our previous studies. 354 As such, the
imaged morphologies are produced by surface-mediated fibrillization.140,354 More AFM
images of these samples are provided in Figure 4-2 and Figure 4-3. The AFM images taken
after 5-10 minutes show that at early time stage the structures are predominantly small
structures with maximum heights in the range of 0.3-0.5 nm. Using volume analysis, the
small features displayed in the 5-min AFM image of Figure 4-1A can be ascribed as
monomers, dimers, trimers, and other short oligomers, as indicated by the labeled
numbers. Some short fibrillar structures with length < 200 nm are also found in both
samples, but with smaller frequency. When the controlled incubation time is increased
above 20 mins, the small globular structures gradually disappear and fibrils became the
main observed morphologies. These SMF fibrils are elongated with time, but their
maximum heights does not change and remains within 0.4-0.5 nm. This is a strong
indication that the SFM process for this A fibril on mica is strictly two-dimensional, as
fibrils are only one monomer thick and never cross each other.
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Figure 4-1. The evolution of surface-mediated fibrillization. (A) Representative AFM
snapshots of surface-mediated fibrillization at for samples held incubated for various
amount of time and spun cast at 1000 RMP. The objects labeled by numbers in the 5-min
AFM image are the estimated quantity of Aβ12-28 peptide within each structure based on
the volume analysis. (B) Normalized population vs. fibril length for each incubation time.
The colored histograms display the experimental length distributions of surface species
imaged by AFM. Black curves are the best-fit simulated results based on the proposed
kinetic model in Scheme 1. N is the number of analyzed samples in each histogram.
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Figure 4-2. Representative AFM images of surface-mediated fibrils formed at (A) 5-min,
(B) 10-min, (C) 20-min, and (D) 30-min incubation time on mica substrate.

Figure 4-3. Representative AFM images of surface-mediated fibrils formed at (A) 40min, (B) 50-min, and (D) 60-min incubation time on mica substrate.
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To quantitatively describe the evolution of the surface-mediated fibrillization
process, we can evaluate the size (length) of the surface species and their distribution using
multiple AFM images at each incubation period. The normalized length histograms are
plotted in Figure 4-1B. Consistent with single AFM snapshots, the length histograms
confirm that at the early time stage (5-10 min) small-sized monomers and oligomers are
the most probable species, evolving into small fibrils (15-30 nm in length) after 20 minutes.
The length and the breadth of the length distribution rapidly increases with time, showing
a shift of the most probable length from 22.5 nm to near 200 nm after 30 minutes. In the
rest of this manuscript we develop a model that accurately predicts the kinetics of this
rapid fibril growth, which is used to generate the black-dashed lines in each panel of Figure
4-1B.
The AFM images, such as those shown in Figure 4-1A, can also provide the peptide
quantity using the volumetric analysis140 described in the previous section. Since all fibrils
are only one peptide thick, the volume of each fibril is proportional to its length. In Figure
4-4, the number density of Aβ12-28 peptides at each time point (left axis, peptide number
per unit area) is plotted as a function of time. The number density reaches a plateau after
20 minutes of incubation time. This data suggests that the adsorption and desorption of
Aβ12-28 peptides on mica substrate reaches equilibrium. Considering a uni-molecular
reaction, Equation 4-1 and Equation 4-2 can be used to illustrate the evolution of Aβ12-28
peptide concentration on the surface.
Equation 4-1: [𝑠𝑢𝑟𝑓𝑎𝑐𝑒]𝑡 = [𝑠𝑢𝑟𝑓𝑎𝑐𝑒]𝑒𝑞 {1 − 𝑒 −(𝑘1 +𝑘2 )𝑡 }
𝑘1 𝑅
[𝑏𝑢𝑙𝑘]𝑡=0
1 +𝑘2

Equation 4-2: [𝑠𝑢𝑟𝑓𝑎𝑐𝑒]𝑒𝑞 = 𝑘
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Here 𝑘1 and 𝑘2 are the adsorption and desorption rates, respectively. 𝑅 is a volume to
surface ratio between to the solution volume used (1.5×10-4 L) and the mica surface area
(2.25×10-4 m2). The red dashed line in Figure 4-4 is the best fit curve to Equation 4-1,
which suggests the equilibrium surface concentration is 4.5×10−9 mol/m2 (2.7 ×103
number/μm2) and 𝑘1 + 𝑘2 = 3.0×10−3 s-1. Based on Equation 4-2, 𝑘1 and 𝑘2 can be
determined as 2.0×10−6 s-1 and 3.0×10−3 s-1, respectively.

Figure 4-4. Evolution of surface concentration as a function of incubation time for 10 μM
Aβ12-28 samples. The number density (left axis) is calculated from the volume of the imaged
amyloid structures, which can be converted to the surface concentration (right axis). The
red dashed curve is the best-fit curve of Equation 4-1 (R2=1.00).

4.4.2 Proposed Model for Surface-Mediated Fibrillization
Figure 4-5A displays our proposed model to describe the surface effects on rapid
fibrillization. Similar to the previous studies16,26,117,118, we hypothesize that the mica
substrate can be considered as a template to accumulate peptides through monomer
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adsorption/desorption, after which the motion of the peptides are confined the twodimensional motion on the surface. This is strengthened by the fact that the fibrils are
never observed to be thicker than a single peptide (0.4-0.5 nm) and never cross one
another. The mobility of surface-species enables diffusion-limited aggregation (DLA) and
regulates the rate of fibril formation and elongation. Since fibrils are formed by hydrogen
bonding of A peptides, one can assume that the rate of fragmentation79 or shrinkage251
is much slower than the elongation rate and can be ignored in our analysis. Furthermore,
we don’t observe any experimental evidence of such fragmentation or shrinkage occurring
as the length distribution continuously and rapidly grows as seen in Figure 4-1B.
Figure 4-5A also outlines the elementary growth steps where the structural
evolution obeys a mass balance equation expressed by Equation 4-3.
Equation 4-3:
𝜕𝑓(𝑡,𝑗)
𝜕𝑡

= 𝑅 ∙ 𝑘1 ∙ [𝑏𝑢𝑙𝑘]𝑡=0 ∙ 𝑒 −(𝑘1 +𝑘2 ) 𝑡 ∙ 𝛿𝑗,1

(4-3a)

+2𝐾(1, 𝑗 − 1)𝑓(𝑡, 1)𝑓(𝑡, 𝑗 − 1) − 2𝐾(1, 𝑗)𝑓(𝑡, 1)𝑓(𝑡, 𝑗)

(4-3b)

𝑗−2
+ ∑𝑖=2 𝐾(𝑖, 𝑗 − 𝑖)𝑓(𝑡, 𝑖)𝑓(𝑡, 𝑗 − 𝑖) − ∑∞
𝑘=2 𝐾(𝑗, 𝑘)𝑓(𝑡, 𝑗)𝑓(𝑡, 𝑘)

(4-3c)

Here, 𝑓(𝑡, 𝑗) denotes the surface concentration of 𝑗 -mers at time 𝑡 . The 𝐾(𝑟, 𝑠) is the
kinetic rate constants for the DLA of two reactants with size 𝑟 and 𝑠, i.e. the probability
that an r-mer and an s-mer aggregate. The first term (4-3a) is the first derivative of
Equation 4-1 represents the change in the concentration of monomers via monomer
adsorption from solution, as previously determined by the fit to Equation 4-2. The terms
in (4-3b) illustrate the population gain and loss of the 𝑗-mers due to the monomer addition
(linear growth in length), where the factor of 2 indicates the two active ends for the fibril
elongation. The final terms in (4-3c) describe the population changes of larger structures
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by nonlinear elongation due to fusion of two oligomeric reactants with size larger than a
monomer. In this model, all oligomers (𝑗 ≥ 2) are assumed to be products of the DLA on
the surface.

Figure 4-5. Simulated models and results for SMF. (A) Schematic diagram and the
elementary steps for surface-mediated fibrillization. The steps include peptides’
adsorption to the surface (a) and diffusion-limited aggregations (DLAs) induced by the
surface mobility of monomers (b) and other larger species (c). (B) Contour plots of the
square error (∆2) between experimental and simulated histograms of length evolution, as
a function of the composite factor (𝑘𝑃 ) and the exponent (𝛼) for 10 μM samples. The black
crosses are best-fit parameters with ∆2 ≤ 2. The interval of each contour line is 1 and the
represented contour colors are listed on the right.
The DLA rate constant, 𝐾(𝑟, 𝑠), can be referred to as a generalized sum kernel and
expressed as Equation 4-4355,356:
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Equation 4-4: 𝐾(𝑟, 𝑠) = 𝑘𝑃 (𝑟 −𝛼 + 𝑠 −𝛼 )
Here 𝑘𝑃 is a composite factor related to the monomer’s diffusivity. 𝑘𝑃 is larger if the
monomer diffusion coefficient is larger. The 𝛼 can be considered as the mobility exponent
corresponding to the inverse of fractal dimension (𝑑𝑓 ). This expression infers that a large
reactant (oligomer or fibril) has a slower aggregation rate due to slower surface diffusion,
and that the surface diffusion slows with the fibril or oligomer size (length) to the power
of 𝛼. If two reactants are considerably different in size (e.g. monomers and 100-mers), the
diffusion of the smaller reactant will govern the aggregation rate as it will be the faster
moving species. Moreover, the generalized sum kernels simplify the mass balance
equation in Equation 4-3, where only two free fitting parameters ( 𝛼 and 𝑘𝑃 ) remain
unknown.

4.4.3 Numerical Simulation
To estimate the kernels for the surface-mediated fibrillization observed here, a
leapfrog method is used to compute the length evolution of surface species with various
combinations of 𝛼 and 𝑘𝑃 based on Equation 4-3 and Equation 4-4 (details are provided
in Section 4.7.1). Then, the simulated length distributions are compared with the
experimental histograms (Figure 4-1B) to determine the best-fit parameters. Figure 4-5B
displays the contour map of the square error (∆2 ) between experimental and simulated
length histograms for samples prepared with 10 μM solution as a function of 𝛼 and 𝑘𝑃 . The
black crosses in this map are the data with ∆2 ≤ 2 for the monitored 𝛼 values, which
exhibits a roughly linear relationship between 𝑙𝑜𝑔 𝑘𝑃 and 𝛼 (white dotted line). These sets
of parameters are summarized in Table 4-1.
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Table 4-1. Summary of the simulated parameters with ∆2 ≤ 2 for 10 μM samples.
𝛼

𝑘𝑃 × 10-6, m2mol-1s-1

∆2 (10 μM)

0.50

3.5

1.56

0.55

4.5

1.33

0.60

5.5

1.36

0.65

7.3

1.60

0.70

9.3

1.98

The best-fit simulated length distributions for 10 μM sample are obtained at 𝛼 =
0.55 and 𝑘𝑃 = 4.5×106 m2mol-1s-1, ∆2 = 1.33. The results of this fit are plotted along with
experimental data at all time points in Figure 4-1B as black dashed lines. It can be seen in
this figure that this prediction describes the shape of the experimental histograms and the
kinetics of structural evolution remarkably well. The consistency between experimental
and simulated histograms supports our assumptions for DLAs and size-dependent kernels
of 𝐾(𝑟, 𝑠) on surface-mediated fibrillization. Likewise, these best-fit simulated results can
reveal the detailed structural evolution during surface-mediated fibrillization that cannot
be achieved in static AFM measurements. Figure 4-6 displays the population evolution of
monomers (j=1), oligomers (j=2-50) and fibrils (j>50) in the best-fit simulated histograms
of the 10 μM sample. Unlike the nucleation-limited aggregation, the surface oligomers
rapidly form once monomers are deposited on the surface. There is no significant lag time
for nucleation processes. Instead, the fibril’s formation progresses as rapidly as the
accumulation of surface oligomers, as indicated by the blue arrow. The structural
evolution suggests the surface concentration of mobile oligomers plays an important role
to regulate the formation of surface-mediated fibrils.
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Figure 4-6. The evolution of surface species in the best-fit numerical simulation using
𝛼 = 0.55 and 𝑘𝑃 = 4.5×106 m2mol-1s-1. The monomers, oligomers, and fibrils were defined
as j=1 (black curve), j=2-50 (red curve), and j>50 (blue curve), respectively. The solid and
dashed lines represent simulated results for 10 μM and 5 μM samples, respectively.

4.4.4 Effects of Bulk Concentration on the Surface-Mediated Fibrillization
To further examine the robustness of best-fit parameters determined in the 10 μM
samples, we monitored the effects of bulk concentration on the evolution of surfacemediated fibrillization. Figure 4-7A displays a representative AFM snapshot of surfacemediated fibrils formed at 30 mins using 5 μM Aβ12-28 sample solution. Compared to the
10 μM sample, the reduction of bulk concentration forms shorter fibrils and exhibits a
slower evolution in the length histogram (Figure 4-7B). In the numerical simulation, in
suffices to only change the [𝑏𝑢𝑙𝑘]𝑡=0 from 10 μM to 5 μM in Equation 4-3, and then
simulate the length evolution using various sets of 𝛼 and 𝑘𝐷 (1). Like the 10 μM samples,
the comparison between simulated and experimental histogram provides the contour
plots of the ∆2 (Figure 4-8), where the best fit data of each 𝛼 value have been plotted into
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Figure 4-7C. For 5 μM sample, both 𝛼 = 0.55 and 0.60 can provide the reasonable values
for simulated length histogram with ∆2 = 0.06.

Figure 4-7. Bulk concentration control on SMF. (A) The representative AFM image of
surface-mediated fibrils prepared by 5 μM peptide solution after 30 min incubation on
mica substrate. (B) The length histograms of surface-mediated fibrils formed at 30 min
using 10 μM and 5 μM sample solution. Two dashed curves were the best-fit simulated
length distributions using α = 0.55 and k P = 4.5×106. (C) The comparison of the best-fit
simulated parameters between 10 μM and 5 μM samples. An intersection (α = 0.55) can
be derived using two linear regression fit in logarithmic scale. The error bars indicate the
boundary of ∆2 ≤ 2 and ∆2 ≤ 0.1 for 10 μM and 5 μM samples, respectively.
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Figure 4-8. Simulated results for 5 μM samples. Contour plots of the square error (∆2)
between experimental and simulated length histograms vs. the composite factor (k P ) and
the exponent of size dependence of the rates (α) for 5 μM samples. The interval of each
contour line is 0.02. The represented contour colors are listed on the right.

Table 4-2. Summary of the simulated parameters with for 5 μM samples.
𝛼

𝑘𝑃 × 10-6, m2mol-1s-1

∆2 (5 μM)

0.40
0.45
0.50
0.55
0.60
0.65
0.70

3.0
3.5
4.0
4.5
5.0
5.8
6.8

0.08
0.08
0.07
0.06
0.06
0.07
0.07
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As shown in Figure 4-7C, the best-fit data between 10 μM (black points) and 5 μM
sample (red points) has an intersection at 𝛼 = 0.55 and 𝑘𝑃 = 4.5×106 m2mol-1s-1, which is
the same value as predicted by the 10 μM measurements. This joint point represents a set
of parameters worked for both 5 μM and 10 μM samples. Besides, it also provides the bestfit simulated length histograms with the minimum ∆2 compared to the experimental
results. This control experiment determines the 𝛼 and 𝑘𝑃 for the DLA rate constants in
surface-mediated fibrillization. Furthermore, it also highlights the bulk concentration can
regulate the surface concentration, and modulate the kinetics of fibril’s formation on
surface.

4.5 Discussion
Our results show that the control of incubation time and drying procedure can
effectively be used to retain the products of surface-mediated fibrillization on the substrate
for static AFM measurements. Compared to the amyloid fibrils formed in solution, the
surface-mediated fibrils are one-peptide thick (~0.5 nm), not across with each other, and
lack of complex geometry and morphological heterogeneity (polymorphism). In addition,
the surface fibrils grow rapidly within an hour, where with no significant lag time for the
nucleation step. Except for qualitative analysis, the AFM images can be used to quantify
time-dependent Aβ12-28 fibril length distributions and surface concentration. In the length
evolution, the dynamic features on most probable length and the growth of long fibrils
suggest that surface-mediated fibrillization has distinct mechanism compared to the fibril
elongation monitored in solution phase.251 The tracking of surface concentration indicates
the equilibrium of the peptide’s concentration between solution and surface. Both kinetic
tracks provide a quantitative assessment for the surface-mediated fibrillization.
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Furthermore, the length distributions are the products of multiple kinetic processes,
which can be used to explore the detailed mechanism.
Based on experimental results, we proposed a DLA model with a mass balance
equation (Equation 4-3) to illustrate the mechanism of rapid fibrillization on surface. In
this model, two assumptions have been made for (a) the equilibrium behavior of
monomer’s adsorption and (b) size-dependent DLA rate constant. The former one
provides the concentration input of surface monomer from bulk solution and implements
the formation of other sized species following the DLA mechanism on the surface. In the
case of a 2D surface, a generalized sum kernel, 𝐾(𝑟, 𝑠), was used to represent the DLA rate
constant that involves the size-dependent diffusivity due to effective island diffusion.44 We
note that different forms of kernels have been used for studying protein aggregation under
various of scenarios, e.g. fragmentation.355,356 However, there is no evidence for the length
shrinkage on the experimental length evolution. The mobile hypothesis made for surface
species is supported by our previous reports 140,354, where we demonstrate that these
surface mediated fibrils are loosely bound to mica and could be easily removed from the
substrate, changed the orientations, or packed parallel to each other by the liquid stream
or air flow under inappropriate drying procedures. Also, Shen et al.143,144 also have shown
that the existence of mobile precursors can determine the formation of surface-mediated
fibrils.
Using a leap-frog method, we can numerically simulate the length evolution of
surface-mediated fibrillization with four experimentally measured parameters (𝑅, 𝑘1 , 𝑘2 ,
[𝑏𝑢𝑙𝑘]𝑡=0) and two predicted parameters (𝛼 and 𝑘𝑃 ). Within various sets of 𝛼 and 𝑘𝑃 , the
𝛼 = 0.55 and 𝑘𝑃 = 4.5×106 m2mol-1s-1 provides the best fit simulated length histograms
for both 5 μM (Figure 4-7B) and 10 μM samples (Figure 4-1B) without changing 𝑅, 𝑘1 , and
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𝑘2 . Unlike static AFM measurements, the numerical simulation can provide detailed
footprints on the structural evolution as demonstrated in Figure 4-6, in which two
characteristic features can be recognized in surface-mediated fibrillization. First, the
spatial confinement facilitates the rate of oligomerization. Second, the decrease of bulk
concentration slows down the formation of oligomers and fibrils. From these results, the
formation of oligomers seems not a rate-determined step for surface-mediated
fibrillization, instead, the surface concentration of oligomers becomes more important to
regulate the rate of fibrillization. The rapid fibrillization requires the surface peptide
concentration and the mobility of surface species, which can facilitate the aggregation rate
and shift the population toward to the longer end shortly. We note that the rapid DLAs
can be attributed to the effects of 2D confinement on the adsorbed amyloid species, which
includes the dimensional reduction in translational and rotational motions Also, the
formation of hydrogen bonds along the backbone of amyloid peptides can lower the
activation energy for aggregation.
The physical meaning of the 𝛼 value involves the size effects on surface diffusivity
and effective hydrodynamic radius, and corresponds to the inverse of the fractal
dimension (𝑑𝑓 ) of the reactants. From the best-fit 𝛼 value, the 𝑑𝑓 of the surface reactants
can be determined as 1.82 that is smaller than the dimensionality of surface. We also
examined the fractal dimension of the surface-mediated fibrils imaged in Figure 4-1A,
which revealed 𝑑𝑓,𝐴𝐹𝑀 is 1.56 (details were described in Experimental Details and Data
Analysis section). Theoretically, the amyloid fibrils can be considered as long, rod-like
aggregates in shape, thus, 𝑑𝑓 ~1. Schreck et al.355 also have been demonstrated 𝑑𝑓 ~1.35 for
the amyloid fibrils formed in solution. Here, one could expect that the 𝑑𝑓 of a fibril will
increase while its length becomes shorter because of the change in aspect ratio. In our DLA
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mechanism, 𝐾(𝑟, 𝑠) is a generalized sum kernel that the small reactants weight heavier
than the large ones. Thus, 𝑑𝑓 = 1.82 mainly is represented for the small reactants rather
than the DLA products, longer surface-mediated fibrils (𝑑𝑓,𝐴𝐹𝑀 ). It is also worth to note
that another set of simulated parameters ( 𝛼 = 0.60 and 𝑘𝑃 = 5.5×106 m2mol-1s-1) can
provide good simulated results for both 5 μM and 10 μM samples. The 𝑑𝑓 derived from
this 𝛼 value is 1.67 and still larger than 𝑑𝑓,𝐴𝐹𝑀 .
In the best-fit DLA rate constant, the 𝑘𝑃 value (4.5×106 m2mol-1s-1) is a composite
factor related to the monomer’s diffusivity. The relation between diffusivities and reaction
rate constants have been studied for the reaction 𝐴 + 𝐴 → 𝐴2 or 𝐴 + 𝐵 → 𝐴𝐵.357–361 In 3D,
continuum mechanics can provide a steady-state DLA rate constant corresponding to the
diffusion coefficient of reactants. When the dimensionality falls into 2D, the kinetics
become more complex due to the inflow and outflow of materials via adsorption and
desorption. It is shown that a pure 2D model of surface reactions yield no steady state rate
constant. After considering the influence of adsorption and desorption, Freeman et al.358
and Agmon361 have demonstrated the steady-state DLA rate constant for surface reaction
under different scenarios. However, we are unable to use their results to determine the
monomer’s diffusivity from 𝑘𝑃 , just simply considering the case of the monomer’s DLA on
surface (that results in the formation of dimers). The major challenge is the sequential
reactions can also undergo quickly that disturbs the mean-field approximation. Therefore,
the best-fit 𝑘𝑃 derived in our simulated results may reflect a time-average DLA rate
constant depending on the monomer’s diffusivity.
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4.6 Conclusions
In summary, we have monitored the formation of surface-mediated fibrils under the
controls of incubation time with mica substrate and drying procedure. Through AFM
imaging analysis, the AFM snapshots of surface-mediated fibrils can provide quantitative
assessments in the evolution of peptide’s surface concentration and fibril’s length. In the
aid of our proposed DLA model and numerical simulation, we demonstrate that the
formation of surface-mediated fibrils can be illustrated by two elementary processes,
adsorption of monomers and two-dimensional DLAs. The mobility of loosely-bound
surface species can initiate the monomer addition, as well as the nonlinear elongation that
expedites fibril’s growth rapidly. Except for the surface mobility, the surface concentration
of these mobile precursors is also crucial to regulate the kinetics of surface-mediated
fibrillization. From the best-fit simulated parameter, we figure out the size-dependence on
the kinetic rate constant ( 𝛼 ) is 0.55 and the kinetic rate constant associated with
monomer’s diffusivity (𝑘𝑃 ) is 4.5×106 m2mol-1s-1. Overall, our studies outline the surface
effects on the formation of amyloid fibrils from experimental and theoretical approaches.

4.7 Supplementary Materials
4.7.1 Simulation Details
In Section 4.4.2, Equation 4-3 was used to illustrate the structural evolution. Based
on the AFM experimental results, the experimental constants of 𝑅 , 𝑘1 , and 𝑘2 are
measured to be 𝑅 = 0.67 Lm-2 (L is liter), k1= 2.0×10−6 s-1, and k2= 3.0×10−3 s-1,
respectively. The [𝑏𝑢𝑙𝑘]𝑡=0 is the used peptide concentration. The 𝐾(𝑟, 𝑠) is the kinetic rate
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constants for the diffusion-limited aggregation (DLA) of two reactants with sizes 𝑟 and 𝑠,
which can be expressed as a generalized sum kernel (Equation 4-4).
In Matlab, we can numerically simulate the concentration evolution of 𝑗-mers at
different time points using a leapfrog algorithm. The algorithm uses the recurrence
relation, Equation 4-5, with 𝛿𝑡 = 1.
Equation 4-5: 𝑓(𝑡 + 𝛿𝑡, 𝑗) = 𝑓(𝑡, 𝑗) +

𝛿𝑓(𝑡,𝑗)
𝛿𝑡

∙ 𝛿𝑡

The total length of time and 𝑗 were set as 3600 s (60 minutes) and 3000, respectively. At
the end of the simulation, the population of 𝑗-mers at different times was normalized to 1,
and then compared with the experimental results. The size conversion of 𝑗-mers from
simulation to experiments is performed by assuming 𝑙𝑒𝑛𝑡ℎ (𝑛𝑚) = 0.5 (𝑛𝑚)×𝑗 + 15 (𝑛𝑚),
where 0.5 nm is the expected inter-stand distance236 and 15 nm is the smallest length that
can be distinguished in our AFM images.
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CHAPTER 5. A Novel Technique to Measure Surface Tension at the
Solid-Liquid Interface of Self-Assembled Amyloid Fibrils

5.1 Abstract
The rupture of a thin dewetting film after being fully spread on a surface can alter surface
morphologies of self-assembled species to dewetting patterns, e.g. holes, stripes, or
droplets. In this report, we combine this effect with spin-induced dewetting to investigate
the changes in the surface energy of mica induced by surface-mediated fibrillization. The
interplay between spin speed, acceleration rate, and the formation of surface-mediated
fibrils shows various morphological transitions from wetting to dewetting patterns in the
spun-dried samples. These threshold of wetting-dewetting transition (WDT) is due to a
critical balance between three surface tensions at substrate-air (𝛾𝑆𝑂 ), liquid-vapor (𝛾𝐿𝑉 )
and solid-liquid interface (𝛾𝑆𝐿 ), and two interfacial tensions induced by the centrifugal
force ( 𝛾𝐶 ) and/or surface-mediated fibrils ( 𝛾𝐹 ). Therefore, we propose a modified
spreading coefficient ( 𝑆𝑠𝑝𝑖𝑛 ) to evaluate the two induced interfacial tensions under
different spun-dried conditions. This novel approach provides a new methodology to
characterize the change of surface energy at a solid-liquid interface in a fluidic system,
where adsorbates are mobile on the surface, and further explains the slow-spinning
conditions that can leave the surface-mediated fibrils or deposited nanostructures on mica
substrate without drying artifacts.
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5.2 Introduction
Spin-coating is one of the most widespread methods to prepare uniform films,
ranging from a few nanometers to micrometers in thickness. This process involves liquid
dispense, spin-up, spin-off, and evaporation stages, and can be broadly applied to various
materials and solvent choices in a wide variety of systems of study, such as photoresists,
organic semiconductors, polymers, and nanoparticles.362–364 The final film thickness and
its properties is highly associated with material’s properties (e.g. concentration, solution
viscosity, solvent evaporation rate, and so on), as well as the parameters chosen for the
spin process (e.g. substrate, acceleration rate, terminal speed, and spin time).365,366
For thin film preparation, the designed materials can be spread evenly over the
substrate using a spin-coating process (Figure 5-1A, wetting region), as long as the
condition is such that the film does not rupture before solvent evaporation. However, if
the film is metastable, the dewetting process (Figure 5-1) can spontaneously break the thin
film into smaller droplets, holes, or stripes.367 A spreading coefficient (𝑆) can be used to
distinguish between wet vs. dewet condition based on the difference between surface
tension values of the solid and liquid, as shown in Equation 5-1.368,369
Equation 5-1: 𝑆 = 𝛾𝑆𝑂 − (𝛾𝐿𝑉 + 𝛾𝑆𝐿 )
In Figure 5-1, three γ coefficients are the surface tensions at the substrate-air (𝛾𝑆𝑂 ), liquidvapor (𝛾𝐿𝑉 ), and solid-liquid interface (𝛾𝑆𝐿 ). When 𝑆 is positive, thin film wets the surface,
while negative 𝑆 causes the spontaneous rupture of a thin film into dewetting patterns.
The spontaneous wetting-dewetting transition (WDT) can be used to characterize the
surface energy and interfacial energy in a polymer thin film.370,371 Here we show that,
compared to the other existing methods, such as the contact angle and the JKR
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technique372, this dewetting method is advantageous for a surface with energy variation or
heterogeneous chemistry.370

Figure 5-1. A static model of wetting and dewetting behavior in a thin film. The spreading
coefficient (S) determines a thin film to be in the (A) wetting region ( S > 0) or (B)
dewetting region (S < 0). S denotes the balance among surface tensions at substrate-air
(γSO), liquid-vapor (γLV) and solid-liquid interfaces (γSL), as shown in Equation 5-1.

In some cases, the dewetting phenomena are undesirable due to the formation of
surface patterns that may interfere with the device performance in industrial application.
But, they can be beneficial for surface patterning and fast drying.337,365,373–375 For example,
Hameren et al.374 demonstrated that highly periodic patterns can be achieved by using the
self-assembled properties of porphyrin trimers combined with the physical dewetting
phenomena. In our previous reports140,354, we demonstrated that a slow-spinning process
can be used to rapidly dry the surface-mediated fibrils without drying artifacts. This
suggested the diluted peptide solution can be spread on the surface (wetting-conditions),
and then flung off the side until the sample was dried. While by increasing the spin speed,
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the dewetting patterns composed of nano-sized droplets with polygonal distributions were
observed on the surface, which was accompanied by self-assembled surface-mediated
fibrils produced on surface prior to drying.354 However, the details of drying during the
spinning stage were not investigated.
Here, we systematically study the effects of spin speed, acceleration rate and the
existence of surface-mediated fibrils on the samples dried during the spin stage. The
remained surface morphologies enable us to identify the drying experience of each sample,
either wetting-like or dewetting-like behavior, which can be denoted as the sign of 𝑆.
Therefore, the WDTs indicate the existence of a critical balance among all interfacial
tensions. Based on a modified spreading coefficient (𝑆𝑠𝑝𝑖𝑛 ), these WDTs are valuable for
estimating the interfacial tensions generated by the centrifugal force ( 𝛾𝐶 ) and the
formation of surface-mediated fibrils (𝛾𝐹 ). More importantly, we outline a guidance for
the spin-coating parameters chosen for the samples deposited with nanostructures in fluid.
It helps the design of sample preparation method in avoiding drying artifacts, as well as
the development in surface nanopatterning with bio-molecules.

5.3 Materials and Methods
Sample Solution. Synthetic Aβ12-28 peptide (purity > 95%, rPeptide) was directly used
to prepare the sample solution without further purification. The Aβ 12-28 peptide was first
dissolved in 1 % NH4OH(aq) at a concentration of 1 mg/ml. The solution was sonicated for
2 minutes, and subsequently diluted with Milli-Q water to a concentration of 10 μM. To
remove large aggregates, the solution was filtered using a 0.22 μm PTFE membrane
syringe filter. The prepared peptide solutions were immediately used for further
experiments.
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Contact Angle Measurement. Water contact angle on fresh-cleaved mica was
measured by OCA15 contact angle analyzer (Dataphysics, Germany) using a 5 µL deionized
water droplet. The experiments were performed under the help with Dr. Dengteng Ge (Shu
Yang’s Group, Penn, MSE).
Spun-cast Samples. 0.2 mL of peptide solutions were placed on fresh-cleaved mica and
were either spun-cast immediately, or incubated for 30 minutes prior to the spun-casting
process. A spin-coater (WS-650 MZ-23, Laurell Technologies Corp.) was used to dry the
samples under various spinning rates in the range of 1000 to 3000 RPM. The acceleration
rate was set as either 250 rpm/s or 400 rpm/s. The duration of spin time was one minute.
Atomic Force Microscopy (AFM). The spun-dried samples were imaged in tapping
mode using a Keysight 5500 AFM instrument (Keysight Technologies) equipped with a
closed-loop scanner. Rotated silicon probes (BudgetSensors, Tap-300G, resonance
frequency ~300 kHz, tip radius ~10 nm) were used to record topographic, amplitude, and
phase images with 512 x 512 pixel resolution. The images were taken from the central
region of each sample to avoid the potential gradient effects at the edges of the sample140,
where the drying rate could be slower. The AFM images were processed and analyzed by
Gwyddion package.328 A third-order polynomial was used to flatten the background for
topographic images.
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5.4 Results and Discussion

5.4.1 Morphological Characterization of Spun-Cast Samples
Figure 5-2 shows representative AFM images of spun-cast samples dried under
variable spin speeds (from 1000 rpm to 3000 rpm in each column) and acceleration rate
(top row: 250 rpm/s, bottom row: 400 rpm/s). To prevent the formation of surfacemediated fibrils, these samples were prepared immediately after dispensing the Aβ12-28
peptide solution (10 μM) on mica substrate. We note that the 1000 rpm was the lowest
speed where solution dried under these conditions. At 500 rpm, the samples could not dry
within the 1 min spin time.

Figure 5-2. Representative AFM images of non-incubated samples dried by spun-casting
process. The acceleration rate was set as 250 rpm/s for (A-E) and 400 rpm/s for (F-G).
The terminal spin-speed for each column is labeled on the top. The letter at the bottom of
each image indicates the classification of the observed surface patterns. D (red-colored)
and W (cyan-colored) indicate dewetting and wetting patterns, respectively. The scale bar
is 2 μm for each image, and the right color bar represents the height range in all of the
images shown here.
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In the top row of Figure 5-2, the non-incubated samples dried using a slow
acceleration rate, 250 rpm/s, exhibit many nano-sized, globular structures. When the
acceleration rate increases to 400 rpm/s, the surface morphologies display a significant
change from a bare mica substrate (Figure 5-2F and Figure 5-2G) to the polygonal
networks (Figure 5-2H) and eventually globular structures (Figure 5-2I and Figure 5-2J)
upon increasing speed speed. This morphological transition highlights that, at a spin speed
of about 2000 rpm, the system experienced a wetting to dewetting transition (WDT).
Notably, the wetting behavior means that the liquid layer was fully spread during spinning
and the excess peptides in the solution flung off the side, which prevents the deposition of
Aβ12-28 peptides on the surface. In contrast, the dewetting patterns are featured as the
formation of polygonal networks or globular structures due to the rupture of the film at
high spin speeds, which produces small Aβ12-28 containing droplets that leave their content
behind upon drying. For the ease of cross-comparisons, a letter labeled in the lower left
corner of each image is used to indicate the dewetting (red-colored D) or wetting patterns
(cyan-colored W) formed under a specific condition. At 250 rpm/s, all samples showed a
dewetting pattern.
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Figure 5-3. Representative AFM images of the samples with 30-min incubation prior to
spun-casting process. Under these conditions, a sub-monolayer of surface-mediated
fibrils is formed during incubation time. The acceleration rate was set as 250 rpm/s for
(A-E) and 400 rpm/s for (F-G). The terminal spin-speed for each column is labeled on the
top. Bottom-left letter in each image indicates the classification of surface patterns, where
D (red color) and W (cyan color) denote to dewetting and wetting patterns, respectively.
The scale bar is 2 μm for each image. For ease of comparison, the height scales are set
within the range of -0.5 and 1.5 nm (top right) for (B-E) and -0.3 and 0.5 nm (bottom
right) for (A, F-J), respectively. The light blue arrows highlight the surface-mediated fibrils
in the background of dewetting patterns, which were formed during the incubation period.

As demonstrated in our previous reports140,354, the low-concentrated solution of
Aβ12-28 peptides used in this study can rapidly self-assemble into fibrils on mica substrate
during the incubation period. To investigate the effects of surface-mediated fibrillization
on the substrate surface energy, we prepared surface-mediated fibrils by incubating Aβ1228

solution for 30 min on mica surface before drying under the same spun-casting

conditions applied to non-incubated samples. Our previous studies showed that under
these conditions, 5-10 % surface coverage of short, mobile surface-mediated fibrils can
form on mica. Figure 5-3 displays representative AFM images of these samples after
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drying. Light blue arrows indicate the self-assembled fibrils or individual fibril (~0.5 nm
in thickness) left behind the dewetting patterns.
In the top row of Figure 5-3, a morphological transition from surface-mediated
fibrils to the dewetting patterns is observed between 1000 rpm (Figure 5-3A) and 1500
rpm sample (Figure 5-3B) using a slow acceleration rate (250 rpm/s). As indicated by blue
arrows in Figure 5-3 B-E, the rupture of the liquid layer appears to draw the sparse fibrils
together, and then form the self-assembled fibrils in the samples dried at a higher spin
speed. Similar morphological transition is also shown between 2000 rpm (Figure 5-3H)
and 2500 rpm sample (Figure 5-3I) prepared at a fast acceleration rate (400 rpm/s). In
Figure 5-3I and Figure 5-3J, the fibrillar morphologies are sparsely distributed behind the
dewetting patters. Compared to non-incubated samples, the existence of the surfacemediated fibrils shifts the WDT towards a higher spin speed.

5.4.2 Distinct Effects on Spun-Cast Samples
Comparisons between the samples shown in Figure 5-2 and Figure 5-3 reveal the
effects of spin-speed, acceleration rate, and surface-mediated fibrils on the surface
morphologies, and therefore WDTs. In Table 5-1, five types of morphological transition
from wetting to dewetting patterns are summarized as different scenarios. Scenario 1 and
3 are attributed to the increase of spin speed after comparing the samples prepared at the
same acceleration rate (same row in Figure 5-2 and Figure 5-3). Scenario 2 and 4 describe
the effect of acceleration rate on the morphological change between two samples in the
same column (same spin speed). We note that both Scenario 3 and 4 have an extra effect
produced by the surface-mediated fibrils pre-covered on the mica substrate prior to spun101

casting process. This results the Scenario 3 and 4 shift to a higher speed compared to
scenario 1 and 2. Scenario 5 illustrates the pure effect of surface-mediated fibrils on the
WDT after superimposing Figure 5-3 on Figure 5-2 (same spin speed and acceleration
rate).

Table 5-1. Scenarios of different wetting-dewetting transitions in spun-dried samples.
Scenario

Effects

Wetting Image a
(𝑆 > 0)

Dewetting Image a
(𝑆 < 0)

Comparison
type

1

Spin Speed

2G

2H

Row

2

Acceleration

2F

2A

2G

2B

3

Spin Speed
+ Fibril

3A

3B

3H

3I

4

Acceleration
+ Fibril

3G

3B

3H

3C

5

Fibril

3A

2A

3H

2H

a

Column

Row

Column

Superposition

The images were from Figure 5-2 and Figure 5-3.

5.4.3 Modified Spreading Coefficient
Contact angle measurement of mica (Figure 5-4) shows that water tends to spread
on fresh-cleaved mica substrate and has a small contact angle, 𝜃 ~8º. The balance of
surface tensions can be described by Young’s equation376, the surface energy of mica in
air/nitrogen (𝛾𝑀𝐼𝐶𝐴 = 𝛾𝑆𝑂 in this study), and the equilibrium spreading pressure of water
on mica (𝜋𝑒 ).377
Equation 5-2: 𝛾𝑆𝑉 = 𝛾𝐿𝑉 𝐶𝑜𝑠𝜃 + 𝛾𝑆𝐿 = 𝛾𝑀𝐼𝐶𝐴 − 𝜋𝑒
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We note that the 𝛾𝑆𝑉 is the surface energy of mica at solid-vapor interface that is different
than the 𝛾𝑀𝐼𝐶𝐴 due to the volatility of solvent (water). For the water-mica system, the 𝛾𝐿𝑉 ,
𝛾𝑆𝐿 and 𝜋𝑒 were reported as 72, 10± 5 and 68± 1 mN m-1, respectively.377,378 Therefore, the
𝛾𝑀𝐼𝐶𝐴 can be estimated as 146± 6 mN m-1. Using Equation 5-1, the spreading coefficient is
calculated as 𝑆 =64± 11 mN m-1 for dispensing a water droplet on mica. Since 𝑆>0, this
value fulfills the wetting condition observed in the contact angle measurement. The 𝛾𝑀𝐼𝐶𝐴
is the only contributor that allows the liquid layer to wet the substrate.

Figure 5-4. Contact angle measurement of the fresh-cleaved mica substrate.

If a WDT happens in the static condition, the process can be described by the sign
change of 𝑆 from a positive value to a negative one. The physical picture is the rupture of
droplet. In the spun-cast samples, the spin-induced surface morphologies enable us to
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track WDT as spin speed is increased. Under these circumstances, besides the surface
tensions displayed in the static condition, two new interfacial tension terms induced by
the centrifugal force (𝛾𝐶 ) and the formation of surface-mediated fibrils (𝛾𝐹 ) also play a role
and must be accounted for the spreading coefficient.

Figure 5-5. Schematic diagram of various among interfacial tensions for (A) nonincubated samples and (B) pre-incubated samples. 𝛾𝐶 and 𝛾𝐹 are interfacial tensions
induced by centrifugal force and surface-mediated fibrils, respectively. The surface
tensions at substrate-air, liquid-vapor, and solid-liquid interfaces are represented as γSO,
γLV, and γSL, respectively.
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Figure 5-5 systematically shows the relationship between difference interfacial
tensions at spin stage (before drying). For all spun-cast samples, the centrifugal force (𝐹𝐶 )
can cause an interfacial tension (𝛾𝐶 ) at the circumstance of an imaginary circle (𝐿𝐶 ) with
any given radius, as shown in Equation 5-3.
𝐹

Equation 5-3: 𝛾𝐶 = 𝐿𝐶 =
𝐶

𝑚𝜔2 𝑘
2𝜋

The 𝑚 and 𝜔 are the mass of solution on the substrate inside the circle (kg) and the spin
speed (rpm), respectively. The 𝑘 is a constant (1.09662×10−2 ) converted the 𝑚𝜔2 term
into SI unit. Unlike 𝛾𝑆𝑂 , the 𝛾𝐶 acts to disperse the liquid layer in the centrifugal direction
and has a negative contribution to 𝑆. This is supported by the experimental observations
in the top row of Figure 5-2, where only the dewetting patterns are observed on the surface
(Figure 5-5A). In Scenario 2, the fast acceleration rate creates a smaller contribution to 𝛾𝐶
compared to the slow acceleration rate. This can be attributed to the different mass of
solution (𝑚) on the mica substrate at the end of acceleration stage. Scenario 4 shows the
same tendency, but it happens at a higher spin speed compared to Scenario 2, where is no
surface-mediated fibrils. The higher speed generates a larger 𝛾𝐶 , thus, the formation of
surface-mediated fibrils decreases the effects of 𝛾𝐶 and contributes positively to 𝑆 (Figure
5-5B). Scenario 5 also delivers the same information for 𝛾𝐹 . Equation 5-4 sums up the
effects of chosen spin parameters and surface-mediated fibrils on a modified spreading
coefficient (𝑆𝑠𝑝𝑖𝑛 ).
Equation 5-4: 𝑆𝑠𝑝𝑖𝑛 = 𝛾𝑆𝑂 − (𝛾𝐿𝑉 + 𝛾𝑆𝐿 ) − 𝛾𝐶 + 𝛾𝐹
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5.4.4 Modified Spreading Coefficient Fits Experimental Observations
Among spun-cast samples, the WDTs indicate the existence of a critical point
where all interfacial tensions are in balance (𝑆𝑠𝑝𝑖𝑛 = 0). Figure 5-6 shows three WDTs
displayed in Scenarios 1 and 3 that can be used to evaluate 𝛾𝐶 and 𝛾𝐹 . We assume that (i)
a critical spin speed exist in the middle of the two used speeds (e.g. 1750, 2250 and 1250
rpm for Figure 5-6 A-C, respectively) where 𝑆𝑠𝑝𝑖𝑛 = 0, (ii) the same acceleration rate
produces the same film thickness and mass (𝑚), (iii) two used acceleration rates create
different values of 𝑚 (𝑚𝐴250 and 𝑚𝐴400 , where the subscripts represents the acceleration
rate), and (iv) 𝛾𝐹 is the same for all incubated samples due to the same incubation time
and therefore the same surface density of surface-mediated fibrils. Based on Equation 5-3
and Equation 5-4, 𝑚𝐴250 , 𝑚𝐴400 , and 𝛾𝐹 can be estimated as 3.9×10−5 kg, 1.2×10−5 kg,
and 41.8 mN m-1, respectively. Detailed calculations are provided in Section 5.6.
To validate 𝑚𝐴250 , 𝑚𝐴400 and 𝛾𝐹 , we use these parameters and the experimental
spin speed to predict 𝑆𝑠𝑝𝑖𝑛 for all spun-cast samples, which summarized in Table 5-2. The
predicted 𝑆𝑠𝑝𝑖𝑛 fulfills the wetting or dewetting conditions observed in the spun-cast
samples. Besides, various scenarios listed in Table 5-1 can be well-explained by the
predicted 𝑆𝑠𝑝𝑖𝑛 . For instance, the difference between Scenario 2 and 4 is due to different
mass of liquid layer on the surface (𝑚𝐴250 = 3.9×10−5 kg vs. 𝑚𝐴400 = 1.2×10−5 kg) at the
end of the acceleration stage. There is a near three-fold difference in the magnitude of 𝛾𝐶
under the same spin speed.
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Figure 5-6. Three cases of the wetting-dewetting transitions used for evaluating 𝑚𝐴250
and 𝑚𝐴400 and 𝛾𝐹 .

For Scenario 3-5, the 𝛾𝐹 shows a tendency to increase the surface energy of mica
substrate (𝛾𝑀𝐼𝐶𝐴 ) and delay the spin-induced WDT to higher spin speeds compared to the
non-incubated samples prepared by a slow spin speed. This highlights the importance of
choosing appropriate parameters for spin-coating process to prevent the potential drying
artifacts from the dewetting behaviors happened at spin stage. Based on our results, a
slower spin speed combined with a faster acceleration rate can be adequately applied to
fast-drying the surface-mediated fibrils. More importantly, utilizing the spin-induced
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dewetting phenomena and our proposed 𝑆𝑠𝑝𝑖𝑛 , we can characterize the change of surface
energy due to the formation of surface-mediated fibrils in fluids (𝛾𝐹 = 41.8 mN m-1). Hence,
for a surface deposited with nanostructures in solution, the change of surface energy can
be estimated by applying the spin-induced dewetting methods generated in this study.

Table 5-2. Predicted 𝑆spin for Spun-Cast Samples.
Images

Acceleration
rate (rpm/s)

Terminal Speed (rpm)
1000

1500

2000

2500

3000

2A - 2E

250

-3.7 (D)

-88.4 (D)

-206.8 (D)

-359.2 (D)

-545.4 (D)

2F - 2J

400

43.1 (W)

17.0 (W)

-19.6 (D)

-66.6 (D)

-124.1 (D)

3A - 3E

250

38.1 (W)

-46.6 (D)

-165.1 (D)

-317.4 (D)

-503.6 (D)

3F - 3J

400

84.9 (W)

58.8 (W)

22.2 (W)

-24.8 (D)

-82.3 (D)

The 𝑆𝑠𝑝𝑖𝑛 (mN m-1) for each image displayed in Figure 5-2 and Figure 5-3 was calculated by
Equation 3 and 4. The red- and blue-color indicate the predicted dewetting (𝑆𝑠𝑝𝑖𝑛 < 0) and
wetting behavior (𝑆𝑠𝑝𝑖𝑛 > 0), respectively. The letter listed in the parenthesis is the surface
patterns displayed in the corresponding AFM image.
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5.5 Conclusions
In summary, we have shown the effects of spin-coating parameters and surfacemediated fibrils on the surface morphologies of spun-dried samples. The resulted surface
patterns allow us to track wetting or dewetting phenomena under each condition. After a
series of cross-comparisons, the wetting-dewetting transitions (WDTs) between two
different conditions can be classified into five distinct scenarios. In the case of WDTs
produced by the increase of spin speed (Scenario 1 and 3), it implies the existence of a spin
speed that can make a critical balance among interfacial tensions. Therefore, we propose
a modified spreading coefficient 𝑆𝑠𝑝𝑖𝑛 to describe the relationship among three static
surface tensions (𝛾𝑀𝐼𝐶𝐴 , 𝛾𝐿𝑉 and 𝛾𝑆𝐿 ) and two induced interfacial tensions (𝛾𝐶 and 𝛾𝐹 ).
Under several assumptions, the 𝛾𝐶 and 𝛾𝐹 can be quantitatively estimated using
the WDTs. The 𝛾𝐶 is the main driving force to cause the spin-induced dewetting
phenomena. A higher acceleration rate (400 rpm/s) will produce a smaller 𝛾𝐶 that causes
the WDTs happened under the same spin speed (Scenario 2 and 4). In contrast, the 𝛾𝐹
(41.8 mN m-1) tends to increase the surface energy of mica substrate and favors to stay in
wetting-like behavior. This explains why a slow-spinning condition can dry the surfacemediated fibrils without drying artifacts. Furthermore, our approaches provide a new
methodology to determine the change of surface tension at solid-liquid interface due to
the formation of surface-mediated fibrils in fluids. Unlike the spontaneous dewetting
method applied in thin polymer film studies370,371, the spin-induced dewetting phenomena
can be controlled by the spin-coating parameters (e.g. acceleration rate) and experimental
conditions (e.g. surface chemistry). Therefore, this method can be generally applied to the
other fluidic system, where a surface depositing with nanostructures.
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5.6 Supplementary Materials
For Figure 5-6, we assume the 𝑆𝑠𝑝𝑖𝑛 = 0 happened at the middle spin speed of the
WDTs. Therefore, using the known parameters (𝛾𝑀𝐼𝐶𝐴 , 𝛾𝐿𝑉 , 𝛾𝑆𝐿 , 𝜔) and Equation 5-4, three
equation listed in below can estimate the 𝑚𝐴250 , 𝑚𝐴400 and 𝛾𝐹 .
Equation 5-5: 0 = 64 − 𝑚𝐴400 ×

17502
×1000×𝑘
2𝜋

(Figure 5-6A)

Equation 5-6: 0 = 64 − 𝑚𝐴400 ×

22502
×1000×𝑘
2𝜋

+ 𝛾𝐹

(Figure 5-6B)

Equation 5-7: 0 = 64 − 𝑚𝐴250 ×

12502
×1000×𝑘
2𝜋

+ 𝛾𝐹

(Figure 5-6C)

The mA250, mA400 and γF can be estimated as 3.9×10−5 kg, 1.2×10−5 kg and 41.8 mN m-1,
respectively.
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CHAPTER 6. Quantitative Analysis of Amyloid Polymorphism at
Mesoscale
Yi-Chih Lin, Hiroaki Komatsu, Jianqiang Ma, Paul H. Axelsen and Zahra Fakhraai.
Quantitative Analysis of Amyloid Polymorphism Using Height Histograms to Correct
for Tip Convolution Effects in Atomic Force Microscopy Imaging. RSC Adv. 2016, 6,
114286–114295. Reproduced by permission of The Royal Society of Chemistry.

6.1 Abstract
Atomic force microscopy (AFM) is widely used to image biological nanostructures. In this
chapter, we demonstrate that AFM can be used to quantitatively characterize the
polymorphism of amyloid fibrils through an analysis of height histogram plots under
conditions where the image lacks high lateral resolution. In this approach, Gaussian fits
are used to determine the characteristic height and volume of fibril species in the heighthistogram plot of an image, and to convert these distributions into a quantitative
assessment of the relative volume content of various species. This approach to fibril
analysis facilitates rapid quantitative analysis of polymorphic species in heterogeneous
samples of amyloid fibrils and other nano-structured materials.
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6.2 Introduction
The formation of β-sheet rich, amyloid fibrils is associated with various
protein misfolding diseases.3,4,6,379 A complicated interplay between protein
structure, environmental conditions, and aggregation pathways appears to
influence the rate of formation and morphology of these fibrils.79,80,101 The
mechanism by which they nucleate and extend remains unclear, as does their
detailed structure. However, it is clear that structural polymorphism exists on a
mesoscopic scale,19 suggesting that quantitative analysis of this polymorphism may
yield insight into the relationship between conditions of formation and structure.
Both transmission electron microscopy (TEM)201 and atomic force microscopy
(AFM)234 can distinguish various polymorphs, but obtaining quantitative mesoscale
information is challenging in both methods.213,380
AFM89,243,251,259 provides three-dimensional information about features
ranging from several nanometers to tens of micrometers in size. The precision of
AFM in the lateral (xy) directions depends on a variety of experimental parameters
such as the number of scanned points, the scanning rate, various properties of the
scanner, and the relative sizes of the tip and the structure being imaged.88,243 Tipdilation (i.e. the fat-tip effect) is a major challenge in AFM imaging of
nanostructures, as it causes lateral measurements to be exaggerated and
inaccurate.381 To some extent, this problem can be addressed by using ultra-high
resolution scanners and ultra-sharp tips.242,252 However, these methods are
expensive and even with specialized instrumentation, the lateral information is
much less precise than the height information (i.e. normal to the surface in the z
direction). Nevertheless, precise height information can be extremely useful, and
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lateral information is sufficiently precise to quantify amyloid fibril characteristics
such as the number of fibrils, their length, and persistence height.213,249,259,287,380,382
In this chapter, tobacco mosaic virus (TMV) and fibrils formed by 40-residue
amyloid beta peptide Aβ40 have been examined to demonstrate that the precise
height information obtained by AFM can be used to quantify the relative volume
content of various polymorphs in an AFM image. Aβ40 forms fibrils that accumulate
in the brains of Alzheimer’s disease patients.12,109 The morphology of Aβ40 fibrils is
strongly influenced by the preparation conditions, such as temperature,
concentration, and ionic strength.19,75,211,249,258,383,384 This work describes an
approach to the analysis of high-precision height information from AFM images
that enables rapid quantitative characterization of Aβ40 fibril polymorphism in
highly heterogeneous amyloid samples. This approach to AFM image analysis can
help rapidly and efficiently correlate the effects of experimental conditions on the
amyloid fibril morphology and polymorphism163,224,254,385,386 and contribute to the
research in this field. It can also be applied more broadly to other nanostructures
with distinct height features, such as mixed nanoparticle systems387 and selfassembled structures.

6.3 Materials and Methods
6.3.1 Tobacco mosaic virus (TMV) samples
100 μL of an aqueous TMV solution, extracted from dried leaves infected by
TMV (ATCC, PV-598), was deposited and tilted to spread over the whole mica
substrate, and then removed solution slowly using Kimwipe. The deposition of TMV
on silicon wafer was used a two-step spin-coating process, 3 minutes at 500 rpm
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and 1 minutes at 3000 rpm, to dry the sample after placing 100 μL of TMV solution
on substrate.
6.3.2 Amyloid Fibril Samples
Synthetic Aβ40 was obtained from Keck Biotechnology Resource Laboratory
Small Scale Peptide Synthesis facility at Yale University with the wild type human
sequence, i.e. DAEFRHDSGY EVHHQKLVFF AEDVGSNKGA IIGLMVGGVV. It
was further purified by HPLC on a 4.6 x 250 mm reversed phase Gemini-NX
5micron C18 column (Phenomenex, Torrance, CA) with the following gradient:
Solution A: 0.1% NH4OH in water; Solution B: 0.1% NH4OH + acetonitrile (1:200
in volume); linear increase over 60 min from 0% to 60% B, a constant flow rate of
0.5 ml/min, and detection by absorbance at 278 nm. The main peak eluted at 〜27
min and was verified by mass spectrometry to have the expected mass and a purity
of ≥ 95%. The concentration of purified amyloid β-protein was determined from the
area of the 278 nm peak, using an extinction coefficient of 1490 M-1cm-1.
Biosynthetic amyloid β-protein (rPeptide, HFIP purified) was dissolved in
40% hexafluoroisopropanol (HFIP) and 60% 5 mM HCl, and then lyophilized. This
lyophilization process was done twice. It was then re-dissolved at a concentration
of 50 µM in 10 mM HCl (pH = 2.4) containing 0.04% sodium azide as a preservative,
and briefly placed in a bath sonicator. Biosynthetic fibril for seeds was formed by
incubating this solution for one month at 37°C without agitation. The resulting
material was then pelleted in a centrifuge at 20,000 x g for 3 hours at room
temperature, re-suspending the pellet in 10 mM HCl solution (pH = 2.4), and
placing the suspension in a bath sonicator for 90 seconds. Seeded fibrils were
prepared by adding seeds to a 200 µM solution of synthetic amyloid β-protein in a
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1:30 molar ratio of seeds:monomer, and incubated for at least 2 months at 37°C
without agitation.
6.3.3 Transmission electron microscopy (TEM) Measurements
Approximately 7 μl of 3 ng/μl of fibrillized amyloid β-protein solution onto
freshly glow-discharged carbon films on 300 mesh nickel grids for 1 min and then
blotted with filter paper. A 1% solution of ammonium molybdate (pH = 7.4) was
applied for 1 min, blotted, air-dried, and examined with a JEOL-1010 transmission
electron microscope (Tokyo, Japan), operating at 80 kV, equipped with a sidemounted CCD digital camera.
6.3.4 Atomic Force Microscopy (AFM) Measurements
Three droplets of the sample solutions were aliquotted onto freshly cleaved
mica, incubated for 5 minutes, and dried by spin-coating.140 The spin process was
held at 750 rpm (250 rpm/s) for 10 minutes. During spinning, each sample was
rinsed three times by water to remove the buffer and eliminate the formation of salt
crystals. Samples were then imaged with a Keysight 5500 AFM (Keysight
Technologies, former Agilent Technologies) equipped with a multi-purpose XYZ
closed-loop scanner. The scanner was calibrated by standard calibration gratings
(MikroMasch, TGZ02 for height and TGX11 for lateral direction) prior to TMV and
amyloid measurements. Rotated monolithic silicon probes with aluminum reflex
coating (BudgetSensors, Tap-300AlG, resonance frequency 〜300 kHz, tip radius
<10 nm, force constant 40 N/m) were used to record topography, amplitude, and
phase images with 512× 512 pixel resolution. Depending on the image size, the
resolution ranged from 2.0 nm/pixel (1 μm×1 μm) to 9.8 nm/pixel (5 μm×5 μm).
The oscillation amplitude setting for all AFM measurements was 92% of the free
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amplitude, except for control experiments on TMV to show that the choice of
amplitude does not affect the measurements presented here.
6.3.5 Quantitative Data Analysis
Gwyddion software was used to analyze AFM images.328

To remove

background, a third-order polynomial was applied to flatten each AFM image.
Height histograms and height profiles were extracted and analyzed after the
flattening process.

While calculating the volume from height histogram, the

number of pixel counts was converted into pixel areas, and then multiplied the
corresponding height value. In order to characterize the type of fibril, normalized
height distribution was fitted by two or more than two Gaussian functions
depending on the composition of the structures within analyzed image. The details
are further discussed in next section.

6.4 Experimental Results and Discussion
6.4.1 Height Histogram Analysis
TMV particles were imaged by AFM in tapping mode as described in the
Materials and Methods section (Figure 6-1A). Twenty line profiles from this image
(one example displayed in Figure 6-1B) yield an average height maximum of
Hmax,P=16.81 ± 0.08 nm. This result is in excellent agreement with the 17.0 nm
diameter for TMV particles determined by Cryo-EM.388,389 To ensure that there was
no tip compression effect, a series of experiments were performed at various
amplitude setpoints from 95% to 40% of free amplitude (A0). Decreasing the
amplitude means that tip is closer to the surface, and therefore larger forces are felt
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by the sample surface. Figure 6-1C shows that changing the amplitude does not
affect the measured height of TMV, and even at and amplitude of 40% of A 0 the
forces are not too large to cause compression during AFM imaging. The measured
width of TMV under these conditions is always in the range of 50-60 nm, three- or
four-fold larger than the measured diameter (height). This enlargement is due to
tip-dilation (discussed below in next section).
A histogram of the height values for the TMV image shown in Figure 6-1A
reveals two distinct peaks (Figure 6-1D). The peak at 0.00 ± 0.09 nm represents the
height of the mica surface. The peak at 16.65 ± 0.17 nm represents heights recorded
in the vicinity of TMV. The long tail of this second peak towards shorter heights is
attributed to the tip-dilation effects as discussed in detail below. The difference
between the maxima of these two peaks is defined as the statistical mean height
(Hmean,S) which, in the case of TMV, is 16.65 ± 0.17 nm. We note that H mean,S is the
most probable height measured when the tip is imaging points above TMV, but it is
not the maximum height (Hmax,P) measured by the line profiles because the
maximum height is not the most frequently measured point on the figure. In
general, Hmax,P> Hmean,S, except for perfectly flat objects.
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Figure 6-1. TMV Height analysis. (A) A representative AFM image of a TMV particle
deposited on a mica substrate. (B) Cross-section profile of the imaged TMV over the white
line displayed in (A). The orange colored circle is the expected dimensions of TMV with
17.0 nm width. The wider width measured by AFM indicates the tip-dilation effect labeled
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with blue-colored shadows. (C) TMV's measured height on silicon wafer versus the value
of the tip oscillation amplitude (A) normalized by the free oscillation amplitude (A0). No
significant compression is observed at low values of A, where the stress on the virus is
expected to be the highest. Red data point is the height measured upon re-imaging TMV
after a series of images were obtained from 95% to 40% A0. The agreement between the
height before and after imaging shows that there was no damage to the virus due to these
tapping mode measurements. (D) The normalized height histogram of the image in (A).
Two colored Gaussian fits represent the mica substrate (red) and the TMV particle
(purple), respectively. The inset figure is the zoomed-in histogram from 16.0 to 17.2 nm,
representing the height population region measured at the top of TMV shown in (B),
purple-colored zone. (E) The correlation diagram of TMV's volume calculated from the
image in A (x axis) and the height histogram (y axis, after converting the pixel counts into
pixel areas) using various height thresholds. The linear regression (y=x, R 2=1.00) shows
that information obtained from both methods are identical. However, the choice of height
threshold, which can be arbitrary, can affect the measured volume, due to the tip dilation
effect. The volume calculated under the Gaussian fit is displayed with a cross. The ideal
TMV volume is calculated using cylindrical volume with the theoretical diameter of 17.0
nm and measured length of 384 ± 5 nm based on the image in (A). The results from the
Gaussian fit closely match the theoretical calculations without any particular assumption
about the virus shape.

In Figure 6-1A, the apparent volume of TMV is VTMV,P = 2.5 × 10-22 m3 using the
measured dimensions of TMV. However, the true volume is VIdeal = 8.7(± 0.1) × 10-23 m3
given the cylindrical geometry of TMV, assuming a diameter of 17.0 nm, and with the
measured length of 384 ± 5 nm in the image shown in Figure 6-1A. The excess apparent
volume can be mainly attributed to the wider width measured by the AFM (blue shadows
in Figure 6-2B). In contrast, if one uses a Gaussian function to fit the TMV peak in the
height histogram (Figure 6-1D), the fit constrains the height coverage within 16.2–17.0
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nm, which is within the region of TMV particle in Figure 6-1B (purple-colored zone). This
is primarily due to the fact that tip-dilation represents a non-symmetric effect and is only
observed at lower height values. Therefore, the area under the Gaussian curve is a better
representative of the volume of the structure after converting the pixel counts into pixel
areas. This approach can exclude the volume contributed from the tip-dilation region,
because those regions typically fall in the shallow height region to the left of the Gaussian
peak.
To demonstrate this concept better, we first demonstrate that the volume of
an individual TMV analyzed using the height histogram plot is the same as the
volume measured directly using the AFM image. For this approach to work,
independent of the height threshold used to define the volume, the two methods
should produce the same value for volume. Figure 6-1E shows the excellent linear
relationship between the two methods, with an almost perfect correlation. In the
inset of Figure 6-1D, the TMV’s Gaussian fit includes the pixels with height above
16.3 nm. After converting pixel counts into pixel areas, the area under the Gaussian
fit is measured to be 7.4 × 10-23 m3. Compared to the volume analyzed from the
height histogram or the image, volume of the Gaussian fit has the same volume as
TMV when the height threshold is set to be above 16.3 nm (7.2 × 10-23 m3). This
suggests that the area of Gaussian fit is proportional to the volume of the structural
feature within its fitted height range. We note that the value is slightly (within the
margin of error) lower than the true volume of TMV (VIdeal) calculated assuming
17.0 nm diameter. Most importantly, the area under the Gaussian fit can efficiently
eliminate the overestimated volume because the heights in the tip dilation region
are mostly located in the left shoulder of the Gaussian function (from 1.0 to 15.5
nm), and excluded from the Gaussian fit.
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6.4.2 A Quantitative Model of Tip Dilation
A simple geometric model was developed to quantify tip dilation and to
illustrate the relationship between (Hmax,P), (Hmean,S), and the height histogram
(Figure 6-2A). In this model, the object being measured and the AFM tip are each
assumed to be circular in cross section, with radii 𝑎 and 𝑏,respectively. A height
profile is created by plotting the height of the AFM tip, ℎ , versus a position
coordinate 𝑥, perpendicular to the cylinder axis. With angle 𝜃 defined as indicated
in the figure, we obtain
Equation 6-1: 𝑠𝑖𝑛𝜃 =

𝑥
𝑎+𝑏

Equation 6-2: ℎ = 𝑎 − 𝑏 + (𝑎 + 𝑏)𝑐𝑜𝑠𝜃
A sample height profile for 𝑎 = 8.5 nm (TMV), and 𝑏 = 10 nm (a typical tip
radius) is shown in Figure 6-2B along with a height histogram plot in which the axes
are reversed (height vs. count) for ease of comparison with the height profile. The
lavender zones indicate regions in the profile where the tip is physically located over
TMV (i.e. 𝑥 < 𝑎). The light blue regions indicate broadening due to tip-dilation.
There are two peaks in the histogram, corresponding to the substrate and the more
probable heights on TMV.
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Figure 6-2. Simulated height profile and height histogram of a single TMV particle. (A)
The relative geometry between the tip apex (red circle, 10 nm in radius) and a cylindrical
nanostructure (black circle, 17.0 nm in TMV's height) in height profile simulation. The red
arrow indicates the measured height, ℎ, at distance 𝑥 from the center of the cylindrical
structure. (B) Simulated cross-section profile and its height histogram (inverted for
clarity) of a single TMV particle with diameter 17.0 nm (literature value388). The purplecolored region indicates the height points obtained when the tip was positioned directly
above the particle (𝑥 < 𝑎). Broadened cross-section (𝑎 < 𝑥 < 𝑎 + 𝑏) is induced by the tipdilation effect (blue-colored region).381 (C) Simulated height histogram of TMV in AFM
measurement. The systematic noise is included as Gaussian broadening for each measured
data point (red bars), with a σ = 0.09 nm, estimated based on the experimentally measured
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noise by fitting a Gaussian function to the mica substrate region in Figure 6-1D. The black
curve shows the broadened height-histogram. The inset figure is the zoomed-in height
histogram from 16.4 to 17.4 nm. The purple peak is the Gaussian fit of this simulated
height distribution. The green peak is the variation of the maximum height point in (B),
where the center is the same as the average maximum height (Hmax,P= 17.00 ± 0.09 nm),
i.e. the physical height of the structure. The blue line shows the Gaussian peak for the
height population positioned just outside the broadened Gaussian peak.

The simulated height histogram plot in Figure 6-2B has much sharper
features compared to the experimental data presented in Figure 6-1D because we
have not included systematic noise in simulation. The points simulated on the flat
substrate ( 𝑥 > 𝑎 + 𝑏 ) displays a single bar in the height histogram. In the tipdilation region (𝑎 < 𝑥 < 𝑎 + 𝑏, blue colored zone), each height value is established
once on each side of the particle, therefore, the number of counts for each height is
always equal to two. When the tip is located above TMV ( 𝑥 < 𝑎 ), the height
distribution is a relatively narrow distribution within the purple-colored region.
Depending on the shape of the object, the number of measured points can vary
significantly in this region. For cylindrical structures, the maximum height of the
object is always higher than the most probable height, and is represented by a single
point. If the object is perfectly flat, the maximum height would be equal to the most
probable height.
In real AFM measurements (Figures 1D), systematic noise broadens the ideal
height distribution in all three regions of the substrate (mica fit), the tip dilation
region (from 0.5 nm to 16.2 nm), and the TMV region (TMV fit). Given the flat
nature of the tip dilation region in experimental histogram, the systematic noise
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does not significantly alter the shape of the distribution, which cannot be fitted to a
Gaussian function. However, both substrate and TMV regions have their own
distinct height distributions. Since the ideal substrate is a perfectly flat, in the height
histogram it is shaped as a sharp vertical bar (histogram in Figure 6-2B), the
broadening measured for this distribution, σMica=0.09 nm in the experiment,
represents systematic noise of the system. This noise can be attributed to random
substrate roughness and scanning noise in the normal direction during AFM
measurements. A Gaussian fit to the experimental TMV region results a much
broader standard deviation of σTMV=0.17 nm. The wider width is due to a
combination of the systematic noise described above, as well as intrinsic height
variations within the TMV region that was seen in Figure 6-2B as discrete bars
(purple-colored region).
In order to model the AFM histogram, the systematic noise of the image
shown in Figure 6-1A (σMica) was added to Equation 6-2, and the simulated results
were plotted in Figure 6-2C. This histogram was generated by assuming each height
point in the noise-free cross-section profile has a height variation that is similar to
the height variation of mica (systematic noise).

More details of simulated

parameters are provided in Section 7.6.1. As depicted in Figure 6-3, both simulated
and experimental histograms have similar shape in the region of TMV. The TMV
peak in the simulated histogram can be further fitted by Gaussian function, as
shown in the inset of Figure 6-2C (purple-colored peak, 16.90 ± 0.12 nm). On the
left side of this fit, a broad shoulder is also observed that is consistent with
experimental observations. The extent of this shoulder depends on the extent of tip
dilation, as well as the AFM noise in the lateral direction.
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Figure 6-3. The comparison between simulated and experimental AFM height histogram
of a TMV particle.

(A) The mica substrate peak for simulated data (red) and the

experimental AFM data (black). Both peaks match well. (B) The normalized height
distributions from 15.0 nm to 18.0 nm. The similar shape and height position of both peaks
indicate the simulation can well describe the evolution from an ideal cross-section to real
AFM measurement. The peak shifting is mainly attributed to the difference between ideal
maximum height in assumed for simulations (17.0 nm) and measured maximum height in
experiment (~16.8 nm).

This simulated histogram for AFM measurement provides insight into the
origins of the broad Gaussian-like TMV peak observed in experiments (Figure 6-1D).
In the inset of Figure 6-2C, the Gaussian peak (purple curve) is broader than the
applied systematic noise (σMica) and it encompasses multiple red bars from the
original noise-free histogram. The combination of the intrinsic height variation of
TMV (red bars), and applied noise, yields a broad Gaussian-like peak in the
simulation, and explains the origins of the broad TMV peak observed in
experiments. The heights populated at the shoulder of TMV (red bar at 16.55 nm)
can potentially skew the TMV peak at the left side, but they are far away from the
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dense heights sitting within the purple peak (above 16.6 nm). After broadening,
those skewed heights (blue curve) do not sufficiently change the shape of TMV peak,
and later fitting with Gaussian function to this peak is still feasible. The initial
height of the structure was set to be 17.00 nm, with the added noise, one would
expect to measure the average maximum height (or TMV diameter) to be H max,P
=17.00 ± 0.09 nm. Since in the noise-free histogram (red bars in Figure 6-2C) this
point is located at a higher value than the most probable height. The addition of
noise broadens the counts for this point (green population under the purple peak)
as well as the most probable point, the relative position of the two remains
unchanged, but the distinction of the height of the object (the last highest data point
measured) becomes impossible. As such, this model shows that in the limit where
the lateral resolution is low and noise is large, because the details of the height
information are lost, a mix of height values near the most probable height show a
Gaussian-like distribution that can be used to identify that object. Furthermore, the
Gaussian-like distribution can eliminate the broad effect of the tip-dilation region,
and provide a statistically relevant value for the volume. As such, the concept of the
height-histogram analysis can be used to model small structures, for as long as one
keeps in mind that the most probable height is not equal to the maximum height of
the object.

6.4.3 Single Fibril Images of Aβ40 Polymorphs
In order to quantify distinct types of Aβ40 polymorphs based on their height
features, we first characterize the signature feature of each polymorphic structure
in the height histogram plot. In the samples prepared for this study, we identified
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seven distinct polymorphs (shown in Figures 4A) with maximum heights less than
10 nm. The original images were provided in Figure 6-6. The patterns, twisting or
striated ribbon-like structures, displayed in these AFM images are similar to those
observed in TEM images (Figure 6-4). However, the limited resolution in lateral
direction of AFM measurement restricts direct correlation between both imaging
techniques. Instead, we will use the height variation imaged by AFM as an indicator
to characterize polymorphs in the following sections.

Figure 6-4. Representative TEM images of Aβ40 fibrils formed under seeding condition.
The images show the polymorphism of Aβ40 fibrils, with structures including twisted and
striated ribbon-like fibrils, as indicated by red and blue arrows, respectively.
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Figure 6-5. Single fibril analysis of Aβ40 fibrils with twisting and striated ribbon-like
morphologies. (A) AFM images of twisted fibrils with average maximum heights of 2.3 ±
0.1 nm, 4.2 ± 0.1 nm, 5.4 ± 0.1 nm, and 7.9 ± 0.2 nm from Type 1 to Type 4 fibrils,
respectively and striated ribbon-like fibrils with average maximum height of 3.2 ± 0.1 nm,
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4.4 ± 0.1 nm, and 4.6 ± 0.1 nm from Type 5 to Type 7 fibrils, respectively. The dimension
of each image is 800 × 200 nm. Scale bar is 50 nm in all figures. (B) Extracted height
profiles along the backbone of twisted fibrils. For cases where the fibril was curved, the
height profiles were combined with several linear, segmental profiles to show the height
variations and the distances between periodic pitches along the fibrils’ backbone. For the
type 4 fibril, the profile is extracted from the dashed rectangle region. (C) Extracted height
profiles across the striated ribbon-like fibrils along the lines shown in images for type 5-7.
(D and E) Height histogram plot of each imaged fibril in (A). Gaussian function(s), dashed
curve filled with color, were used to fit the characteristic peak of each single fibril, which
indicates the height variation on twisting or striated ribbon-like fibrils. The fitting results
are summarized in Table 6-1. Due to high height variations in Type 4 twisted fibrils, two
separate Gaussian functions were used to fit the data.
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Figure 6-6. Original AFM images (512×512 pixels) of different fibrils used for single
fibril analysis in Figure 6-5.

Based on the observed morphology, the Aβ40 fibrils were classified into two
groups: twisted fibrils and striated ribbon-like fibrils. The twisted fibrils show
periodic peaks and troughs alternating along the fibril, as plotted in Figure 6-5B.81
In total, for the Aβ40 fibrils imaged in this study, four distinct types of twisted Aβ40
fibrils were identified with maximum heights of 2 nm, 4 nm, 5 nm, and 8 nm (Figure
6-5B) and designated as Type 1, Type 2, Type 3, and Type 4 fibrils, respectively.
Their height information was characterized in the same manner as TMV sample and
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listed in Table 6-1. Hmean,S is the characteristic mean height of a specific polymorph,
obtained from the Gaussian fits in height histogram. Hmax,P shows the featured
maximum heights along the fibril's backbone, as measured by extracted height
profile.
Unlike the uniform TMV particle, twisted Aβ40 fibrils have strong
characteristic height variations along their backbones. The average pitch,
characterized by the peak-to-peak distance as measured from line profiles, are 41.9
± 7.0 nm, 74.9 ± 9.4 nm, and 64.8 ± 7.3 nm from Type 2 to Type 4 fibrils,
respectively. Compared to TMV’s Gaussian fit, the consequence of strong height
variations results a broad characteristic distribution, where the σ of the Gaussian
fit is in the range of 0.4-0.6 nm (Figure 6-5D), except for Type 4 fibril. The height
variations on Type 4 fibril (peak and trough) are strong enough that two Gaussian
functions are required to fit the height histogram plot as described in Table 6-1.
In contrast to the twisted Aβ40 fibrils, striated ribbon-like fibrils have fewer
twists and reveal sequential bands in the observed geometry (highlighted by red
dashed rectangles in Figure 6-5A). Three distinct types of striated ribbon-like fibrils
were identified in this study, with maximum heights of 3.2 nm, 4.4 nm, and 4.6 nm
from Type 5 to Type 7 fibrils, respectively. We note that the Type 6 fibril has a
relatively narrow width (w < 40 nm), compared to the Type 7 fibril (w > 40 nm) as
shown in Figure 6-5C. These widths can be used to estimate the number of
protofilaments in a ribbon-like polymorph,201 but such quantification is difficult
due to the tip dilation effect and are outside the scope of this study. The height
information and the pitch distance (the lengths of sequential bands) of striated
ribbon-like fibrils were analyzed in the same manner as twisted Aβ40 fibrils, and
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summarized in Table 6-1. Owing to the flat nature on the top of striated ribbon-like
fibrils, the height histograms of each type (Figure 6-5E) display narrower
distributions (σ~0.2–0.3 nm), compared to the twisted fibrils. We also note that as
a result of this flat morphology type 6 and type 7 fibrils are essentially
indistinguishable in the height histogram plot. Similarly, one can see that type 3
and type 4 fibrils share at least one overlapping peak.

Table 6-1. Summary of feature heights for different amyloid fibril polymorphs.
Fibril
Classification

Description

Hmean,S (nm) a

Hmax,P (nm) b

Pitch Distance
(nm) b

Type 1

Twist, 2 nm

1.9 ± 0.4

2.3 ± 0.1 (n=10)

N.A.

Type 2

Twist, 4 nm

3.3 ± 0.6

4.2 ± 0.2 (n=12)

41.9 ± 7.0 (n=13)

Type 3

Twist, 5 nm

5.0 ± 0.5

5.4 ± 0.2 (n=17)

74.9 ± 9.4 (n=18)

7.9 ± 0.1 (n=4)

64.8 ± 7.3 (n=4)

5.2 ± 0.7
Type 4

Twist, 8 nm
7.4 ± 0.4

a

Type 5

Striated Ribbon,
3 nm

2.9 ± 0.2

3.2 ± 0.1 (n=16)

102.5 ± 7.7 (n=10)

Type 6

Striated Ribbon,
4.5 nm c

4.2 ± 0.3

4.4 ± 0.1 (n=12)

149.6 ± 48.1 (n=8)

Type 7

Striated Ribbon,
4.5 nm c

4.4 ± 0.2

4.6 ± 0.1 (n=15)

225.4 ± 19.7 (n=5)

Data is collected from the corresponding AFM images shown in Figure 6-5A. b Data is collected

from original AFM images displayed in Figure 6-6. c The width of Type 7 fibril (> 40 nm) is wider
than Type 6 fibril (< 40 nm).
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6.4.4 Evaluating the Polymorphism of Aβ40 Fibrils in Large-Area Images
In order to quantify the amount of fibril types in the previous section, there
were no discernible differences between analyzing the AFM image directly and
using the height histogram plots in identifying a particular polymorph. However,
for studying mixed polymorphs in a large area, there is a clear advantage in utilizing
the height histogram plots to explore polymorphism. Using height-histogram
method larger number of fibrils can be investigated per frame, and therefore it
provides better statistics for the polymorphism compared to direct image analysis.
As discussed in previous sections, this method can also provide more accurate
volume content of each polymorph. However, due to reduced lateral resolution in
large-area images, it is hard to directly distinguish different types of fibrils in these
images, solely based on the structural features. As such, identifying various
polymorphs before performing large area images can sometimes improve the
reliability of the height histogram analysis.
For example, Figure 6-7A shows a large-area AFM image where multiple Aβ40
fibrils are present. The variations in the color (height) of various structures clearly
indicates the existence of polymorphism. In this image, all polymorphs are
observed except for the Type 7 fibril (structural characterization is provided in
Figure 6-8). Some characteristic features, such as the observed morphology or the
pitch distances, become obscured in larger area images as the lateral resolution is
decreased to 〜9.8 nm/pixel in each direction, which is lower than the resolution of
images displayed in the previous section. Conversely, the resolution in the z
direction (height) is not compromised even when large area image size or dull tips
are used. Therefore, the height histogram still contains accurate height information
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on each polymorph. Employing this feature, along with height information obtained
from each polymorph, it is still possible to quantify the relative volume of each
polymorph based on the height analysis in a large area image.

Figure 6-7. Statistical height analysis of different types of amyloid fibrils. (A) Large-area
AFM image that contains multiple polymorphs, except for Type 7 fibril. (B) Gaussian peak
fitting results for the height histogram of the image in (A). FIT 1 is an unconstrained fit
with no limits on the parameters. FIT 2 is performed by using single fibril data to constrain
the fits. The width of peak 4 (green) in FIT 2 was restricted to be the width of Type 6 fibril
in single fibril analysis. Colored arrows point out the center of each Gaussian fit. (C) A
comparison of the height variation obtained by fitting multiple fibrils in the large area
image versus single fibril fitting analysis. The symbols show the position of the statistical
mean heights (Hmean,S) fitted by Gaussians. The width of Gaussian fit (σ) was used to
represent the lateral bars. The colored regions show the corresponding height coverage of
single fibril results to guide visual comparison with the fitted Gaussians in FIT1
(unconstrained) and FIT 2 (constrained). The peak assignments are summarized in Table
6-2.
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Figure 6-8. Polymorphism in a large AFM image. (A) Large area AFM image showing
the polymorphism of Aβ40 fibrils (Figure 6-7A). Type 4 fibril is not observed in this image.
(B and C) The height profiles of various type structures (B) along the twisted fibril’s axis
and (C) across the striated-ribbon like fibril, marked in the top image by white boxes. For
each type of fibril, the height variations on the fibril's backbone are similar to the single
fibril results. However, some detailed features are not clearly visible due to the lower
relative image resolution for a large area image compared to single fibril data.
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The height histogram in Figure 6-7B shows at least four features, including
two apparent characteristic peaks (green and pink arrow), a mixed peaks region
(red arrow), and a distinguishable shoulder (cyan arrow). Unlike the single fibril
analysis, the histogram here includes the heights of multiple polymorphs and can
be considered as the sum of contributions from various single fibrils displayed in
Figure 6-5, with an unknown weight function. As a result, the peak positions
obtained from analysis in the previous section can be used to interpret the height
histogram in terms of pre-identified components. This concept is similar to the peak
deconvolution of spectroscopic data in IR and Raman spectra when multiple
components or structural signals overlapped.295,390
To show the importance of using single fibril information in guiding the
fitting procedure, we first demonstrate the results of a free, unconstrained-fit
depicted as “FIT 1” in Figure 6-7B. The height histogram plot was fitted step-wise
starting from the most populated and significant peak as illustrated in Figure 6-9.
Five Gaussian distributions (dashed color lines) were used to reconstruct the height
histogram as summarized in Table 6-2. These results are then compared with single
fibril analysis in Figure 6-7C using the width of Gaussian fits (peak center
plus/minus one standard derivation). In Fit 1, the Peak 1 is mainly contributed from
Type 1 fibril and protofibrils (dot-like structures, observed in Figure 6-7A). Peak 2
covers the height range of Type 2 (red colored background) and Type 5 fibrils (blue
colored background). Peak 3 is within the region of Type 6 and Type 7 fibrils (green
colored background). However, peak 4 is deviated from the region of Type 3 fibrils
(cyan colored background). This is because the peak 3 in FIT 1 is wider than Type 6
and Type 7 fibrils, that hidden the featured shoulder indicated by cyan arrow in
Figure 6-7B. We note that the Type 4 fibril is not observed in the Figure 6-7A,
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therefore, peak 5 in FIT 1 is a fake peak generated by the overlap of various types of
fibrils.

Table 6-2. Statistical Height Analysis of Amyloid Fibrils in Large Scanning Area.
FIT 1

Hmean,S

V% b

Assignment

FIT 2

Hmean,S

V% b

Assignment

Peak 1

1.8 ±
0.6

38.1

PFs c
Type 1

Peak 1

1.8 ±
0.4

27.9 %

PFs c
Type 1

Peak 2

2.7 ±
0.3

19.7 %

Type 5

Peak 3

3.5 ±
0.3

17.6 %

Type 2

Peak 2

3.2 ±
0.4

27.5

Type 2
Type 5

Peak 3

4.2 ±
0.4

28.8

Type 6
Type 7

Peak 4

4.2 ±
0.3

24.0 %

Type 6
Type 7

Peak 4

5.4 ±
0.5

3.4

Type 3
Type 4 d

Peak 5

4.9 ±
0.4

6.5 %

Type 3
Type 4 d

Peak 5

7.5 ±
1.0

2.2

Type 4
Region with
overlaps d

Peak 6

7.4 ±
1.2

2.5 %

Type 4
Region with
overlaps d

All units are nm, except for V%. a The variation of Hmax,S is 0.1 nm (σMica, not shown in Figure 67). b V% (Relative volume percent) is the relative occupied area of its fitted Gaussian function to
all of the fitted Gaussian functions. c PFs means the protofibrils. They are dot structures displayed
in Figure 6-7A. d Type 4 fibril is not observed in Figure 6-7A. Therefore, the peak near 7.5 nm is
originated from the morphologies of stacked or entangled fibrils.
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Figure 6-9. Step-wise fitting procedures for the height histogram plot of large area AFM
image in Figure 6-7A. FIT 1 is a free-fit without any limitation on the peak positions or
peak widths. FIT 2 is utilizing the height information from single fibril analysis (Table 61) as initial fitting parameters to deconvolute the height histogram curve. The initial fitting
parameters for peak center and peak width are originated from (i) Type 6 (4.2 ± 0.3 nm),
(ii) Type 3 (5.0 ± 0.5 nm), (iii) Type 2 (3.3 ± 0.6 nm), (iv) Type 5 (2.9 ± 0.2 nm), (v) Type
1 (1.9 ± 0.4 nm), and (vi) Type 4 fibril (7.4 ± 0.4 nm). We note that only the peak width (±
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0.3 nm) in (i) is fixed during fitting. The reason for applying six fits in FIT2 is that the
featured heights of Type 6 and Type 7 are very similar. They can be considered as sharing
the same characteristic heights, 4.2 ± 0.3 nm in step (i). The results are summarized in
Table 6-2.

To modify FIT 1, parameters obtained from the single fibril analysis, listed
in Table 6-1, were used as initial conditions for the analysis of the height histogram
displayed in Figure 6-7B. The details of the step-wise fitting procedures are also
illustrated in Figure 6-9. In this trial (FIT 2), the peak width of peak 4 (± 0.3 nm)
was fixed in the first step to avoid overfitting. For the rest of peaks, the fitting range
is within the same range used in single fibril analysis. The reason for choosing six
Gaussian fits was that the Type 6 and Type 7 fibrils share the same height
population near 4.3 nm (Figure 6-5E) and are indistinguishable in this method.
Similarly, the peak for Type 3 fibril is near the first peak of Type 4 fibril within the
region of 4.5–6.0 nm (Figure 6-5D). The reconstructed results of Fit 2 are
illustrated in the right of Figure 6-7B and summarized in Table 6-2.
In FIT 2, the results of two characteristic peaks, peak 4 (green) and peak 6
(pink), are similar to FIT 1. But, the constraint on the width of green peak separates
the distinguishable shoulder (cyan arrow) as peak 5, which is mainly contributed
from the Type 3 fibrils displayed in Figure 6-8 (larger image of Figure 6-7A). Within
the mixed peaks region (red arrow), the broad peak 2 in FIT 1 was split into peak 2
and peak 3 in FIT 2, which can be assigned to Type 5 and Type 2 fibrils (Figure 67C), respectively. The use of single fibril data can distinguish between more
polymorphs from a broad, mixed distribution. Furthermore, fitted peaks can be
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assigned to different types of single fibrils based on the feature height variations
(Figure 6-7C).
It is worth noting that the height described here is the pixel height. Thus, the
area under the Gaussian curve represents the volume of each type of fibril, as
demonstrated above for TMV particles. The relative volume ratio (V%) of each type
of fibril can be therefore obtained by dividing the volume under a peak to the total
volume (Table 6-2). For example, the most abundant types of fibrils in Figure 6-7A
are Type 6 and Type 7 fibrils with a relative volume ratio of 24.0 %. Type 1 fibril has
a relative volume ratio of 27.9 %, however, some protofibrils (dot-like structures)
observed in Figure 6-7A and objects with lower height values from other types of
fibrils are indistinguishable from Type 1 in the height histogram. It is also possible
that the tail ends of other distributions somewhat contribute to this value. Thus, the
real amount of Type 1 fibril is lower than 27.9% and this value only sets the upper
bound for the volume percent of this type of fibril. The V% can further be considered
as the relative mass percent if one can assume that the densities of these fibril types
are similar.
The V% of each polymorph demonstrated here are obtained from a single
AFM image over an area of 25 μm2. To provide a more reliable V% for different
polymorphs in this system, several strategies can be adopted. For example, one can
increase the imaged area and the number of analyzed fibrils. The sampling size can
also be increased by performing multiple images. A new height histogram can be
produced by accumulating the height histograms (without normalization) from
multiple AFM images with the same scan resolution and scan size. If the AFM
images are different in resolution and size, the pixel size can be considered as a
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weight factor to combine different height histograms for further volume analysis to
obtain a more reliable V% for a particular system of interest.
Although FIT 2 can separate more peaks compared to FIT 1, some challenges
remain when analyzing structures with similar heights. For example, Peak 4 in FIT
2 contains the height information from Type 6 and Type 7 fibrils, which both peaks
are around 4.0 to 4.5 nm in height. To resolve this problem, one needs to either
increase the resolution of the AFM image, or increase the population of those fibrils
to enhance the differences between them in the height histogram. Another
challenge in this statistical analysis is that the relative volume percent is estimated
assuming an ideal condition where the structure is well-represented by a symmetric
Gaussian function without significant tail on the low height side. However, the
height values around the perimeter of these fibrils, including tip-dilation region,
give to a potentially large population at lower height regions. Those data will
contribute to an over-estimated value for the polymorphs smaller than the highest
one when the relative volume percent is estimated based on the Gaussian fits, but
the degree of over-estimation will be very different depending on object’s size and
the relative population. The smaller polymorphs will have more overestimated
volumes due to the contributions from the tails of larger polymorphs. As such, this
method works best when polymorphs have distinct heights from each other with
minimum overlap. In our case, the V% of most abundant species (Type 6 and 7
fibrils) can be considered as the lower bound ratio. If one desires better accuracy,
more time-consuming high-resolution imaging becomes necessary. However, for
most practical purposes, this method is still able to provide quantitative
information for the polymorphic studies, and allow facile characterization of images
taken over large area.
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6.5 Conclusions
In this chapter, we demonstrated a statistical height analysis method to
identify various fibrillar polymorphs in a large-area, fairly low-resolution AFM
images and quantify their relative volume in the image. This is important, as it
provides a facile method to use AFM imaging for more quantitative analyses that
are typically employed by the community.
Using an example of tobacco mosaic virus, we demonstrated how the heighthistogram plot can be used as opposed to the image, with arbitrary height threshold
values, to measure the volume of an object in a fairly low-resolution AFM image
without the need of using ultra-sharp tips. This can help improve our ability to
identify volume content of various nanostructures in an AFM image. This approach
was then applied to a polymorphic amyloid sample to show that by simply fitting
multiple Gaussian functions to the height-histogram various polymorphic species
can be identified and quantified.
For polymorphic amyloid species, this analysis can be further improved by
first identifying essential polymorphs in smaller images, and then using that
information to de-convolve the height histogram plot into the contributions of these
polymorphs. This approach will inform on the existence of species that are too
similar to each other to be separated in a large area image.
The method developed here is suitable to study systems with structures that
have significant height difference among them, such as a heterogeneous amyloid
fibril samples as demonstrated here. Compared to other well-established
techniques, this AFM-based method has several advantages. This technique does
not require fluorescent labels or stains for identifying the polymorphs, which can
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be at times more selective to one particular polymorph, and can be equally applied
to fibrils, protofibrils, and potentially oligomeric features, allowing facile
determination of statistically relevant population of aggregates in a heterogeneous
sample. With further comparison in sample preparation conditions, one may be
able to quickly evaluate the effects of various variables on aggregation mechanism,
in a robust manner, without the need to take many AFM images for good statistics,
or use of labels and stains for other characterization techniques. More generally,
this method can be used to characterize many other nanostructures with significant
height heterogeneity.

6.6 Supplementary Materials
6.6.1 Height Histogram Simulation
The mica fit in Figure 1D defines the systematic noise in AFM measurement. This
information can be used to simulate the height histogram of AFM measurement from ideal
cross-section of TMV. We assume the height point in the cross-section profile (Figure 62B) has the same height variation as mica's Gaussian fit (systematic noise) in the
experimental measurement. The pre-fitted, normalized Gaussian function in shown below.
𝑓=𝑒

−0.5×

(ℎ−ℎ0 )2
0.0922

, where h0 is the height value of the data point being broadened

Therefore, each bar in the ideal height histogram (red bar in Figure 6-2C) becomes
broadened as shown in Figure 6-2C. In Figure 6-3, the strong agreement between AFM
experimental data and simulated result indicates the evolution of height from ideal
situation to real AFM data can be simulated by just considering the substrate roughness
and the uncertainty of the AFM measurement in defining the height of a nanostructure.
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The shift of TMV peak is mainly attributed to the difference between measured maximum
height in experiment (~16.8 nm) and ideal maximum height assumed in theory (17.0 nm).

6.6.2 Estimated Tip-Dilation Effects for a Cylindrical Nanostructure
Based on our proposed model (Figure 6-2A), the object’s height, object’s geometry,
and tip sharpness will influence the degree of tip-dilation. The tip coating and tip material
only change the intrinsic properties, e.g. the resonance frequency, hardness, conductivity,
which is not considered in our model under the assumptions of no tip-induced
compression and tip-object interactions. Figure 6-10A displays our model to evaluate the
enlargement (∆W) caused by tip-dilation. When tip radius (𝑏) is larger than object’s radius
(𝑎), the measured width (2W) is equal to √8𝑏𝐻 (𝐻 = 2𝑎, object’s height). Once 𝑏 < 𝑎, the
tip’s geometry near apex controls the tip-object contact. Assuming the tip’s geometry is
almost vertical, the measured width becomes 𝐻 + 2𝑏. The ∆W can be further defined as
the difference between measured width (2W) and object’s width (2𝑎). In Figure 6-10B, we
plotted the object’s height (𝐻) versus enlargement (∆W) for our used AFM tip (𝑏 = 10 𝑛𝑚).
Basically, the ∆W reaches a plateau when the 𝐻 > 20 nm for cylindrical objects. Figure 610C and Figure 6-10D display the influence of tip sharpness on the ∆W of TMV particle
(𝑎 = 8.5 nm) and cylindrical fibrils (𝑎 = 2 nm). We note that even the amyloid fibrils are
not simply as cylindrical shape, but the geometrical factor doesn’t change the ∆W due to
the nature of tip dilation happened on the two edges of an object. The object’s geometry
can be further modified as elliptical cylinder or other geometries, which merits further
studies and will be addressed in the future.
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Figure 6-10. The simulated enlargement of the measured width (∆W) for a cylindrical
nanostructure due to the tip-dilation effect. (A) The relative geometry between the tip (𝑏
nm in radius) and cylindrical object (𝑎 nm in radius). The enlargement (∆W) is defined as
the difference between object’s width ( 2𝑎 ) and the measured width ( 2𝑊 ). (B) The
influence of object’s height (𝐻) on the ∆W using 10 nm AFM tip (expected tip radius used
in experiments). The yellow arrow indicates that the enlargement becomes fixed when the
tip and object are in the same size (𝐻 = 2𝑎 = 2𝑏). (C, D) The influence of tip sharpness on
the ∆W for TMV and cylindrical fibrils, respectively.

6.6.3 Evaluation of Amyloid Polymorphism under different Experimental Conditions
The histogram analysis can provide the relative volume percent (V%) of each
amyloid polymorph displayed in an AFM image. To evaluate the variation of (V%), we
measured the amyloid sample under different experimental conditions.
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Scan speed: The scan speed in all experiments (including the data shown below) is set as
0.4-0.6 line per second for high quality images. Admittedly, higher scan rates can result
in lower resolution images affecting all data accordingly. However, in this paper, we
assume that given all other limitations quasi-static scan rates can be used for imaging.
Image resolution: Figure 6-11 shows the influence of scan resolution on the height
histogram analysis. When the same scanner is used (multi-purpose XYZ closed-loop
scanner equipped with 10 nm AFM tip used in the manuscript), the increase of scanning
resolution (pixel/line) slightly broadens the feature peak near 4 nm in Figure 6-11C, but
does not significantly change the shape of height histogram. Therefore, the relative V% of
each amyloid polymorph will be similar in both AFM images. In general, image resolution
only helps improve the statistics by providing larger number of data points for rare
population (on the lower side of the most probable heights), but images still suffer from
the tip convolution problem.

Figure 6-11. The effect of scanning resolution (pixel/line) on the height histogram of an
AFM image that contains multiple polymorphs. (A, B) Large-area AFM images using
different pixel/line values. (C) The normalized height histograms for the AFM images with
different pixel/line values. In this set of experiments, the multi-purpose XYZ closed-loop
scanner was used along with the same tip used in the manuscript (Tap-300AlG, Budget
Sensors).
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Tip Sharpness: Figure 6-12 shows the effects of tip-sharpness while using a highresolution scanner. The combination of high-resolution scanner and ultra-sharp tip can
clearly provide distinct peaks in the height histogram (Figure 6-12C) by suppressing the
tip-dilation effect. In Figure 6-12D, the V% of each polymorph displayed in Figure 6-12A
and Figure 6-12B was analyzed in the same manner as details mentioned before.
Compared to the FIT 2, the results of high-resolution images indicate some extent of
variation on the V% in using the Gaussian fit method. This can be attributed to (1) the
difference on scan area that contains different polymorphic content, and (2) the small scan
size (9 μm2). To provide a more reliable V%, one can follow up our suggestions to increase
the sample size as addressed in the manuscript.
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Figure 6-12. The influence of tip-sharpness on the height histogram of an AFM image
that contains multiple polymorphs. (A, B) Large-area AFM images scanned by 10 nm AFM
tips (Tap-300AlG, Budget Sensors) and 1 nm AFM tip (SHR150, Budget Sensors),
respectively. The image resolution is 512× 512 pixels for both images. We note that the used
AFM scanner was a high-resolution scanner (9 μm in sXY and 2 μm in Z direction). (C)
The normalized height histograms for both AFM images. (D) The comparison of volume
analysis between FIT 2 and the AFM images measured by HR-scanner equipped with tips
with different sharpness.
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CHAPTER 7. High-Resolution Atomic Force Microscopy Studies on
Seeding Amyloid-β Fibrils

7.1 Abstract
Characterizing the structures of amyloid-β (Aβ) fibrils is an essential imaging target for
the diagnosis and tracking of the evolution of Alzheimer’s disease. Despite advances of
imaging techniques, the connection between molecular-level substructures and
filamentous structures at mesoscale within an individual Aβ fibril is still unclear,
especially for samples with a high degree of polymorphism. This is primarily due to
challenges in identifying and quantifying various mesoscale polymorphic structures in
heterogeneous samples. In this report, we demonstrate how high resolution atomic force
microscopy (HR-AFM) studies, combined with a volume-per-length (VPL) analysis, can
elucidate polymorphic structures at mesoscale and allow their quantification. VPL analysis
applied to HR-AFM images reveal that Aβ40 fibrils formed under a seeding condition are
composed of distinct number of protofilaments, which involve two layers of Aβ40 peptides
with a cross-β motif. Compared to the mass-per-length analysis for molecular
quantification, HR-AFM provides access to the three-dimensional profiles of an imaged
Aβ fibril that simultaneously provides spatial confinement, polymorphic identification,
and molecular quantities. Overall, the combination of these advantages allows us to
identify the polymorphism of Aβ 40 fibrils at mesoscale.
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7.2 Introduction
Amyloid fibrils spontaneously formed by the aggregation of a diverse class of
polypeptides are associated with numerous diseases, including Alzheimer's, Parkinson's
Diseases, and type II diabetes.4 They are the end products of a complex fibrillation
pathway that proceeds from abundant on- or off-pathway intermediates16, and are
structurally composed of one or several filamentous substructures (protofilaments) with
cross-β motifs.214 In the past two decades, the building blocks of fibril structures have been
extensively studied using various techniques. However, the details of the structure at
mesoscale remain unclear, especially for fibrils formed by amyloid-beta (A) peptides. The
main challenge in understanding the structure at this scale is the diverse polymorphic
structures (polymorphism) formed under distinct experimental conditions. The results of
intra-sample polymorphism cause the difficulty in structural characterization, and further
cross-study comparisons.
The polymorphism of amyloid fibrils can be either defined as the difference
between the number and relative orientation of underlying protofilaments (morphological
polymorphism), or the variations in the protofilament’s substructure (molecular-level
polymorphism). Single particle imaging tools, such as electron microscopy (EM) and
atomic force microscopy (AFM), can identify morphological polymorphs based on their
characteristic widths, heights, or crossover distances within a single fibrillar structures.
Spectroscopic techniques (e.g. solid-state NMR19 and 2D-IR210) or a variety of diffraction
techniques (e.g. X-ray scattering190) can provide ensemble-averaged atomic- or molecularlevel information. However, connecting such information to morphological polymorphism
on mesoscale can be quite challenging.
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To overcome this issue, a homogeneous pool of monomorphic fibrils or the
capability of selecting analytes is required for further structural characterization and
modeling. For example, Tycko and his co-workers199–201 utilized the self-propagating
property of amyloid fibrils to investigate molecular-level polymorphism between two
distinct forms of monomorphic A40 fibrils. Based on solid state NMR (ssNMR) and EM
studies, they established two-fold and three-fold symmetric protofilaments within pure
striated-ribbon like and twisted A40 fibrils, respectively. In contrast to spectroscopic
measurements, high resolution cryo-electron microscopy (cryoEM) can specifically select
analyzed fibril and reconstruct 3D topography of twisted forms of A40 fibrils with the aid
of simulations.211,240 In these studies, the mass-per-length (MPL) analysis plays an
important role in quantifying the number of molecular layers with a cross- motif (𝜂)
within the studied A40 fibrils, which provides the protofilament information for further
structural modeling.201,235,239 But, such analysis usually gives a broad mass distribution or
overestimates the MPL values due to the highly localized electron density in compact
geometries or retained salts, which increases electron scattering efficiency of an object.240
Furthermore, the weak scattering intensity could potentially depress the spatial resolution
to identify morphological features and polymorphic forms, especially for smaller features
consisting of fewer protofilaments or oligomers. As such, in the case of highly polymorphic
A40 fibrils, it becomes more difficult to investigate the association between various
polymorphic types and their MPL values. To improve such deficiency, one needs an
imaging tool that can characterize polymorphic identity and measure the relevant quantity
parameter (e.g. mass and volume) of individual fibril on the same fibril.
Among different single particle imaging tools, atomic force microscopy (AFM) is
the one that can directly explore 3D morphologies, and has no staining or labeling
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requirement for the structure of interest.66,234,242,243 Besides the topography, tapping-mode
AFM can also provide chemical mapping of surfaces (phase image) using the oscillating
feedbacks of the scanning probe. However, AFM has seldom been considered as the
primary tool to quantify the morphological polymorphism within amyloid fibrils because
object's dimensions are typically close to or smaller than the size of most commercially
available tips (~10 nm in radius). The fat tip or tip dilation effect decreases the lateral
resolution of the image, unless ultrasharp tips are used.230,242,256
In this work, we have used atomic force microscopy equipped with ultrasharp tip
(HR-AFM) to study polymorphism of amyloid fibrils formed from amyloid-beta (1-40)
peptides (A40) using a seeding condition that promotes polymorphism. We demonstrate
that the improved lateral resolution in HR-AFM measurements can provide an accurate
3D topography for various forms of A40 fibrils. We propose a volume-per-length (VPL)
analysis and demonstrate that this method can be used to quantify the 𝜂 values among
Aβ40 polymorphs. After scaling 𝜂 to the encompassed protofilament number (𝑛) within
each analyzed polymorph, the fundamental cross- A40 layers within A40 protofilament
can be further determined in a statistical manner. In the confinement of fibril morphology
and peptide quantity, we can connect the 3D topography of A40 polymorphs to the current
existing structural models. Our studies provide another route to understand the
polymorphism of amyloid fibrils from top to down.
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7.3 Materials and Methods
MPL analysis. Dark-field images of unstained samples were obtained with a
transmission electron microscope by tilting the objective aperture. Data processing was
performed as previously described.210,391
HR-AFM measurements. Aβ40 fibrils were imaged using a Keysight 5500 atomic force
microscope (Keysight Technologies, formerly Agilent Technologies), equipped with a
small high-resolution scanner (N9520B). The scanner was calibrated before performing
experiments. Ultrasharp tips (BudgetSensors, SHR150, resonance frequency ~150 kHz,
tip radius <1 nm, force constant ~5 N/m) were used to record topography, amplitude, and
phase images in tapping mode with 512× 512 pixel imaging resolution. Depending on the
image size, the imaging resolution ranged from 0.40 nm/pixel (for 200 nm × 200 nm
images) to 2.0 nm/pixel (for 1 μm × 1μm images). To eliminate potential compression of
the sample by the tip during measurement the amplitude was set to 93% of free amplitude
during imaging. The frequency during imaging was set to -0.1 kHz of the maximum
resonance frequency of the tip. Scanning rate was set to 0.3-0.5 line per second.
Imaging Processing Procedure and Quantitative Analysis. Gwyddion software
was used to analyze HRAFM images.328 To remove the background, a first-order (for small
area images, < 500 nm × 500 nm) or second-order polynomial (for larger area images)
was applied to flatten each AFM image. Cross-section profiles were extracted after the
flattening process for dimensional analysis. Each data point in the h-w correlation
diagram (Figure 7-7A and Figure 7-8A) was calculated using the maximum height (h) and
the width (w) between the two edges of the object with 1 nm height threshold in crosssection profile. The selection of 1 nm threshold prevents the potential tip dilation effect
induced by the ultrasharp tip. For volume analysis, a height mask (≥ 1.0 nm) was used to
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mark the segment within each polymorph that was analyzed. The volume was then
calculated after subtracting the Laplacian background (grain analysis provided in
Gwyddion software), which is the basis surface formed by the Laplacian the interpolation
of surrounding values.

7.4 Experimental Results
7.4.1 Polymorphs of Amyloid Fibrils in Electron Microscopy (EM)
Polymorphism of Aβ40 fibrils were examined by EM under different imaging modes.
Negatively stained TEM images shown in Figure 7-1A demonstrate the coexistence of
striated-ribbon like (R-type, untwisted flat-appearing forms) and twisted (T-type) fibrils.
The high imaging contrast provided by the negatively staining reagents shows the number
of encompassed protofilaments (𝑛) and their relative orientation in each fibrillar structure.
Therefore, the morphological polymorphism can be assigned using a combination of the
value of 𝑛 the morphological feature of the fibril (R- vs. T-type), as labeled in Figure 7-1A.
Besides the polymorphic identity, TEM images can also provide the average width for each
polymorph, as summarized in Table 7-1. Using the 𝑛 value characterized in the TEM image,
the average width of the underlying protofilament can be determined as 6.7± 0.2 nm for
the R-type polymorphs and 7.2± 0.5 nm for the T-type polymorphs (estimated from the
widths in the trough regions, where the protofilaments are packed parallel to each other).
The average pitch distances in these images are measured to be 43.6± 3 nm and 146.7± 15.4
nm for the 2T and 3T type polymorphs, respectively.
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Figure 7-1. The EM studies on seeded Aβ40 fibrils. (A) Representative TEM images of
negatively-stained Aβ40 fibrils. The blue lines are plotted in Figure 7-4 for comparison with
corresponding AFM images. (B) A representative dark-field EM image of Aβ40 fibrils and
TMV particles without staining. (C) Mass-per-length (MPL) analysis of Aβ40 fibrils. The
red dashed lines indicate the MPL of the corresponding 𝜂 value. The black solid line is the
percentage of accumulation.
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Table 7-1. Summary of Dimensional and Volumetric Results among Aβ40 Polymorphs.
𝜼 (# of analyzed
fibrils) d

𝜼/𝒏

3.5 ± 0.2

3.9 ± 0.2 (20)

1.9 ± 0.1

24.9 ± 1.2

4.3 ± 0.2

6.1 ± 0.5 (15)

2.0 ± 0.2

26.7 ± 0.8

30.4 ± 1.3

4.5 ± 0.2

8.2 ± 0.3 (22)

2.1 ± 0.1

5R

N.A.

38.2 ± 1.9

4.5 ± 0.2

10.1 ± 0.6 (19)

2.0 ± 0.1

6R

N.A.

46.7 ± 1.5

4.6 ± 0.2

12.3 ± 0.8 (6)

2.0 ± 0.1

T1

N.A.

18.1 ± 1.8

2.0 ± 0.3

1.9 (1)

1.9

T2 (peak)

7.3 ± 0.4

21.2 ± 1.3

4.5 ± 0.2

T2 (trough)

14.3 ± 1.0

20.6 ± 0.9

3.7 ± 0.1

4.5 ± 0.4 (19)

2.2 ± 0.2

T3 (peak)

7.2 ± 0.6

24.2 ± 1.5

5.4 ± 0.4

T3 (trough)

21.0 ± 0.6

22.0 ± 1.1

4.2 ± 0.3

6.6 ± 0.3 (8)

2.2 ± 0.1

w, TEM
(nm)a

w, AFM
(nm)b

2R

13.4 ± 0.6

18.8 ± 1.1

3R

20.4 ± 0.4

4R

Polymorph

a

h (nm)c

This width is calculated using the distance between two edges with lowest intensity, as

demonstrated in Figure 7-4 C-E. b The distance between two edges with 1 nm height is used to
define the polymorphic width (w, AFM), which eliminates the potential tip dilation made by
ultrasharp tip (1 nm in radius). c The height (h) is calculated using the maximum height difference
in cross-section profile. d The height mask is set as above 1 nm while analyzing the volume of each
fibril, except for T1 (used 0.8 nm as threshold).

EM imaging of unstained fibrils can be used for mass per length (MPL) analysis.
Figure 7-1B demonstrates a representative dark-field EM image of an unstained Aβ40 fibril
doped with tobacco mosaic virus (TMV) particles. The MPL value of the analyzed Aβ 40
fibril can be determined by comparing its scattered electron intensity (imaging contrast)
to that of the TMV standard.236 However, the weak scattering intensity of the unstained
fibrils lower the spatial resolution of this method and hinders the ability to distinguish the
polymorphic form. Figure 7-1C shows the MPL histograms after analyzing nearly one
thousand samples. The seeded Aβ40 fibrils used here have multiple peaks within the range
of 20-90 kDa/nm, where the red dashed-lines and numbers correspond to the ideal 𝜂
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values. The MPL peaks of our Aβ40 fibrils are centered from 𝜂 = 3 to 𝜂 = 9. Due to the high
degree of polymorphism, there is no single smallest integer number that can be
determined as the basic 𝜂 value within the underlying protofilament. The lack of spatial
resolution disrupts the connection between polymorphic forms of Aβ 40 fibrils and their
MPL values.

7.4.2 Polymorphs of Amyloid Fibrils in HR-AFM Images.
Except for EM, we also performed HR-AFM to investigate the polymorphism of
our seeded Aβ40 fibrils. As demonstrated in Figure 7-2, while imaging a 2R polymorph
(polymorphic assignment will be addressed latter), the use of ultrasharp tip (~ 1 nm in tip
radius) can effectively eliminate the tip-dilation effect compared to a typical AFM tip (~10
nm in tip radius). The width difference, 18.6 nm, means that the ultrasharp tip prevents
the exaggerated dimensions measured at the perimeter of an imaged object. In Figure 73, the representative HR-AFM images show the morphological polymorphs among R-type
and T-type fibrils. More HR-AFM images are provided in Section 8.7.
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Figure 7-2. The difference between regular and high resolution AFM images.

(A)

Schematic diagram of the tip dilation effect on measured line profiles (blue curves) of a
rod-like nanostructure (red color). The radius ratio is 10:5:1 for regular AFM tip, the
nanostructure, and the ultra-sharp tip, respectively. (B) The 2R fibrils imaged using AFM
tips with different sharpness. (C) The height profile of two cross-sections extracted from
images in (B). The narrow width, 18.1 nm, measured by sharp tip indicates the
improvement of the lateral resolution in evaluating the width of the 2R amyloid fibrils. We
note that both widths are evaluated at the positions of height equal to 1 nm (indicated by
arrows).
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Figure 7-3. Representative HR-AFM images of polymorphs in seeded Aβ40 fibrils. (A)
The morphologies of R-type fibrils and T1 fibril. The height scale displayed in right is used
for all topographic images. The white arrows indicate the reduction of protofilament
number, which helps the polymorphic assignment. (B, C) Zoomed-in topography (B) and
phase images of a 6R fibril displayed in the red solid rectangle of (A). (D) The overlay of
height and phase change through the cross-section of the zoomed-in 6R fibril shown as a
red solid line in both the topography and phase images. The variations in the two signals
indicate six protofilaments within this fibril (blue dashed lines) with an average width of
7.5 nm/protofilament. The green dashed lines indicate the two edges. (E-G) The
morphologies of 2R, T2 and T3 fibril. The classification of T-type fibrils is based on the
height difference at peak positions. The red dashed lines labeled in (A, E-G) are plotted in
Figure 7-4 for width comparison. The scale bars are 400 nm for (A) and 50 nm for the rest
of images.
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For R-type polymorphs, the difference is mainly attributed to the protofilament
number within parallel-packing geometry (Figure 7-1A). Among HR-AFM images, we
observed a representative R-type fibril (Figure 7-3 B-C) exhibited six protofilaments
within two edges after overlaying the height variations and phase changes through the
cross-section, as plotted in Figure 7-3D. Therefore, this fibril can be assigned to a 6R fibril.
The measured width (45.1 nm) and height (4.4 nm, the average maximum height of six
protofilaments) provides a preliminary dimension for single protofilament within the Rtype polymorphs that is roughly 7.5 nm in width (wR) and 4.4 nm in height (hR). This
information is valuable to recognize other R-type polymorphs, e.g. 2R-5R fibril displayed
in Figure 7-3A and Figure 7-3E, by considering their widths as multiples of wR. An example
of width comparison among 2R-6R polymorphs is plotted in Figure 7-4A. Furthermore,
the width reduction of imaged fibrils observed in the Figure 7-3A (two white arrows) can
be used to distinguish distinct R-type polymorphs. We note that the high contrast phase
image can only be achieved by fresh used ultrasharp tip. Other examples of topographyphase correlation for R-type polymorphs are provided in Figure 7-5.
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Figure 7-4. Dimensional comparisons of R-type and T-type Aβ40 fibrils. (A) Comparison
between cross-section profiles of R-type polymorphs in HR-AFM images. (B) Comparison
between cross-section profiles of 2R, 3R, 4R, T2, and T3 polymorphs in HR-AFM images.
(C-E) Comparison between the cross-section profiles obtained by TEM (blue) and HRAFM measurements (red) for (C) 3R and 4R polymorphs, (D) 2T/T2 polymorphs, and (E)
3T/T3 polymorphs, respectively. The black dashed lines indicate the polymorphic widths
estimated in TEM images. For T type fibrils, the top row shows the cross sections along
the trough region and the bottom row shows the cross sections along the peak region of
the fibril.
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Figure 7-5. Correlation between AFM topography, phase, and amplitude images of Rtype polymorphs. (A-C) AFM images of (A) topography, (B) phase and (C) amplitude
images of 3R-6R polymorphs. (D-G) The overlay of height (black solid line), phase (red
solid line), and amplitude (green dashed line) changes through the labeled cross-section
of 3R-6R polymorphs. The blue arrows indicate the location of protofilament within
individual polymorph.
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In contrast to the flat nature of R-type polymorphs, the morphological difference
between T-type fibrils are highly associated with the protofilament number and
arrangement. The height and width variations along the fibril axis can be separated as
peak and trough region that theoretically reflect the stacking and parallel packing of
encompassed protofilaments, respectively. Unlike R-type polymorphs, there is no
significant correlation between topographic and phase image to quantify n values within
the T-type fibrils (Figure 7-5). As such, we used the characteristic peak height to assign the
T-type polymorphs displayed in Figure 7-3. The characteristic peak heights are roughly
2.0 nm, 4.5 nm, and 5.4 nm for T1, T2, and T3 fibril, respectively. We note that the T1 fibril
seems to be the dissociated product from a more complex fibril, which will not be further
discussed here. The average pitch, characterized by the peak-to-peak and trough-totrough distance, are 39.0 ± 5.0 nm for T2 polymorphs and 67.0 ± 13.0 nm for T3
polymorphs (Figure 7-6). Figure 7-4B demonstrates the overlays of cross-section profiles
in HR-AFM measurements among 2R, 3R, 4R, T2 and T3 polymorphs. The dimensions of
T2 trough and T2 peak are close to 2R and 3R fibril, respectively. The T3 fibril has a similar
trough dimension for the 3R fibril, but the peak dimension is much higher than the R-type
polymorphs. The correspondence at trough dimension of T2 and T3 polymorphs may
suggest protofilament number are two and three, respectively.
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Figure 7-6. The histogram of periodicity of T2 and T3 fibrils in HR-AFM measurements.

To connect the dimensional results between both imaging tools, the cross-section
profile of different polymorphs was extracted from TEM (blue lines in Figure 7-1A) and
HR-AFM images (red dashed lines in Figure 7-3 D-G), and then plotted in Figure 7-4 C-E
for comparison. Basically, the measured widths are similar in both imaging techniques,
except for the peak regions of 2T/T2 and 3T/T3 polymorphs (discussed further, below). By
TEM results, the troughs of 2T and 3T polymorphs exhibit encompassed protofilaments
associated laterally in Figure 7-1A. Therefore, the compatible trough widths measured by
HR-AFM and TEM (Figure 7-4 D-E) also suggest the n value for T2 and T3 fibril are two
and three, respectively.
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7.4.3 Dimensional Analysis of Amyloid Fibrils in HR-AFM Images.
While we can distinguish polymorphic type in HR-AFM measurements, the
dimensions of each polymorph, represented by width (w) and height (h), can be evaluated
statistically by analyzing their cross-section profiles. Figure 7-7A displays the w-h
correlation plot, w histogram (bottom), and h histogram (right) among R-type
polymorphs. The average dimensions are summarized in Table 7-1, and plotted in Figure
7-7 B-C for comparison. The same dimensional analysis for T-type polymorphs was also
provided in Figure 7-8 and summarized in Table 7-1.

Figure 7-7. Statistical Analysis of the heights and widths of R-type Aβ40 fibrils. (A) The
correlation diagram between the heights and the widths of R-type polymorphs. Each data
point is calculated using the maximum height and the width of a fibril as measured as the
distance between the two edges with a height of 1.0 nm. The height and width histogram
are displayed at the right and the bottom of this plot, respectively. (B) The average height
of each R type fibril. (C) The average width of each R type fibril. The linear regression
(dashed line) measures a width of 7.8 nm/protofilament with 𝑅 2 = 0.97.
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Figure 7-8. Dimensional analysis of T-type Aβ40 fibrils. (A) The correlation diagram
between height and width of T-type polymorphs. Each data point is manually calculated
using the maximum height and the width at a 1 nm height threshold. The height and width
histogram are displayed on the right and the bottom of the graph, respectively. The
average values of the height and the width of different T-type polymorphs are plotted in
(B) and (C), respectively. The triangle and circle symbols denotes the peak and trough
region, respectively.

In Figure 7-7, the dimensional features of R-type polymorphs are the heights
gradually increase until 𝑛 = 4, and the widths grow up with the increase of n value. The
dispersions of w and h for each Aβ40 polymorph shown in Figure 7-7A indicate the
heterogeneity of the sub-structures within analyzed fibrils and the uncertainty of HR-AFM
measurements in the lateral or normal direction. Averaging the height data from 4R-6R
polymorphs provides the hR,avg=4.5 ± 0.2 nm for R-type protofilament (red dashed line in
Figure 7-7B). The average width of R-type protofilament can be determined using linear
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regression to fit the average widths among 2R-6R polymorphs (red dashed line in Figure
7-7C), which is 7.8 ± 0.2 nm (wR,avg). Results indicate only 2R polymorphs exhibit a lower
height (3.5 ± 0.2 nm) and a wider width (18.8± 1.1 nm) than the expected values of hR,avg
and 2wR,avg. It is worth to note that similar geometrical feature can be observed at the
positions of the two edge protofilaments of other R-type polymorphs, e.g. protofilament 1
and 6 in Figure 7-3C. For T-type polymorphs, the dimensional features are like the results
displayed in the cross-section comparison (Figure 7-4B), where T2 and T3 polymorphs
have a wider width and a higher height at peak region.

7.4.4 Volumetric Analysis of Amyloid Fibrils
The compatible dimensions between TEM and HR-AFM results demonstrates the
ultrasharp tip can minimize the tip-dilation effect and provide a more accurate 3D profile
for the structure of interest. Therefore, the underlying volume of each imaged polymorph
may reveal the peptide quantities within itself. Because of the well-established cross-β
motifs within Aβ40 fibrils, one could expect the volume per length (VPL) of single layer
Aβ40 molecules with a cross-β motif will be equal to 𝑉/𝑑 (nm3/nm), where 𝑉 is the
estimated volume of single Aβ40 peptide (5.24 nm3)392 and 𝑑 is expected inter-stand
distance (4.7 Å )236. Such concept is the same as MPL analysis developed in EM-based
techniques that is widely used to quantify 𝜂 values within amyloid fibrils.235,236
In HR-AFM images, the VPL of imaged fibril can be calculated by dividing the
analyzed volume to its length. Figure 7-9A shows a VPL histogram established by
analyzing near hundred Aβ40 polymorphs and grouping VPL values based on their
polymorphic identity. The gray dashed lines are the theoretical VPLs for different 𝜂 values.
The VPL distributions are centered to near 4, 6, 8, 10, and 12 for R-type polymorphs, and
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2, 4.5, and 6.5 for T-type polymorphs. The average VPL values for distinct Aβ40
polymorphs are plotted in Figure 7-9B and summarized in Table 7-1. With known
protofilament number (n), the number of cross-β layer per protofilament can be further
defined as 𝜂/𝑛. For distinct Aβ40 polymorphs, the average 𝜂/𝑛 values (purple rectangles,
Figure 7-9B) suggest that the underlying protofilaments contain two layers of Aβ 40
peptides with a cross-β motif. Figure 7-9C shows the histogram of 𝜂/𝑛 values for all
analyzed fibrils, where the Gaussian fit gives an average value of 2.02 ± 0.14 to all studied
Aβ40 fibrils.
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Figure 7-9. Volumetric analysis of Aβ40 fibrils. (A) Histogram of volume per length (VPL)
of various Aβ40 polymorphs. Gray dashed lines represent the theoretical VPLs estimated
by 𝜂×𝑉/𝑑 nm3/nm, where 𝜂 is the number of Aβ40 peptide layer with a cross-β motif, 𝑉 is
the estimated volume of single Aβ40 peptide (5.24 nm3)392, and 𝑑 is expected inter-stand
distance (4.7 Å )236. (B) The average 𝜂 value (colored circles) and 𝜂/𝑛 value (purple
rectangles) among Aβ40 polymorphs. The 𝜂/𝑛 value represents the number of Aβ40 peptide
layer per protofilament. (C) The histogram of 𝜂/𝑛 values for all analyzed Aβ40 fibrils. The
Gaussian fit is centered to 2.02 with a standard derivation of 0.14.
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7.5 Discussion

The seeded Aβ40 fibrils display a high degree of polymorphism in both EM and
AFM results. In TEM images, the high spatial resolution can be easily achieved by staining
the sample. Using the morphological features, the polymorphs of Aβ 40 fibrils can be
classified as R-type and T-type fibrils with different number of encompassed
protofilaments. But, the spatial resolution was depressed while quantifying the mass
content of the Aβ40 peptides under unstained situation in dark-field EM images. The high
polymorphism of Aβ40 fibrils contributes to a broad MPL distribution, and causes multiple
smallest integers available while determining the fundamental number of cross-β layers
within the studied Aβ40 protofilament (e.g. 2, 3, 5, and 7, Figure 7-1D). The poor
connection between morphological polymorphs and their contributed MPL values causes
certain difficulties in further structural characterization and molecular modeling using
high-resolution techniques, such as 2D-IR and solid-state NMR.
To identify Aβ40 polymorphism and quantify molecular content, we performed
HR-AFM measurements to investigate the polymorphism Aβ40 fibrils. The uniqueness of
AFM measurement is its ability of scanning 3D topography, where the underlying volume
theoretically reflects molecular quantity within the analyzed structure. However, as
demonstrated in our previous work230, the tip-dilation effect blinds the fine structures of
Aβ40 fibrils and also produces an over-estimated volume. In this study, the use of
ultrasharp tip can efficiently suppress the tip-dilation effect and provide a more accurate
width for distinct Aβ40 polymorphs after comparing the dimensional results between TEM
and HR-AFM images. Notably, except for the topographic information, the phase images
reveal significant contrast to identify protofilament number and protofilament
dimensions within R-type polymorphs that can be applied to the polymorphic recognition
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in HR-AFM images. Using the same concept in MPL analysis, the volume of imaged fibril
defined by HR-AFM can be used to quantify the Aβ40 cross-β layers (𝜂) within itself, as
well as the fundamental Aβ40 cross-β layers within the underlying protofilaments (𝜂/𝑛).
For R-type polymorphs, the morphological difference is simply contributed from
the protofilament number (𝑛). The increase of 𝑛 values causes a step-wise increase in
width (Figure 7-4A). Therefore, the characteristic dimension of protofilaments can be
determined as 7.8± 0.2 nm in width (wR,avg) and 4.5± 0.2 nm in height (hR,avg) based on the
HR-AFM results. The wR,avg is highly compatible with the average protofilament width
characterized in TEM results (6.7± 0.2 nm). We note that the small width difference may
be raised from the weak height reduction at the two edge protofilaments (e.g.
protofilament 1 and 6 in Figure 7-3C) that broadens the width a little bit. Similar weak
deformation also observed on small 2R and 3R polymorphs (Figure 7-4A), which can be
attributed to the strong surface adhesion while preparing the dried samples. The larger
applied stress from ultrasharp tip can also cause sample’s deformation, but we performed
low force tapping mode (93% of free amplitude) to prevent potential influence from AFM
measurements. In Figure 7-9B, the average 𝜂 values among different R-type polymorphs
also increase in a step-wise manner corresponding to growth on 𝑛 values. After scaling 𝜂
to 𝑛 , the results (purple rectangles in Figure 7-9B) imply the underlying Aβ40
protofilaments within R-type polymorphs have two fundamental cross-β layers. It is worth
noting that further secondary or tertiary structures within the imaged fibrils can be
characterized using near-field spectroscopic measurements (e.g. tip-enhanced Raman),
which merits for further studies.
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Figure 7-10. Protofilament models and proposed protofilament arrangements within our
seeded Aβ40 fibrils. (A) A representative two-fold symmetric protofilament model for
striated-ribbon like Aβ40 fibril (PDB: 2LMN).199,200 The colored mesh surface is the
estimated volume.392 (B) Proposed protofilament arrangements within R-type Aβ40
polymorphs. Each blue-colored frame represents for individual protofilament displayed
in (A). The blue dashed lines indicate the HR-AFM measures the topography from top to
down. The gray shadows represent the accumulation of negatively staining reagents,
which provides the TEM contrast displayed in below. (C) A representative model for
twisted Aβ40 fibril (EMD-5008), where the green line represents a single β-strand
composed of fully extended Aβ40 peptides.393 (D) Proposed protofilament arrangements
within T2 polymorphs. Each green-colored frame represents individual protofilament
circled in (C).

Figure 7-10A demonstrated a molecular structural model for R-type Aβ40 fibrils
proposed by Tycko and his co-workers199,200. In this model, the twofold-symmetric
protofilaments with in-register parallel β sheets are determined based on ssNMR and EM
data. The dimensions of this protofilament model are near 6.0 nm in width and 4.0 nm in
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height, where the unstructured N-terminal residues 1-8 are omitted. Under the constrains
of imaged dimensions (w and h), protofilament number (𝑛), and molecular quantity (𝜂),
our data suggests the R-type Aβ40 polymorphs fit to this experimentally hypothesized
structural model. Figure 7-10B illustrates the schematic correlation among HR-AFM,
TEM, and protofilament model for our R-type polymorphs. The ultrasharp tip can be
effectively used to explore 3D profile of the R-type Aβ40 fibrils with different number of
protofilaments (blue dashed line), which provides similar dimension from the bottom of
staining reagents (gray shadows) in TEM images. The twofold-symmetric protofilament
model fits to the dimensional and volumetric constrains provided from HR-AFM data. To
the best of our knowledge, this is the first HR-AFM experiment which demonstrates a 3D
approach in quantifying the molecular contents within the R-type Aβ40 fibrils.
The polymorphic characterization of T2 and T3 fibrils becomes more difficult to
model than the R-type fibrils because their topography and phase image cannot provide
the protofilament number in HR-AFM measurements. Moreover, the inconsistency at
peak region of T-type polymorphs (Figure 7-4 D-E) also causes certain confusion while
connecting the HR-AFM results to TEM data. From the dimensional similarity at trough
region, 𝑛 is expected to be 2 and 3 for T2 and T3 polymorphs, respectively. Our volumetric
analysis indicates the 𝜂 values are 4.5± 0.4 for T2 polymorphs and 6.6± 0.5 for T3
polymorphs. Periodic twists may potentially produce steric hindrance and an overestimated volume in HR-AFM measurements that contributes to the half integer number
in 𝜂.
Considering the twisted geometry of two R-type polymorphs, the measured
dimensions of T2 polymorphs doesn’t fit the expected dimension in any orientation,
especially, at peak region, where should be either wR,avg or 2hR,avg. Among other structural
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models proposed for R-type fibrils19,74,214,241, Sachse et. al.240 demonstrated a paired βsheet protofilament model for a twisted Aβ40 fibril with 20 nm width based on EM data
(Figure 7-10C). The width, height, and MPL value are fit to our results, except for the peak
region. In their 3D reconstruction, the peak region within twisted geometry was induced
by the 90º rotate along the central axis (black cross in Figure 7-10C). However, our
measurements did not exhibit the corresponding changes in width and height, as indicated
as “flip” in Figure 7-10D. Based on our 3D profile, we expect two protofilaments entangle
together as the “rotate” labeled in Figure 7-10D. The width difference between HR-AFM
and TEM data can be potentially attributed to the fact of that staining reagents only reflect
the surface contact protofilament, where exhibits a narrow width at crossover. In this
hypothesized geometry, steric hindrance, as indicated by red colored region in Figure 710D, can provide an over-estimated volume for VPL analysis. For T3 polymorphs, the
mosaic geometries and the lack of current existing model causes a great difficulty in
comparison. From the dimensional and volumetric aspects (h, w, 𝜂 ), the underlying
protofilaments within T3 polymorphs seem to be orientated like the case of T2 polymorphs
(Figure 7-10D), however, which still needs further investigation.
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7.6 Conclusions
In summary, both EM and HR-AFM can be successfully used to characterize the
morphological polymorphism within our seeded Aβ40 sample. In HR-AFM measurements,
the use of ultrasharp tip can eliminate the tip-dilation effect and provide the geometrical,
dimensional, and volumetric information for individual fibril, which helps morphological
characterization and polymorphic assignment. Relying on the precise dimensions, the
volumetric information becomes meaningful and indicates the quantity of molecules
within a fibril. Therefore, we propose a volume-per-length (VPL) analysis, which is like
the concept of MPL analysis in EM studies, to quantify the molecules within single
protofilament among different polymorphs. In the confinement of fibril geometry and
peptide quantity, we can bridge the existing structural models and the real 3D topography
of amyloid fibrils. Such high-resolution AFM study provides another route to understand
the building blocks of amyloid fibrils from real 3D structures.
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7.7 Supplementary HR-AFM images

Figure 7-11. HR-AFM images of Aβ40 fibrils in large scanning area. The lateral resolution
in these images is not high enough (5.9 x 5.9 nm/pixel for images with 1 μm length scale
bar or 3.9 x 3.9 nm/pixel for the image with 500 nm length scale bar) for the geometrical
and volumetric analysis presented in the manuscript. As an alternative, the statistical
height analysis method demonstrated in our previous work230 could be used to quantify
the relative amount of each polymorph.
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Figure 7-12. Representative HR-AFM images of R-type Aβ40 fibrils.
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Figure 7-13. Representative HR-AFM images of T-type Aβ40 fibrils.
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CHAPTER 8. Future Work

8.1 Surface Mediated Fibrillization (SMF)
In chapter 2-5, it was shown that the SMF of Aβ12-28 peptides on mica surface can be
characterized using the incubation and drying controls. However, the influence of surface
property and Aβ peptide sequence on SMF remains unclear. In this section, several
experimental results are demonstrated to show the impacts of above factors on the SMF,
which can be further explored in the near future.

8.1.1 SMF of Aβ12-28 peptides on other surfaces
As demonstrated in section 2.4.6 and 4.4.1, surface-mediated fibrils share the same
height feature of one peptide thickness, ~0.5 nm. Technically, an atomically-flat surface
(like mica or HOPG/highly oriented pyrolytic graphite/ substrate) is suitable for AFM
studies due to small height variations on the background. To understand the effects of
surface property, we have designed a series of flat substrates with different surface
hydrophobicity values. Figure 8-1 shows the AFM images of the spun-dried samples after
incubating the 10 μM Aβ12-28 on these designed surfaces for 30 min. Both vapor-deposited
gold film (Figure 8-1A, strongly hydrophobic) and spin-coated polystyrene film (Figure 81B, intermediate hydrophobic) display dewetting patterns, where no fibrillar structures
are left behind those patterns. The hydrophilic PEG film (Figure 8-1C, PEG: polyethylene
glycol) shows a few nanostructures spread on the surface, but not fibrillar structures. Thus,
the SMF of Aβ12-28 seems not to work on the designed substrates with different
hydrophobicity.
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Figure 8-1. Spun-cast samples prepared by incubating 10 μM Aβ12-28 peptide solution on
various solid surfaces.

To form surface-mediated fibrils, the peptide solution was

incubated on a (A) gold film, (B) polystyrene film and (C) polyethylene glycol (PEG) film
for 30 mins, and then removed via the slow spinning procedure illustrated in chapter 2
and chapter 3. Top row images display the initial surface morphologies before performing
the experiments.

Compared to the mica substrate, this set of experiments lacks the complex
electrostatic interactions between molecules and the designed substrates. Shen et. al.143,
Wang et. al.247 and Charbonneau et. al.188 demonstrated that the molecule-substrate
interactions have a subtle effect in modulating the rate of SMF. One could expect that
strong molecule-substrate interactions enables one to accumulate a high surface
concentration from the solution phase, but it lowers the surface mobility of the adsorbents
at the same time. Similar concept can be adopted into our proposed SMF kinetic model in
chapter 4, therefore, the subtle molecule-substrate interactions merit further studies.
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Besides the solid surfaces, the membrane model systems, e.g. vesicle, liposome,
micelle, supported lipid monolayers and tethered supported lipid bilayers, have received
considerable attention due to their physiological relevance to natural cell membranes.16
Figure 8-2 displays the influence of Aβ12-28 peptides incubated on DOPC/DPPC (1:1)
supported lipid bilayers. After 60 mins incubation (Figure 8-2B and Figure 8-2C), the
topography of supported lipid bilayers appears to be influenced by Aβ12-28 peptides. A few
clumps with heights in the range of 5-6 nm can be observed at the edges of the supported
lipid bilayers. Due to the intrinsic disorder of the surface, the Aβ12-28 peptides and their
aggregates are difficult to visual or identify in small area image (Figure 8-2C). Similar
experimental results can be found in the previous studies153,159,162,163,169,175, which suggests
that the lipid bilayers are ruptured by the amyloid aggregates. Such processes can interfere
with the membrane permeability163 and may be the potential cause of the cell dysfunction.
As such, it is worth to further explore the detailed molecular mechanism.

Figure 8-2. Incubation of the Aβ12-28 peptides on DOPC/DPPC (1:1) supported lipid
bilayers. The fluidic contact AFM images of (A) the DOPC/DPPC (1:1) lipid bilayer and
(B, C) the same lipid bilayer after incubating 10 μM Aβ12-28 peptide solution for (B) 60
minutes and (C) 90 minutes. This work is collaborated with Dr. Tobias Baumgart, Chun
Liu and Vinicius Ferreira (Penn, Chemistry).
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8.1.2 SMF of wild-type Aβ40 peptides
Except for the Aβ12-28 fragment, it is fundamentally interesting to understand the
SMF of the wild-type Aβ40 peptides that play a major role in the physiological development
of Alzheimer’s disease.16,26 Figure 8-3 shows the spun-dried samples after incubating the
10 μM Aβ40 peptide solution on mica or silicon wafer with various time. On mica surface,
Aβ40 peptides can rapidly self-assemble into highly crowded, surface-mediated fibrils after
30 min incubation (Figure 8-3A). The high fibrillar coverage indicates that the Aβ40 has a
faster growth rate of SMF compared to Aβ12-28 (Figure 2-3) under the same bulk
concentration and surface type. When silicon wafer is used as substrate (Figure 8-3B), the
surface-mediated fibrils formed by Aβ40 peptides can only be observed in the 60-min
sample. The slow aggregation implies the influence of surface roughness and the moleculesubstrate interactions on the SMF of Aβ40 peptides.144 As shown in chapter 4, one can
utilize the interplays between the bulk concentration and incubation time to investigate
the SMF of Aβ40 peptides and elucidate the influence of Aβ peptide sequence on the SMF.
The membrane-assisted fibrillization of Aβ40 peptides is also examined by
incubating the 5 μM Aβ40 solution on DOPC/DPPC (1:1) supported lipid bilayers. Figure
8-4 shows the time-dependent AFM images taken in fluid. As indicated by green and red
circles, the formation of short fibrils can be found on supported lipid bilayers. However,
due to limits of scan speed and spatial resolution, the AFM only can monitor the immobile
surface species in fluidic environments. If the membrane-assisted fibrils move faster than
the AFM image speed (typically 0.4-0.5 line per second), they are observed only as noise
or single point of structure. Even the technical bottlenecks exist in AFM studies, the
membrane-assisted fibrillization still merits for further investigations because of its close
connection to the physiological events.
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Figure 8-3. SMF of the Aβ40 peptides on mica and silicon wafer. The samples were dried
using the slow spinning method (described in chapter 2) at different incubation time (from
left to right: 0 min, 30 min, and 60 min). The used bulk concentration was 10 μM.

Figure 8-4. Incubation of the Aβ40 peptides on DOPC/DPPC (1:1) supported lipid
bilayers. The time-lapsing AFM images were measured in fluid using the light tapping
mode. The initial bulk concentration was 5 μM. The labeled time is the start time of each
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frame. This work is collaborated with Dr. Tobias Baumgart, Chun Liu and Vinicius
Ferreira (Penn, Chemistry).

8.2 Volumetric Analysis
Among the imaging tools used for biological samples, AFM is the one that can directly
access the 3D topography of an imaged object. In previous chapters, we showed that the
volumetric information can be used to estimate the molecular quantities within the Aβ
aggregates formed at different stages. To provide the generalizability of volumetric
analysis for the other amyloid systems, we investigate the aggregation of α-synuclein
proteins, a major constituent of Lewy bodies in Parkinson’s diseases, in this section.

8.2.1 Effects of TMAO on the Aggregation of α-Synuclein Proteins
α-Synuclein is an intrinsically disordered protein with 140-amino acid residues
(~14.4-kDa), whose aggregated forms are the prominent components within Lewy bodies,
a hallmark of the Parkinson’s disease and Lewy body dementia.17,330,394–397 The kinetics of
α-synuclein fibrillization in solution is suggested to follow a nucleation-dependent
mechanism, where the structural transformation at early stages involves the critical
formation of a partially folded intermediate for later aggregation.17,101,398,399 These early
events strongly depend on the intrinsic protein’s folding energy landscape and their
environment,

such

as

temperature,

pressure,

pH,

ionic

strength,

and

co-

solvents.17,293,397,399–404 Trimethylamine N-oxide (TMAO) is a protecting osmolyte that can
counteract the denaturing effects of urea (another balancing osmolyte) and stabilize the
folded state of proteins, but it inhibits or delays the aggregation of folded proteins.85,405–
413

Under a high TMAO concentration, Ferreon et al. showed that α-synuclein proteins
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become compact based on the single molecular FRET (Förster/fluorescence resonance
energy transfer) measurements.413 However, the effects of TMAO on α-synuclein proteins,
especially their aggregation, are still unclear.
To study the TMAO effects, we treated the low-concentrated α-synuclein solutions,
most in monomeric forms, with different TMAO concentration. These sample solutions
were pre-incubated on mica substrate for 5-minutes to deposit α-synuclein structures
from solution phase, and then dried with a water-rinsing procedure to remove unbounded
structures and buffer solution. We note that the 5-minute incubation cannot activate the
SMF of α-synuclein proteins because of low bulk concentration and their intrinsically
disorder. Figure 8-5 displays the remained surface morphologies and the corresponding
volume distributions. Under the low TMAO concentration (Figure 8-5A and Figure 8-5B),
the imaged structures are tiny and with maximum heights in the range of 0.3-0.5 nm. Both
samples exhibit a similar trend in the volume distribution, which indicates the 2 M TMAO
doesn’t significantly form α-synuclein aggregates. While the TMAO concentration
increases to 4 M, the surface morphologies displayed in Figure 8-5C (average maximum
height ~2.0 nm) become larger than the other samples. The broad volume distribution
clearly reflects the size difference, as well as the influence of 4 M TMAO on the α-synuclein
aggregation. However, based on our data, the ability of these observed α-synuclein
structures underwent further fibrillization is still unknown. This merits further
examinations to elucidate the role of TMAO in the α-synuclein fibrillization.
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Figure 8-5. The trimethylamine N-oxide (TMAO) effects on the aggregation of αsynuclein proteins. Top: AFM images of the dried samples. Bottom: volume histogram of
the alpha-synuclein aggregates. The expected shell volume of an monomer is 17.5 nm 3.392
The α-synuclein concentration is (A) 10 μM, (B) 0.1 μM and (C) 0.5 μM. We note that αsynuclein fibrillization in solution can’t experience in low concentration and static
conditions (no agitation or shacking solution). This work is collaborated with Dr. E. James
Petersson and John J. Ferrie (Penn, Chemistry).
8.2.2 VPL Analysis of Alpha-Synuclein Fibrils
α-synuclein fibrils play a key role in the formation of Lewy bodies that are
associated with the development of Parkinson’s disease or Lewy body dementia. 330,395–
397,414,415

Therefore, it is crucial to understand the detailed structures of α-synuclein fibrils

for the design of therapeutic treatments and diagnostic reagents.416–419 However, due to
the complex fibrillization pathways, α-synuclein fibrils also exhibit polymorphism in most
in-vitro and in-vivo studies.101,229,252,286,289,292,386,398,420–423 In chapter 7, we showed that
AFM can be used to characterize the filamentous number and identify the molecular basis
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within Aβ40 fibrillar polymorphs. The same AFM analysis can be generally applied to
investigate α-synuclein fibrils.
Figure 8-6 shows an AFM image of a μm-long, periodically twisted α-synuclein
fibril formed in BPS buffer solution at pH 7.4. The dimensions of this fibril are measured
as 3.16 μm for length, 121.3±6.4 nm for pitch distance, 9.5±0.4 nm for peak height and
5.2± 0.2 nm for trough height. The periodic height variation and the height difference
indicate there are two filaments entangled together (Figure 8-6B and Figure 8-6C).
Through VPL analysis (Figure 8-6D), the number of cross-β layers (η) formed by αsynuclein proteins is estimated to be near 4.5. The combination of dimensional
information and VPL analysis suggests two-fold cross-β layers are the molecular basis
within individual α-synuclein filament. Our data is consistent with α-synuclein fibril
model predicted by Khurana et. al.386 More importantly, the volumetric analysis provides
a solid support for the contents of cross-β layers within individual filaments. Similar to
Aβ40 fibrils, the AFM analysis can be further used to study other α-synuclein fibrillar
polymorphs in a statistical manner, which can help the understanding of molecular basis
among α-synuclein fibrils.
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Figure 8-6. Volumetric analysis of an α-synuclein fibril. (A) AFM image of an αsynuclein fibril formed in BPS buffer solution at pH 7.4. (B) A proposed fibril geometry
for this α-synuclein fibril. The height variation indicates two filaments entangled together.
(C) The 3D orientation of two entangled filaments in the proposed fibril geometry. (D) 3D
profile of this imaged fibril and its volume-per-length analysis. The inter-strand distance
(d) is measured as 0.48 nm for α-synuclein fibril.424 The estimated η value indicates each
filament contains two cross-β layers. This work is collaborated with Dr. E. James
Petersson and Dr. Yanxin Wang (Penn, Chemistry).
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